data_5vln_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5vln _Structure_validation_residue.Date_analyzed 2017-05-19 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.545 ' HE2' ' OD2' ' A' ' 75' ' ' ASP . 27.1 ttm . . . . . 0 N--CA 1.479 0.991 0 N-CA-C 110.264 -0.272 . . . . 0.0 110.264 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -73.18 109.23 6.56 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 174.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -66.39 -13.06 60.12 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -173.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.3 tt -55.79 -41.07 64.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.572 0.701 . . . . 0.0 109.322 172.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.649 ' HB3' ' CG1' ' A' ' 82' ' ' VAL . 55.2 m-85 -83.37 -27.0 29.96 Favored 'General case' 0 C--O 1.215 -0.75 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.162 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.549 ' O ' ' HG3' ' A' ' 10' ' ' GLU . 8.6 ttpt -65.17 -32.36 74.0 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 174.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.675 ' HA ' ' CG ' ' A' ' 10' ' ' GLU . . . -79.15 -23.76 43.76 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.976 173.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.526 ' O ' ' HG ' ' A' ' 12' ' ' LEU . . . -71.42 -27.34 63.23 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 166.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.467 ' HB ' ' O ' ' A' ' 6' ' ' LYS . 54.3 t -72.5 -29.92 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 121.183 0.516 . . . . 0.0 109.82 167.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.675 ' CG ' ' HA ' ' A' ' 7' ' ' ALA . 45.3 mt-10 -69.81 -27.27 64.75 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 122.195 0.998 . . . . 0.0 108.802 171.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.477 ' HB3' ' O ' ' A' ' 8' ' ' ALA . 6.3 tp-100 -79.94 -34.91 38.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 113.622 -1.626 . . . . 0.0 110.19 178.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 8' ' ' ALA . 51.2 mt -58.82 135.36 57.48 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.85 172.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.576 ' OG1' ' HG3' ' A' ' 16' ' ' GLN . 17.5 p -77.08 166.72 22.91 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -58.54 -35.11 71.8 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 175.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -63.7 -48.28 77.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.736 176.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.576 ' HG3' ' OG1' ' A' ' 13' ' ' THR . 35.2 mt-30 -58.07 -54.08 50.96 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 121.396 0.617 . . . . 0.0 111.176 177.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.495 ' HA ' HD23 ' A' ' 78' ' ' LEU . 55.0 mtpt -55.55 -42.51 74.73 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.363 176.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -58.64 -37.52 76.12 Favored 'General case' 0 CA--C 1.51 -0.596 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.315 177.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -65.7 -37.47 86.52 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-O 121.255 0.55 . . . . 0.0 110.036 -176.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.436 ' HD1' ' CD2' ' A' ' 78' ' ' LEU . 21.4 m-85 -78.56 -23.09 46.32 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.496 176.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.461 ' HD3' ' CD1' ' A' ' 74' ' ' PHE . 22.4 tptp -65.17 -52.79 52.83 Favored 'General case' 0 CA--C 1.499 -1.013 0 CA-C-O 122.031 0.919 . . . . 0.0 109.028 174.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.15 -36.74 31.35 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 113.476 -1.693 . . . . 0.0 110.403 173.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.49 ' O ' ' HB2' ' A' ' 27' ' ' PHE . . . -71.94 -46.54 57.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.381 175.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.709 ' O ' HG22 ' A' ' 28' ' ' VAL . 20.8 t80 -47.87 -49.52 29.35 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 124.091 0.869 . . . . 0.0 109.597 175.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -49.44 -52.5 28.53 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 113.892 -1.504 . . . . 0.0 112.527 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 21.7 mt -77.82 -33.51 18.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.206 -177.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.663 ' HE1' ' SD ' ' A' ' 153' ' ' MET . 0.7 OUTLIER -56.25 -36.7 68.83 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 114.506 -1.225 . . . . 0.0 109.302 177.73 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.709 HG22 ' O ' ' A' ' 24' ' ' PHE . 29.1 m -114.65 23.68 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.634 -178.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.6 mt -64.04 118.19 8.13 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 173.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.97 12.78 67.74 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.442 -0.885 . . . . 0.0 111.936 -175.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -84.64 143.38 29.27 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.583 0.706 . . . . 0.0 111.014 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -78.73 -45.53 20.97 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.134 -178.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -87.25 -17.24 33.03 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.345 -177.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.07 1.89 75.8 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.766 -178.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.428 ' HB2' ' HB ' ' A' ' 71' ' ' THR . 2.5 m -119.74 155.09 33.14 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 173.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.715 ' O ' ' HA ' ' A' ' 71' ' ' THR . 69.9 mt -64.45 107.84 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.049 -171.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 84.4 p -82.73 175.93 9.74 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 169.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.58 ' O ' HD12 ' A' ' 57' ' ' LEU . 12.9 p -69.76 -45.14 68.74 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.303 -178.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -51.76 -40.98 61.25 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.434 0.635 . . . . 0.0 109.807 171.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.17 -42.35 93.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.98 176.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.749 HD21 ' SD ' ' A' ' 60' ' ' MET . 0.5 OUTLIER -71.02 -36.23 72.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.859 0.838 . . . . 0.0 109.711 -179.113 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.48 -21.52 76.14 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 114.705 -1.134 . . . . 0.0 112.014 178.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.598 ' O ' ' HG3' ' A' ' 47' ' ' MET . 8.1 ptmt -55.4 -50.3 70.12 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.462 ' N ' ' CG ' ' A' ' 43' ' ' LYS . 5.6 p -78.01 -28.11 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 CA-C-N 116.793 -0.185 . . . . 0.0 110.944 -174.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.62 ' CB ' ' HG3' ' A' ' 52' ' ' PRO . 9.1 mmt -64.08 -41.83 97.18 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 174.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -59.47 -43.95 93.12 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.977 172.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.598 ' HG3' ' O ' ' A' ' 43' ' ' LYS . 37.0 mtm -66.0 -9.97 35.26 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.541 175.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.481 HD12 ' HG3' ' A' ' 153' ' ' MET . 8.9 mt -108.56 3.15 22.68 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.914 -173.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 95.41 -1.51 64.39 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.994 -0.622 . . . . 0.0 113.015 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -93.02 177.21 6.14 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 120.952 0.406 . . . . 0.0 111.264 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -145.87 66.23 11.59 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-O 121.989 0.9 . . . . 0.0 110.177 165.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.62 ' HG3' ' CB ' ' A' ' 45' ' ' MET . 59.3 Cg_endo -66.9 143.82 68.09 Favored 'Trans proline' 0 C--N 1.327 -0.566 0 C-N-CA 123.379 2.72 . . . . 0.0 113.604 -174.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 22.0 p -82.59 144.08 48.49 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.143 174.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.426 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 13.6 Cg_endo -58.46 -18.94 41.52 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.699 2.266 . . . . 0.0 111.628 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -70.51 -49.23 50.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.932 174.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.586 ' CG ' HG21 ' A' ' 146' ' ' VAL . 0.9 OUTLIER -63.38 -40.28 96.82 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 121.772 0.796 . . . . 0.0 109.833 177.367 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.58 HD12 ' O ' ' A' ' 38' ' ' THR . 52.5 mt -67.05 -36.1 81.32 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.542 178.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.426 ' HB2' ' O ' ' A' ' 54' ' ' PRO . 25.8 tt0 -64.07 -44.34 92.71 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 121.235 -0.186 . . . . 0.0 110.894 -174.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.569 ' O ' ' HG3' ' A' ' 63' ' ' GLU . 12.1 mm-40 -61.97 -44.0 97.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.74 -0.209 . . . . 0.0 110.659 175.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.749 ' SD ' HD21 ' A' ' 41' ' ' LEU . 20.9 ttm -53.33 -49.16 67.65 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 174.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.519 HG13 HG23 ' A' ' 38' ' ' THR . 1.0 OUTLIER -54.99 -56.9 8.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.869 177.372 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -50.01 -40.57 45.03 Favored 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 124.532 1.133 . . . . 0.0 112.154 -176.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.59 ' HB2' ' O ' ' A' ' 60' ' ' MET . 80.4 mt-10 -46.54 -42.17 15.37 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 113.729 -1.578 . . . . 0.0 111.894 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.667 HG22 ' HB2' ' A' ' 80' ' ' MET . 3.4 m -116.46 -14.64 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.591 -173.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -65.96 116.92 7.61 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 170.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -76.9 -18.38 58.34 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -174.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -112.3 -8.43 13.94 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.133 0.492 . . . . 0.0 111.34 -174.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 73.8 19.61 79.74 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.785 -0.722 . . . . 0.0 111.495 -178.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 76.1 p -68.38 -32.44 72.51 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 121.25 0.548 . . . . 0.0 112.329 -172.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 107.77 16.35 13.01 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.429 -178.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.715 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 2.0 p -145.41 132.06 19.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.121 0.486 . . . . 0.0 110.76 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.533 ' HB ' ' HB ' ' A' ' 36' ' ' ILE . 2.7 t -100.05 118.79 47.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.155 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.426 ' HA ' ' CE1' ' A' ' 24' ' ' PHE . 15.6 t70 -98.87 -172.03 2.21 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.461 ' CD1' ' HD3' ' A' ' 21' ' ' LYS . 12.7 t80 -58.14 -54.23 49.34 Favored 'General case' 0 C--O 1.219 -0.546 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -162.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.545 ' OD2' ' HE2' ' A' ' 1' ' ' MET . 34.7 t70 -71.82 -34.12 69.07 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.073 0.463 . . . . 0.0 110.44 -174.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -59.74 -44.64 93.69 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.813 169.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.601 ' CE2' ' HE3' ' A' ' 81' ' ' MET . 60.1 t80 -65.22 -35.67 81.78 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.412 176.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.495 HD23 ' HA ' ' A' ' 17' ' ' LYS . 17.0 mt -63.9 -43.93 94.49 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 122.297 0.239 . . . . 0.0 110.68 176.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.471 ' O ' HG13 ' A' ' 82' ' ' VAL . 5.0 t -64.39 -45.78 94.92 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.608 0 C-N-CA 120.449 -0.501 . . . . 0.0 109.777 174.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.667 ' HB2' HG22 ' A' ' 64' ' ' VAL . 43.4 ttp -61.05 -39.04 88.32 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.144 0.497 . . . . 0.0 111.343 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.601 ' HE3' ' CE2' ' A' ' 77' ' ' PHE . 8.6 mmt -68.43 -51.16 46.82 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.946 174.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.649 ' CG1' ' HB3' ' A' ' 5' ' ' TYR . 0.4 OUTLIER -63.86 -29.49 47.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.114 -177.759 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.501 HH11 HG12 ' A' ' 64' ' ' VAL . 26.9 mtp180 -58.48 -35.55 72.38 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.462 -178.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.4 m -79.4 -17.46 54.33 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.849 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.503 ' HE1' ' CG2' ' A' ' 82' ' ' VAL . 2.7 ptt? -93.88 -9.6 36.7 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.543 -0.463 . . . . 0.0 112.104 -175.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -61.94 -40.79 96.75 Favored 'General case' 0 C--N 1.339 0.136 0 CA-C-O 121.616 0.722 . . . . 0.0 109.976 -178.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -136.55 -159.0 0.91 Allowed 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 172.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -55.92 -58.49 7.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 118.363 0.529 . . . . 0.0 110.365 174.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.7 m -134.19 -7.89 2.64 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.823 175.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.437 ' HE2' ' OH ' ' A' ' 5' ' ' TYR . 16.3 mmmt 68.25 137.31 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.753 -174.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -102.11 -86.97 1.97 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.534 -177.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 43.0 mmtm -100.79 -174.9 2.74 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.641 0.258 . . . . 0.0 111.374 -178.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 9.9 t80 58.98 36.47 24.47 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -167.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.41 ' HG2' ' O ' ' A' ' 140' ' ' ARG . 37.5 tttt -171.32 143.76 1.9 Allowed 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 112.891 -1.959 . . . . 0.0 108.35 -170.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.41 ' O ' ' HG2' ' A' ' 139' ' ' LYS . 23.4 mmm180 -77.45 151.11 80.39 Favored Pre-proline 0 C--N 1.325 -0.5 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 175.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -86.96 -5.32 7.83 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 124.017 3.145 . . . . 0.0 113.079 -168.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 3.9 m 58.21 50.3 10.01 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.682 0.753 . . . . 0.0 109.841 -177.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.7 mm? 64.55 -89.04 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.125 -175.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.43 ' N ' ' HD3' ' A' ' 144' ' ' ARG . 0.0 OUTLIER 174.7 -27.05 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.499 0.72 . . . . 0.0 109.246 178.09 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -72.83 -59.88 2.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.9 -176.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.586 HG21 ' CG ' ' A' ' 56' ' ' GLU . 3.2 m -98.87 155.82 3.85 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.823 0 C-N-CA 120.48 -0.488 . . . . 0.0 112.301 -177.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.53 ' HD2' ' H ' ' A' ' 148' ' ' ILE . 17.7 tpt180 -169.94 133.01 1.15 Allowed 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.03 161.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.728 HG13 ' SD ' ' A' ' 60' ' ' MET . 13.5 mt -65.35 111.65 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 114.838 -1.073 . . . . 0.0 112.197 177.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 48.7 m -82.82 99.78 9.92 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 167.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.606 ' O ' ' HG2' ' A' ' 154' ' ' MET . . . -44.93 -62.64 1.15 Allowed 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.824 0.702 . . . . 0.0 112.812 -168.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -62.2 -43.26 99.24 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.114 -175.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.06 -34.77 79.22 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.609 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.663 ' SD ' ' HE1' ' A' ' 27' ' ' PHE . 34.7 ttp -76.42 -33.13 58.81 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.754 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.606 ' HG2' ' O ' ' A' ' 150' ' ' ALA . 4.8 mmt -53.57 -37.92 63.4 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 173.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -61.85 -44.98 95.74 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.63 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -65.02 -33.35 75.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.421 -0.808 . . . . 0.0 112.568 -173.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.414 ' HG ' ' CG2' ' A' ' 44' ' ' VAL . 9.4 mt -93.72 -63.55 1.19 Allowed 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.831 0.824 . . . . 0.0 112.257 -178.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.512 ' HB3' ' HB3' ' A' ' 161' ' ' ARG . 68.2 mt -63.44 -42.22 98.67 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 113.468 -1.696 . . . . 0.0 112.837 -161.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.433 ' O ' ' HB1' ' A' ' 160' ' ' ALA . . . 54.01 94.37 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.602 -178.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.433 ' HB1' ' O ' ' A' ' 159' ' ' GLY . . . 87.41 -51.7 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.897 0.879 . . . . 0.0 111.356 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.674 ' HD3' ' O ' ' A' ' 161' ' ' ARG . 0.0 OUTLIER -60.06 -25.71 65.58 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.583 -178.057 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.401 ' HB1' ' HB2' ' A' ' 158' ' ' LEU . . . -68.2 -11.3 59.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.477 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.494 ' HD2' ' N ' ' A' ' 163' ' ' LYS . 0.2 OUTLIER -92.81 119.97 32.7 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.063 0.459 . . . . 0.0 110.022 178.045 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 167.11 -47.15 0.25 Allowed Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.251 -178.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 18.9 p-80 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.855 -0.593 . . . . 0.0 110.557 178.214 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.603 ' SD ' ' HG3' ' A' ' 6' ' ' LYS . 24.0 ttm . . . . . 0 N--CA 1.479 1.022 0 CA-C-O 120.859 0.361 . . . . 0.0 111.294 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.447 ' OD2' HG21 ' A' ' 4' ' ' ILE . 1.0 OUTLIER -89.84 143.2 27.0 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 175.746 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.521 ' HA ' ' CB ' ' A' ' 6' ' ' LYS . 4.5 p30 -77.53 -11.53 59.87 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.689 -0.405 . . . . 0.0 112.034 -173.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.447 HG21 ' OD2' ' A' ' 2' ' ' ASP . 2.7 tp -62.13 -44.83 99.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 122.311 1.053 . . . . 0.0 108.864 169.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.552 ' HB2' HG22 ' A' ' 79' ' ' VAL . 25.1 m-85 -81.5 -29.1 33.75 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 114.143 -1.389 . . . . 0.0 109.995 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.72 ' O ' ' HG3' ' A' ' 10' ' ' GLU . 15.6 ttpt -67.3 -31.5 71.84 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.016 176.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.663 ' HA ' ' CG ' ' A' ' 10' ' ' GLU . . . -76.46 -26.44 55.4 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.163 0.506 . . . . 0.0 110.821 176.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.41 -40.99 94.08 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 167.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.671 ' HB ' ' O ' ' A' ' 6' ' ' LYS . 17.8 t -60.02 -29.18 42.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 114.3 -1.318 . . . . 0.0 111.412 171.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.72 ' HG3' ' O ' ' A' ' 6' ' ' LYS . 75.0 mt-10 -69.52 -30.39 68.21 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.635 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -78.1 -36.07 48.53 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 170.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.502 HD13 ' HA ' ' A' ' 9' ' ' VAL . 81.6 mt -56.76 143.89 34.93 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 169.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 61.6 p -104.24 165.46 11.04 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 120.074 -0.65 . . . . 0.0 109.696 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -54.55 -29.09 49.94 Favored 'General case' 0 C--O 1.212 -0.919 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 177.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -69.04 -51.48 38.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.469 175.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -55.78 -57.08 13.53 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.943 0.878 . . . . 0.0 111.37 174.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.404 ' HD2' HG12 ' A' ' 9' ' ' VAL . 57.8 mtpt -53.21 -40.83 64.77 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 114.13 -1.395 . . . . 0.0 111.732 175.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -59.51 -47.45 85.48 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 121.02 0.438 . . . . 0.0 110.657 174.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -58.12 -38.61 76.84 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.754 -179.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.525 ' CD1' ' HG3' ' A' ' 81' ' ' MET . 18.2 m-85 -70.24 -34.44 72.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.51 177.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.604 ' O ' ' HD2' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -70.87 -53.13 16.31 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.572 ' O ' HG13 ' A' ' 26' ' ' ILE . . . -48.3 -45.66 35.15 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.29 -1.323 . . . . 0.0 110.211 175.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.475 ' HB3' HD21 ' A' ' 158' ' ' LEU . . . -70.54 -31.7 68.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.36 178.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.634 ' O ' HG23 ' A' ' 28' ' ' VAL . 55.6 t80 -52.63 -52.86 53.56 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 173.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -48.23 -39.62 21.83 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 113.605 -1.634 . . . . 0.0 111.439 177.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.575 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 1.8 mt -83.04 -35.89 12.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.101 -174.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.672 ' CE2' ' HA ' ' A' ' 41' ' ' LEU . 7.8 t80 -62.04 -29.71 70.47 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 177.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 24' ' ' PHE . 30.8 m -108.73 26.0 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.638 175.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.575 ' HB2' ' O ' ' A' ' 26' ' ' ILE . 0.2 OUTLIER -71.67 116.34 11.92 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -178.471 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.28 9.34 60.55 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.93 -174.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -85.7 148.93 25.64 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.047 0.451 . . . . 0.0 111.28 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -77.1 -45.86 25.5 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.54 -178.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -91.52 -17.91 24.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.879 0.371 . . . . 0.0 111.176 -176.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.96 5.75 85.8 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.745 177.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.535 ' HB2' ' HB ' ' A' ' 71' ' ' THR . 3.9 m -120.11 154.14 35.13 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 176.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.529 ' HB ' ' HB ' ' A' ' 72' ' ' VAL . 54.5 mt -68.97 107.72 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-O 121.119 0.485 . . . . 0.0 111.27 -172.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 96.3 p -90.4 -176.67 4.86 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 171.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.594 ' O ' HD12 ' A' ' 57' ' ' LEU . 47.1 p -69.26 -34.03 74.15 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -61.32 -56.08 24.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.832 176.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.504 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 0.7 OUTLIER -49.22 -44.58 43.51 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.938 174.888 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.672 ' HA ' ' CE2' ' A' ' 27' ' ' PHE . 4.6 tt -74.91 -37.53 62.04 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.371 -0.532 . . . . 0.0 109.709 -175.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -67.77 -35.77 85.98 Favored Glycine 0 C--N 1.333 0.366 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 175.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.504 ' HB3' ' O ' ' A' ' 40' ' ' GLU . 9.3 tttp -46.83 -53.22 12.48 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.498 0.719 . . . . 0.0 110.634 172.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.742 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 77.1 t -72.7 -44.06 60.41 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.7 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.759 -178.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.55 ' HE1' ' HA ' ' A' ' 45' ' ' MET . 31.5 mmt -53.44 -45.29 69.41 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 123.047 0.217 . . . . 0.0 111.306 178.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.537 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 29.2 mtt180 -60.35 -49.61 76.89 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.26 0.552 . . . . 0.0 110.989 176.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.27 -25.89 49.71 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.622 173.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.742 ' HB2' ' O ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -99.98 6.1 45.14 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.104 -169.316 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 107.12 -18.64 36.12 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 120.726 -0.75 . . . . 0.0 114.025 177.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.537 ' O ' ' HA ' ' A' ' 46' ' ' ARG . 1.7 mp0 -86.47 -177.97 6.31 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 117.649 0.724 . . . . 0.0 111.139 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.9 p-10 -156.01 62.12 2.97 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.845 169.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.558 ' HB3' ' CG1' ' A' ' 146' ' ' VAL . 72.9 Cg_endo -69.03 161.84 44.17 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 123.404 2.736 . . . . 0.0 113.855 -174.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.54 156.39 35.27 Favored Pre-proline 0 N--CA 1.441 -0.896 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.652 169.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -44.86 -37.6 12.19 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.885 2.39 . . . . 0.0 112.645 176.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.469 ' O ' ' HG2' ' A' ' 59' ' ' GLU . 1.3 tt0 -54.89 -51.82 64.8 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.636 178.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.452 ' HG3' HG23 ' A' ' 146' ' ' VAL . 7.5 tp10 -67.63 -41.93 83.13 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.689 0.757 . . . . 0.0 110.191 177.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.706 ' O ' HG12 ' A' ' 61' ' ' ILE . 73.6 mt -62.71 -41.39 99.11 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.079 -0.964 . . . . 0.0 112.057 -174.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -67.25 -23.39 65.7 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.759 0.314 . . . . 0.0 110.317 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.59 ' HG3' HH12 ' A' ' 144' ' ' ARG . 9.7 mm-40 -73.07 -37.2 66.89 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.974 0.416 . . . . 0.0 110.274 176.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.489 ' HE3' ' HB ' ' A' ' 148' ' ' ILE . 0.0 OUTLIER -71.9 -37.19 70.15 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 174.253 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.706 HG12 ' O ' ' A' ' 57' ' ' LEU . 51.2 mm -57.69 -54.12 35.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.453 171.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.5 ' HA ' ' HB3' ' A' ' 65' ' ' ASP . 9.3 t70 -60.86 -29.82 69.76 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.074 -176.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -43.44 -49.46 7.17 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-O 122.309 1.052 . . . . 0.0 109.639 175.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.588 HG22 ' SD ' ' A' ' 80' ' ' MET . 0.0 OUTLIER -116.03 -1.9 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.722 0 CA-C-N 113.628 -1.623 . . . . 0.0 111.96 -172.169 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.5 ' HB3' ' HA ' ' A' ' 62' ' ' ASP . 21.6 t0 -88.69 82.59 6.81 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.036 0.446 . . . . 0.0 110.003 175.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -83.16 -26.25 31.08 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.742 -176.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -80.59 -8.53 59.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.224 0.535 . . . . 0.0 110.514 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 74.68 25.61 69.45 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.498 177.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.0 m -78.44 -8.7 58.8 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.948 0.404 . . . . 0.0 111.499 -175.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 72.59 9.96 75.0 Favored Glycine 0 C--N 1.323 -0.166 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.892 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.535 ' HB ' ' HB2' ' A' ' 35' ' ' SER . 0.6 OUTLIER -152.3 133.39 14.26 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.236 0.541 . . . . 0.0 110.136 -177.832 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.552 HG21 HG23 ' A' ' 64' ' ' VAL . 3.6 t -91.63 118.1 36.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.248 -177.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.407 ' HA ' ' CE1' ' A' ' 24' ' ' PHE . 1.9 p30 -94.39 179.04 5.42 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.405 176.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.419 ' CD2' ' HG2' ' A' ' 21' ' ' LYS . 10.9 t80 -53.42 -48.89 68.34 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -171.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.489 ' O ' ' HE2' ' A' ' 1' ' ' MET . 27.4 t70 -68.74 -35.94 77.76 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.732 0.301 . . . . 0.0 110.54 -173.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.418 ' HB3' ' O ' ' A' ' 64' ' ' VAL . 3.8 mm-40 -64.03 -49.99 70.19 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.854 0.835 . . . . 0.0 109.752 172.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.409 ' CD2' ' HE1' ' A' ' 80' ' ' MET . 5.2 t80 -57.62 -33.79 68.61 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 113.931 -1.486 . . . . 0.0 111.394 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.495 ' O ' HG13 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -62.72 -51.37 67.43 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 177.221 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.7 ' O ' ' HG3' ' A' ' 83' ' ' ARG . 1.2 t -53.24 -44.34 52.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.687 169.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.588 ' SD ' HG22 ' A' ' 64' ' ' VAL . 62.1 ttp -56.83 -44.87 82.49 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 122.002 0.906 . . . . 0.0 109.783 -179.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.607 ' O ' ' HG3' ' A' ' 85' ' ' MET . 18.5 mmt -60.85 -40.4 92.71 Favored 'General case' 0 N--CA 1.424 -1.766 0 CA-C-N 113.741 -1.572 . . . . 0.0 112.555 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.67 ' HA ' ' SD ' ' A' ' 85' ' ' MET . 0.8 OUTLIER -77.41 -28.53 16.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.448 178.203 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.7 ' HG3' ' O ' ' A' ' 79' ' ' VAL . 23.8 mtp180 -62.17 -36.36 81.63 Favored 'General case' 0 CA--C 1.522 -0.13 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.7 p -80.35 -6.92 58.77 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.334 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.67 ' SD ' ' HA ' ' A' ' 82' ' ' VAL . 61.4 mtt -76.0 -63.64 1.27 Allowed 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -177.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.58 ' HB3' ' HA ' ' A' ' 90' ' ' LYS . 17.6 tptp -61.2 -67.14 0.43 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.791 0.805 . . . . 0.0 110.857 -174.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.41 ' CG ' ' H ' ' A' ' 88' ' ' ASP . 19.2 t70 -125.11 -164.6 1.3 Allowed 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 -177.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.41 ' H ' ' CG ' ' A' ' 87' ' ' ASP . 9.0 m-20 -66.05 -36.11 82.34 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 173.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.9 p -119.89 3.09 11.06 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.917 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.58 ' HA ' ' HB3' ' A' ' 86' ' ' LYS . 9.7 tmtt? 66.46 -68.59 0.13 Allowed 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -171.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -163.27 84.86 0.11 Allowed Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 176.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.7 175.67 4.07 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -173.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -90.8 -64.02 1.19 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.624 -174.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -142.03 -53.85 0.43 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.909 0.385 . . . . 0.0 110.943 -173.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -68.61 159.5 81.33 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.561 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -72.97 168.48 24.59 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.349 2.033 . . . . 0.0 110.627 176.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 6.2 m -75.92 67.26 2.27 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.085 0.469 . . . . 0.0 110.943 -177.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 19.6 mt 63.86 -171.63 0.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.017 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.59 HH12 ' HG3' ' A' ' 59' ' ' GLU . 0.7 OUTLIER -118.63 -65.09 1.21 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.082 0.468 . . . . 0.0 110.493 -176.673 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -85.46 -56.64 3.42 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.649 -175.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.558 ' CG1' ' HB3' ' A' ' 52' ' ' PRO . 14.6 m -101.64 156.07 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -170.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 19.5 tpt180 -163.99 135.67 4.72 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 114.395 -1.275 . . . . 0.0 110.106 164.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.489 ' HB ' ' HE3' ' A' ' 60' ' ' MET . 13.7 mt -87.22 127.62 40.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.153 178.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.5 ' HB2' ' CB ' ' A' ' 152' ' ' ALA . 31.2 m -93.82 141.15 28.83 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 163.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.597 ' O ' ' HG2' ' A' ' 154' ' ' MET . . . -46.9 -62.96 1.16 Allowed 'General case' 0 N--CA 1.467 0.379 0 O-C-N 123.249 0.343 . . . . 0.0 111.908 -173.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.605 ' HA ' ' HB2' ' A' ' 154' ' ' MET . 3.9 p30 -73.99 -24.56 59.61 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.524 -174.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.5 ' CB ' ' HB2' ' A' ' 149' ' ' SER . . . -58.24 -42.35 86.16 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.899 177.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.466 ' HG2' HD23 ' A' ' 157' ' ' LEU . 1.1 tmt? -80.57 -35.17 34.64 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.179 174.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.605 ' HB2' ' HA ' ' A' ' 151' ' ' ASP . 28.4 mmt -47.86 -56.61 7.1 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.104 177.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.526 ' HG2' ' O ' ' A' ' 151' ' ' ASP . 11.3 pt20 -56.92 -46.17 82.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.469 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.447 ' N ' ' HG3' ' A' ' 155' ' ' GLN . . . -51.62 -44.1 62.79 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.727 -177.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.466 HD23 ' HG2' ' A' ' 153' ' ' MET . 3.9 mm? -91.27 -52.45 4.81 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.485 0.66 . . . . 0.0 111.767 -174.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.498 ' HB2' ' HB3' ' A' ' 162' ' ' ALA . 4.7 mt -85.71 -47.87 9.37 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.021 -0.991 . . . . 0.0 112.966 -170.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 66.32 -97.09 0.3 Allowed Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 111.229 -0.749 . . . . 0.0 111.229 -170.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -67.82 -33.46 74.83 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.536 0.684 . . . . 0.0 111.479 177.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.439 ' HB3' ' HB3' ' A' ' 158' ' ' LEU . 0.2 OUTLIER -84.72 23.47 1.16 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.384 -172.935 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.498 ' HB3' ' HB2' ' A' ' 158' ' ' LEU . . . -126.99 23.06 6.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.381 178.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -155.85 -172.91 4.3 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.948 -176.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 88.0 29.86 19.16 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.629 178.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 56.7 m-70 . . . . . 0 C--O 1.245 0.86 0 CA-C-O 118.369 -0.824 . . . . 0.0 109.475 179.623 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.2 ttt . . . . . 0 N--CA 1.48 1.063 0 CA-C-O 120.75 0.31 . . . . 0.0 110.548 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.419 ' HB2' ' CD1' ' A' ' 5' ' ' TYR . 9.9 m-20 -69.53 115.19 8.49 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 176.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -76.84 -12.56 59.99 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -173.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.3 tp -57.89 -40.99 78.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 122.195 0.998 . . . . 0.0 108.649 167.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.528 ' CZ ' ' HG2' ' A' ' 83' ' ' ARG . 22.9 m-85 -82.82 -34.22 26.99 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.934 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.715 ' O ' ' HG3' ' A' ' 10' ' ' GLU . 14.1 ttpt -66.39 -30.85 71.32 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.36 176.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.691 ' HA ' ' CG ' ' A' ' 10' ' ' GLU . . . -77.64 -27.25 51.01 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.058 0.456 . . . . 0.0 111.046 176.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.442 ' O ' ' HG ' ' A' ' 12' ' ' LEU . . . -63.15 -41.0 99.2 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 167.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.61 ' HB ' ' O ' ' A' ' 6' ' ' LYS . 16.8 t -61.5 -33.11 55.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.246 171.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.715 ' HG3' ' O ' ' A' ' 6' ' ' LYS . 71.5 mt-10 -65.1 -27.22 68.61 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.035 178.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -85.61 -36.27 20.48 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.831 172.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.532 HD23 ' HE2' ' A' ' 85' ' ' MET . 73.4 mt -56.78 141.51 44.06 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-O 121.78 0.8 . . . . 0.0 109.644 172.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.429 HG21 ' OE1' ' A' ' 16' ' ' GLN . 3.3 p -100.61 164.95 11.65 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.511 -176.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -57.4 -25.9 60.27 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.343 -0.543 . . . . 0.0 109.954 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -73.09 -51.67 17.14 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.475 173.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.526 ' OE1' ' HA ' ' A' ' 12' ' ' LEU . 38.4 mt-30 -54.31 -58.0 9.08 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-O 121.727 0.775 . . . . 0.0 111.054 174.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -50.79 -45.5 59.26 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.581 -1.19 . . . . 0.0 111.969 174.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -60.12 -43.38 95.68 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 120.951 0.405 . . . . 0.0 110.691 175.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -57.77 -40.24 79.34 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.025 -177.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.436 ' CD2' ' HG3' ' A' ' 81' ' ' MET . 40.8 m-85 -70.57 -38.57 74.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.901 176.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.698 ' O ' ' HB3' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -62.7 -51.54 66.78 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 122.121 0.962 . . . . 0.0 109.579 178.846 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.626 ' O ' HG13 ' A' ' 26' ' ' ILE . . . -50.52 -49.54 55.44 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.06 -1.427 . . . . 0.0 110.643 177.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.512 ' HB3' HD22 ' A' ' 158' ' ' LEU . . . -67.32 -33.37 75.12 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.172 177.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.698 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 40.2 t80 -48.98 -55.51 11.68 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 172.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.513 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 23.9 t70 -51.68 -36.77 47.75 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 113.705 -1.589 . . . . 0.0 111.914 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.626 HG13 ' O ' ' A' ' 22' ' ' ALA . 2.8 mt -80.38 -41.19 20.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.93 -175.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.565 ' CE2' ' HA ' ' A' ' 41' ' ' LEU . 2.8 t80 -56.72 -30.86 63.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.324 177.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.541 HG22 ' O ' ' A' ' 24' ' ' PHE . 27.0 m -107.71 16.41 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.96 -176.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 25' ' ' ASP . 33.8 mt -72.78 121.2 19.51 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 173.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.46 5.71 58.92 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.268 -171.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.45 149.44 21.7 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.338 0.589 . . . . 0.0 110.692 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -78.98 -45.61 19.94 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.219 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -94.66 -18.33 21.43 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.088 0.471 . . . . 0.0 111.302 -175.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.4 3.28 84.51 Favored Glycine 0 C--O 1.225 -0.436 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.043 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.474 ' HB2' ' HB ' ' A' ' 71' ' ' THR . 5.1 m -111.57 148.01 34.19 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 174.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.554 ' O ' ' HA ' ' A' ' 71' ' ' THR . 53.0 mt -68.15 107.17 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 C-N-CA 121.313 -0.155 . . . . 0.0 111.059 -175.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 82.0 p -90.88 -175.43 4.35 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 170.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.543 ' O ' HD11 ' A' ' 57' ' ' LEU . 55.5 p -64.15 -36.24 83.41 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 120.992 0.425 . . . . 0.0 110.132 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -59.46 -56.11 26.15 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.094 177.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -48.98 -49.62 39.74 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 114.647 -1.16 . . . . 0.0 112.489 175.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.565 ' HA ' ' CE2' ' A' ' 27' ' ' PHE . 2.3 tt -71.07 -34.39 71.13 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 120.42 -0.512 . . . . 0.0 109.993 -174.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.889 ' O ' ' HG3' ' A' ' 46' ' ' ARG . . . -64.23 -46.93 89.53 Favored Glycine 0 C--O 1.218 -0.872 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 173.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 35.0 tttt -46.31 -47.79 18.33 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.328 0.651 . . . . 0.0 111.138 -178.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.514 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 92.1 t -74.44 -38.65 47.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.151 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.543 ' HG3' ' HG3' ' A' ' 52' ' ' PRO . 34.2 mmt -55.03 -49.72 70.85 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 174.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.889 ' HG3' ' O ' ' A' ' 42' ' ' GLY . 41.1 mtt180 -50.16 -59.41 3.95 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.682 0.753 . . . . 0.0 110.286 174.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 4.9 ttp -52.27 -23.87 6.43 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.074 -1.421 . . . . 0.0 112.534 174.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.55 HD23 ' O ' ' A' ' 152' ' ' ALA . 5.2 mt -97.68 0.29 46.85 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -175.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 105.92 -2.59 38.49 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.8 -0.714 . . . . 0.0 113.089 177.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.651 ' HB3' ' HD3' ' A' ' 52' ' ' PRO . 1.2 mp0 -99.77 -179.6 4.23 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 120.747 0.308 . . . . 0.0 111.037 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -159.36 58.23 1.17 Allowed Pre-proline 0 CA--C 1.536 0.426 0 CA-C-O 121.544 0.687 . . . . 0.0 111.223 166.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.651 ' HD3' ' HB3' ' A' ' 50' ' ' GLN . 43.7 Cg_endo -63.41 157.72 49.0 Favored 'Trans proline' 0 N--CA 1.476 0.499 0 C-N-CA 123.964 3.109 . . . . 0.0 113.473 -177.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.99 156.48 57.81 Favored Pre-proline 0 CA--C 1.504 -0.816 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.376 175.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -46.29 -35.5 15.69 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 122.641 2.227 . . . . 0.0 113.048 174.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -63.23 -51.11 67.57 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.581 177.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.559 ' O ' HG22 ' A' ' 146' ' ' VAL . 7.5 tt0 -65.01 -32.48 74.23 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.662 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.666 ' O ' HG12 ' A' ' 61' ' ' ILE . 65.7 mt -76.12 -37.72 57.74 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.811 178.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.53 -36.21 75.69 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-O 120.563 0.22 . . . . 0.0 110.792 -178.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.461 ' HG3' ' CD1' ' A' ' 143' ' ' LEU . 7.6 pt-20 -77.88 -27.31 49.65 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.578 -177.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.459 ' SD ' ' HG ' ' A' ' 143' ' ' LEU . 10.5 tpt -71.68 -39.98 69.87 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 169.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.666 HG12 ' O ' ' A' ' 57' ' ' LEU . 47.6 mm -58.55 -54.13 37.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.275 172.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -62.63 -30.22 71.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.331 -172.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.59 ' OE2' HG23 ' A' ' 142' ' ' THR . 2.6 tt0 -56.03 -37.6 69.43 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 121.875 0.845 . . . . 0.0 109.329 177.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.758 ' CG1' ' HB2' ' A' ' 80' ' ' MET . 0.1 OUTLIER -100.3 -33.36 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.722 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.702 -173.067 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -58.28 111.71 1.3 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.297 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -70.48 -31.85 69.14 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.146 -177.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -107.35 -6.33 17.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.807 -173.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 75.16 26.06 67.24 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.654 175.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.7 m -75.29 -26.77 58.99 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.219 0.533 . . . . 0.0 111.621 -175.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 104.97 20.04 10.23 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -176.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.554 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 0.8 OUTLIER -149.89 131.48 14.87 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.345 0.593 . . . . 0.0 111.147 -178.63 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.485 HG23 ' HB ' ' A' ' 64' ' ' VAL . 18.0 t -101.36 113.05 36.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.777 178.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.536 ' HA ' ' CE2' ' A' ' 24' ' ' PHE . 3.2 t70 -99.62 174.18 6.36 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.403 ' O ' ' HB3' ' A' ' 77' ' ' PHE . 17.7 t80 -42.94 -55.64 3.65 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -167.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -62.13 -41.14 97.95 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 118.15 0.432 . . . . 0.0 110.766 -176.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.426 ' O ' HG13 ' A' ' 64' ' ' VAL . 1.6 mp0 -56.99 -56.32 23.26 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.593 0.711 . . . . 0.0 109.287 169.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.535 ' O ' ' HG2' ' A' ' 81' ' ' MET . 20.7 t80 -47.73 -35.62 10.08 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.21 -1.359 . . . . 0.0 111.445 -176.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.439 ' HG ' HG23 ' A' ' 9' ' ' VAL . 3.0 tp -75.36 -42.82 53.28 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.239 -177.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.795 ' O ' ' HG3' ' A' ' 83' ' ' ARG . 1.0 OUTLIER -55.5 -44.96 78.19 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.523 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 167.052 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.758 ' HB2' ' CG1' ' A' ' 64' ' ' VAL . 55.2 ttp -59.2 -44.02 92.24 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.134 0.492 . . . . 0.0 110.785 177.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.618 ' O ' ' HB2' ' A' ' 85' ' ' MET . 24.5 mmt -57.87 -55.1 39.25 Favored 'General case' 0 N--CA 1.426 -1.669 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.078 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.552 ' HA ' ' HE3' ' A' ' 85' ' ' MET . 18.8 m -63.0 -29.16 46.55 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.635 0 C-N-CA 120.729 -0.388 . . . . 0.0 111.026 176.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.795 ' HG3' ' O ' ' A' ' 79' ' ' VAL . 57.9 mtt-85 -58.77 -42.39 88.81 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.951 0.405 . . . . 0.0 110.55 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.486 ' HG ' ' HA ' ' A' ' 149' ' ' SER . 29.1 t -79.4 -44.21 21.89 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.533 0.682 . . . . 0.0 109.759 174.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.618 ' HB2' ' O ' ' A' ' 81' ' ' MET . 0.2 OUTLIER -50.36 -40.52 49.66 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 124.563 1.145 . . . . 0.0 113.998 177.869 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.505 ' HA ' ' HE2' ' A' ' 86' ' ' LYS . 3.5 mmpt? -54.31 -61.47 2.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.918 0.389 . . . . 0.0 111.716 -176.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -174.12 151.25 1.66 Allowed 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -175.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -69.55 -15.78 63.3 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.92 0.39 . . . . 0.0 110.417 -178.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 56.3 m -100.71 -9.78 21.49 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.323 174.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 22.1 tptp -57.63 -41.56 81.6 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 176.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.657 ' C ' HG22 ' A' ' 142' ' ' THR . . . -151.55 115.1 0.68 Allowed Glycine 0 N--CA 1.435 -1.41 0 CA-C-N 114.616 -1.175 . . . . 0.0 110.889 174.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.456 ' O ' ' HB ' ' A' ' 142' ' ' THR . 4.6 tptm -152.94 -80.2 0.1 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.765 0.317 . . . . 0.0 110.281 177.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -104.01 -43.22 5.34 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.51 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 99.6 mttt -68.05 148.75 50.56 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 172.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.51 ' HB2' ' O ' ' A' ' 139' ' ' LYS . 0.2 OUTLIER 68.77 162.21 0.14 Allowed Pre-proline 0 C--O 1.234 0.259 0 O-C-N 124.02 0.825 . . . . 0.0 110.229 -168.903 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -64.75 57.15 0.26 Allowed 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 123.996 3.13 . . . . 0.0 111.463 171.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.657 HG22 ' C ' ' A' ' 136' ' ' GLY . 1.4 m -98.1 -159.4 0.74 Allowed 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.78 -175.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.618 ' H ' HG21 ' A' ' 142' ' ' THR . 3.2 mm? -125.0 122.25 36.77 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -160.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 22.0 tpt180 -90.72 127.73 36.42 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 167.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.483 ' CZ ' ' HG3' ' A' ' 50' ' ' GLN . 0.0 OUTLIER 76.14 -51.35 0.61 Allowed 'General case' 0 N--CA 1.471 0.6 0 O-C-N 123.775 0.672 . . . . 0.0 111.714 178.312 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 56' ' ' GLU . 0.9 OUTLIER -87.98 27.24 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.662 0 CA-C-O 121.049 0.452 . . . . 0.0 111.716 -178.022 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 32.7 tpt180 -88.09 95.54 10.19 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 120.214 -0.594 . . . . 0.0 109.412 177.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.453 ' H ' ' HE1' ' A' ' 60' ' ' MET . 32.2 mt -54.32 116.43 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.322 -0.853 . . . . 0.0 111.129 176.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.495 ' HB2' ' CB ' ' A' ' 152' ' ' ALA . 21.2 m -80.89 134.61 35.77 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 167.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.653 ' O ' ' HG2' ' A' ' 154' ' ' MET . . . -44.63 -63.48 0.89 Allowed 'General case' 0 N--CA 1.465 0.284 0 O-C-N 123.805 0.69 . . . . 0.0 112.297 -173.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.551 ' HA ' ' HB2' ' A' ' 154' ' ' MET . 5.5 m-20 -75.34 -22.71 57.4 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.318 -175.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.55 ' O ' HD23 ' A' ' 48' ' ' LEU . . . -59.09 -46.14 89.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.791 0.329 . . . . 0.0 111.169 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.417 ' HA ' HD12 ' A' ' 48' ' ' LEU . 7.7 ptm -79.74 -26.42 40.77 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 119.916 -0.714 . . . . 0.0 110.175 176.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.653 ' HG2' ' O ' ' A' ' 150' ' ' ALA . 27.8 mmt -51.66 -56.97 10.6 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.224 177.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.542 ' HG3' ' N ' ' A' ' 156' ' ' ALA . 10.6 pt20 -58.91 -48.45 81.43 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.791 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.542 ' N ' ' HG3' ' A' ' 155' ' ' GLN . . . -53.31 -42.37 66.6 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.025 -0.989 . . . . 0.0 112.44 -176.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.491 ' HB3' ' HB ' ' A' ' 26' ' ' ILE . 3.3 mm? -91.51 -44.03 9.33 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.951 0.405 . . . . 0.0 111.805 -177.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.512 HD22 ' HB3' ' A' ' 23' ' ' ALA . 16.3 mt -85.56 -48.08 9.27 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.127 -171.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 67.05 3.28 22.41 Favored Glycine 0 CA--C 1.508 -0.353 0 CA-C-N 115.686 -0.688 . . . . 0.0 113.98 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.55 ' C ' ' H ' ' A' ' 162' ' ' ALA . . . 177.81 -48.06 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.687 0.756 . . . . 0.0 110.613 -169.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.478 ' HB3' HD21 ' A' ' 158' ' ' LEU . 0.0 OUTLIER -75.34 32.16 0.1 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.707 179.081 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.55 ' H ' ' C ' ' A' ' 160' ' ' ALA . . . -114.08 -8.78 13.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.12 171.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.45 ' HD3' ' N ' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -129.05 -48.84 1.21 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.961 -1.018 . . . . 0.0 108.707 179.063 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 143.54 -106.18 0.41 Allowed Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.503 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 45.7 m80 . . . . . 0 C--O 1.246 0.904 0 CA-C-O 118.554 -0.736 . . . . 0.0 109.733 176.977 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.1 ttt . . . . . 0 N--CA 1.477 0.877 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.441 ' HB2' ' CD2' ' A' ' 5' ' ' TYR . 11.0 m-20 -65.08 118.72 9.58 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -75.48 -10.59 59.58 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -171.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.2 tt -59.27 -38.47 74.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 122.0 0.905 . . . . 0.0 108.775 169.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.505 ' CZ ' ' HG2' ' A' ' 83' ' ' ARG . 18.1 m-85 -83.06 -30.38 28.07 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.57 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.8 tttt -70.01 -33.5 72.1 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.094 177.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.2 -34.73 78.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.995 0.426 . . . . 0.0 110.321 176.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.514 ' O ' ' HG ' ' A' ' 12' ' ' LEU . . . -62.05 -46.95 86.87 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.163 171.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.488 ' HA ' ' HB2' ' A' ' 12' ' ' LEU . 1.5 t -54.42 -37.88 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.683 172.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -69.5 -27.79 65.5 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.014 -0.994 . . . . 0.0 112.097 -178.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -85.59 -29.71 23.9 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.529 170.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 8' ' ' ALA . 22.6 mt -59.86 135.75 57.79 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.129 172.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.427 ' H ' ' HB2' ' A' ' 16' ' ' GLN . 31.6 p -98.89 165.51 11.73 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.566 -176.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -55.63 -28.7 56.74 Favored 'General case' 0 C--O 1.212 -0.875 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 179.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -70.67 -48.72 53.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.649 176.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.444 ' HB3' HD22 ' A' ' 12' ' ' LEU . 69.9 mm-40 -57.83 -57.9 10.74 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.816 0.817 . . . . 0.0 111.355 174.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.411 ' HG3' ' HB3' ' A' ' 12' ' ' LEU . 58.4 mtpt -54.71 -44.07 73.14 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 113.971 -1.468 . . . . 0.0 111.577 178.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -59.39 -45.44 91.48 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.755 174.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -56.96 -41.3 78.06 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.539 -177.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.432 ' CD1' ' HG3' ' A' ' 81' ' ' MET . 32.2 m-85 -68.55 -36.92 79.46 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.112 176.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.65 ' O ' ' HB3' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -65.37 -51.14 62.49 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 122.037 0.922 . . . . 0.0 108.865 179.602 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.749 ' O ' HG13 ' A' ' 26' ' ' ILE . . . -48.73 -49.04 40.03 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.127 -1.397 . . . . 0.0 110.351 175.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.463 ' HB3' HD21 ' A' ' 158' ' ' LEU . . . -67.85 -33.67 75.2 Favored 'General case' 0 CA--C 1.518 -0.265 0 O-C-N 123.054 0.221 . . . . 0.0 110.959 178.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.65 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 64.8 t80 -51.29 -56.17 14.41 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 171.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.449 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 35.7 t70 -49.53 -43.48 45.77 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 113.835 -1.529 . . . . 0.0 111.921 178.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.749 HG13 ' O ' ' A' ' 22' ' ' ALA . 4.5 mt -72.06 -43.97 66.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.68 0.753 . . . . 0.0 109.922 -177.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.653 ' CE2' ' HA ' ' A' ' 41' ' ' LEU . 3.7 t80 -58.6 -29.66 66.63 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.286 -1.325 . . . . 0.0 109.628 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.549 HG21 ' O ' ' A' ' 24' ' ' PHE . 30.2 m -109.7 18.66 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.119 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.456 ' HG ' ' HA ' ' A' ' 26' ' ' ILE . 18.3 mt -67.53 117.24 9.22 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 119.808 -0.757 . . . . 0.0 109.46 177.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.21 11.97 53.05 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.814 -174.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -85.78 151.76 23.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.23 0.538 . . . . 0.0 111.052 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -77.95 -45.66 23.33 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.486 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -95.24 -17.55 21.61 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.109 -176.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.54 -2.04 86.05 Favored Glycine 0 C--O 1.221 -0.665 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.065 -176.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.8 m -105.81 157.04 17.74 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 176.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 71' ' ' THR . 66.1 mt -72.74 107.69 3.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.954 -175.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 62.7 p -90.62 -175.97 4.58 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 170.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.527 ' O ' HD12 ' A' ' 57' ' ' LEU . 62.8 p -66.69 -38.82 87.54 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 120.655 -0.418 . . . . 0.0 109.938 178.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 58.6 tttp -58.31 -51.35 70.17 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.42 176.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.698 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 0.6 OUTLIER -51.96 -43.87 63.72 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.782 175.511 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.653 ' HA ' ' CE2' ' A' ' 27' ' ' PHE . 4.5 tt -75.26 -33.5 61.29 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.9 -175.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.787 ' O ' ' HG3' ' A' ' 46' ' ' ARG . . . -66.27 -33.61 85.58 Favored Glycine 0 C--O 1.222 -0.602 0 C-N-CA 120.324 -0.941 . . . . 0.0 111.182 173.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.698 ' HB3' ' O ' ' A' ' 40' ' ' GLU . 0.6 OUTLIER -45.92 -47.84 16.3 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.598 0.713 . . . . 0.0 109.949 175.412 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.616 HG22 ' CD1' ' A' ' 27' ' ' PHE . 98.3 t -80.14 -42.08 21.5 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.922 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.51 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.455 ' HE3' ' HA ' ' A' ' 45' ' ' MET . 4.9 mmt -59.64 -51.48 69.63 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 117.826 0.285 . . . . 0.0 111.043 -177.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.787 ' HG3' ' O ' ' A' ' 42' ' ' GLY . 76.3 mtt180 -50.97 -56.64 11.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.406 0.622 . . . . 0.0 110.346 172.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.405 ' CE ' ' HA ' ' A' ' 44' ' ' VAL . 6.1 ttp -51.35 -29.7 16.17 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.778 -1.101 . . . . 0.0 112.82 173.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.608 ' HB2' ' O ' ' A' ' 44' ' ' VAL . 4.3 mt -92.57 -2.27 56.29 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 123.152 0.581 . . . . 0.0 112.085 -172.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 103.01 -9.51 54.95 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.339 177.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.566 ' HB3' ' HD3' ' A' ' 52' ' ' PRO . 10.8 mp0 -84.64 175.54 9.16 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 175.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -158.31 63.54 2.63 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-O 122.035 0.922 . . . . 0.0 109.708 172.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.566 ' HD3' ' HB3' ' A' ' 50' ' ' GLN . 48.9 Cg_endo -68.89 161.93 43.61 Favored 'Trans proline' 0 CA--C 1.512 -0.623 0 C-N-CA 123.673 2.915 . . . . 0.0 113.087 -178.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.9 p -87.87 161.49 44.15 Favored Pre-proline 0 CA--C 1.499 -0.989 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.905 166.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -47.78 -26.38 6.92 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 122.846 2.364 . . . . 0.0 112.576 169.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -65.65 -53.8 36.33 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.813 177.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -65.25 -41.4 94.36 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.586 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.693 ' O ' HG12 ' A' ' 61' ' ' ILE . 98.5 mt -59.34 -45.6 90.92 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.091 175.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -65.38 -29.84 70.59 Favored 'General case' 0 C--O 1.216 -0.671 0 C-N-CA 121.077 -0.249 . . . . 0.0 110.485 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -68.52 -39.97 81.0 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.829 0.347 . . . . 0.0 111.037 176.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.572 ' HE3' ' HB ' ' A' ' 148' ' ' ILE . 0.0 OUTLIER -71.15 -37.39 72.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.945 175.727 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.693 HG12 ' O ' ' A' ' 57' ' ' LEU . 47.4 mm -59.12 -49.92 81.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.636 0.732 . . . . 0.0 109.149 171.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.401 ' HA ' ' HB3' ' A' ' 65' ' ' ASP . 15.6 t70 -65.15 -25.34 67.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.873 -174.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.435 ' HB2' ' O ' ' A' ' 60' ' ' MET . 2.6 mm-40 -49.43 -33.16 13.36 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-O 121.712 0.768 . . . . 0.0 110.102 173.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.632 ' CG1' HG13 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -130.5 -14.46 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.568 0 CA-C-N 114.318 -1.31 . . . . 0.0 113.431 -167.768 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.411 ' OD1' ' HA2' ' A' ' 68' ' ' GLY . 25.3 t70 -63.21 92.03 0.05 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.079 0.466 . . . . 0.0 111.301 176.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -91.18 -35.74 14.36 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.405 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -78.88 -8.74 59.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.169 0.509 . . . . 0.0 110.783 -176.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.411 ' HA2' ' OD1' ' A' ' 65' ' ' ASP . . . 74.27 18.17 79.78 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.947 -0.57 . . . . 0.0 113.07 174.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 57.5 m -90.87 6.86 42.77 Favored 'General case' 0 C--N 1.321 -0.64 0 O-C-N 122.585 -0.362 . . . . 0.0 111.661 -176.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 71.31 19.81 77.76 Favored Glycine 0 CA--C 1.507 -0.464 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.216 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 0.8 OUTLIER -146.6 139.67 25.51 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 114.802 -0.699 . . . . 0.0 110.496 -175.89 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.579 HG23 HG22 ' A' ' 64' ' ' VAL . 6.7 t -96.52 121.66 47.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.458 176.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -96.69 179.27 5.04 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 177.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.403 ' CZ ' HD21 ' A' ' 78' ' ' LEU . 12.0 t80 -53.1 -54.33 37.19 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -170.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -67.44 -34.05 76.41 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.636 -172.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.591 ' O ' HG13 ' A' ' 64' ' ' VAL . 82.0 mt-10 -62.34 -54.14 44.89 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-O 121.6 0.714 . . . . 0.0 109.749 171.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.468 ' O ' ' HG2' ' A' ' 81' ' ' MET . 4.1 t80 -55.55 -30.59 61.05 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.577 178.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.504 ' O ' HG12 ' A' ' 82' ' ' VAL . 0.9 OUTLIER -69.78 -47.78 61.63 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 178.116 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.796 ' O ' ' HG3' ' A' ' 83' ' ' ARG . 0.5 OUTLIER -54.52 -43.48 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 168.768 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.578 ' SD ' HG21 ' A' ' 64' ' ' VAL . 64.0 ttp -56.24 -47.65 78.06 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.459 0.647 . . . . 0.0 110.122 177.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.628 ' O ' ' HG3' ' A' ' 85' ' ' MET . 23.7 mmt -60.42 -37.49 81.05 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 114.785 -1.098 . . . . 0.0 112.158 -177.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.566 ' HA ' ' SD ' ' A' ' 85' ' ' MET . 1.3 m -79.95 -28.87 12.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 119.934 -0.706 . . . . 0.0 110.319 176.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.796 ' HG3' ' O ' ' A' ' 79' ' ' VAL . 54.6 mtp85 -62.33 -34.56 76.87 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 177.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.463 ' HB3' ' O ' ' A' ' 148' ' ' ILE . 3.9 p -80.15 -16.98 53.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.054 -0.976 . . . . 0.0 112.394 177.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.628 ' HG3' ' O ' ' A' ' 81' ' ' MET . 57.0 mtt -69.37 -46.19 67.55 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 121.319 0.581 . . . . 0.0 111.366 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.42 ' HB2' ' HG2' ' A' ' 90' ' ' LYS . 64.9 mmtt -60.0 -37.99 81.31 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.051 -0.977 . . . . 0.0 112.11 -175.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.429 ' OD2' ' HD3' ' A' ' 137' ' ' LYS . 21.1 t70 -178.97 165.15 1.53 Allowed 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -178.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -47.91 -43.95 29.34 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 123.372 0.42 . . . . 0.0 109.897 175.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.4 ' HG ' ' HB3' ' A' ' 137' ' ' LYS . 0.1 OUTLIER -123.17 23.94 9.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.853 -179.062 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.42 ' HG2' ' HB2' ' A' ' 86' ' ' LYS . 0.4 OUTLIER 52.12 -95.03 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.226 0.61 . . . . 0.0 110.367 -179.396 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -94.8 61.03 1.69 Allowed Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 178.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.429 ' HD3' ' OD2' ' A' ' 87' ' ' ASP . 49.9 pttt -56.99 139.37 52.33 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.607 -0.297 . . . . 0.0 110.884 -178.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 61.3 t80 76.91 -24.18 0.23 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.658 -177.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -95.72 -30.12 13.91 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.28 0.562 . . . . 0.0 110.682 178.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.422 ' NE ' ' HA ' ' A' ' 140' ' ' ARG . 2.4 mmp_? -121.31 155.15 59.04 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-O 121.342 0.592 . . . . 0.0 110.342 177.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -80.62 53.36 4.73 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 123.585 2.857 . . . . 0.0 111.169 174.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.08 60.05 2.33 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.389 -175.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.568 ' HB3' ' O ' ' A' ' 145' ' ' ARG . 6.4 mp 70.14 138.99 0.04 OUTLIER 'General case' 0 C--N 1.334 -0.094 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.753 169.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 20.7 ptp180 -88.76 -4.89 58.4 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.443 173.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.568 ' O ' ' HB3' ' A' ' 143' ' ' LEU . 0.1 OUTLIER -160.09 170.69 20.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.485 -179.707 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.478 ' O ' ' HG2' ' A' ' 60' ' ' MET . 28.1 m 44.82 37.94 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 N-CA-C 114.684 1.365 . . . . 0.0 114.684 173.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.518 ' NH2' ' HB3' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -84.36 94.14 8.41 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 169.872 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.572 ' HB ' ' HE3' ' A' ' 60' ' ' MET . 35.3 mt -51.37 132.51 12.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.414 -176.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 74.2 m -92.89 144.57 25.14 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 165.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.562 ' O ' ' HG2' ' A' ' 154' ' ' MET . . . -50.12 -62.73 1.41 Allowed 'General case' 0 C--N 1.33 -0.28 0 O-C-N 123.306 0.379 . . . . 0.0 111.653 -172.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.596 ' HA ' ' HB2' ' A' ' 154' ' ' MET . 4.2 p-10 -72.76 -24.87 61.01 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.706 -174.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.433 ' O ' HD21 ' A' ' 48' ' ' LEU . . . -55.09 -48.37 73.64 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.757 176.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.567 ' O ' HD22 ' A' ' 157' ' ' LEU . 3.7 ppp? -80.85 -28.1 36.22 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.591 177.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.596 ' HB2' ' HA ' ' A' ' 151' ' ' ASP . 26.9 mmt -50.76 -55.95 14.34 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.002 0.429 . . . . 0.0 110.777 177.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.506 ' HG2' ' O ' ' A' ' 151' ' ' ASP . 7.0 pt20 -58.38 -50.88 72.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.113 -176.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.408 ' H ' ' HG3' ' A' ' 155' ' ' GLN . . . -55.19 -40.97 71.33 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.098 -0.956 . . . . 0.0 112.298 -175.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.567 HD22 ' O ' ' A' ' 153' ' ' MET . 3.8 mm? -86.02 -53.08 5.3 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.403 0.62 . . . . 0.0 111.434 -177.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.514 HD23 ' HG2' ' A' ' 161' ' ' ARG . 57.4 mt -79.17 -47.59 15.75 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.003 -0.999 . . . . 0.0 112.573 -169.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.409 ' O ' ' HE3' ' A' ' 163' ' ' LYS . . . 68.5 -107.16 1.97 Allowed Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.3 -172.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.411 ' O ' ' HG2' ' A' ' 163' ' ' LYS . . . -61.06 -43.38 98.97 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.558 0.694 . . . . 0.0 111.559 177.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.514 ' HG2' HD23 ' A' ' 158' ' ' LEU . 1.8 tpm_? -62.88 -20.81 65.49 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.023 -0.99 . . . . 0.0 111.674 -177.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.489 ' HB3' ' HB2' ' A' ' 158' ' ' LEU . . . -71.21 -45.25 63.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.236 0.541 . . . . 0.0 110.685 178.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 160' ' ' ALA . 9.8 ptpt -85.73 -31.3 22.51 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.137 -175.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 79.79 -47.94 3.4 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.791 177.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 54.3 m80 . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.703 -0.665 . . . . 0.0 110.454 -178.418 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.6 ttt . . . . . 0 N--CA 1.478 0.941 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -69.84 116.05 9.78 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 178.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.444 ' HA ' ' CB ' ' A' ' 6' ' ' LYS . 5.0 p-10 -76.38 -12.61 60.09 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.98 -172.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 7.1 tt -59.36 -40.56 81.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 121.686 0.755 . . . . 0.0 109.439 169.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.532 ' CZ ' ' HG2' ' A' ' 83' ' ' ARG . 23.1 m-85 -82.39 -32.44 29.17 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.246 177.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.724 ' O ' ' HG3' ' A' ' 10' ' ' GLU . 18.4 ttpt -66.95 -34.52 77.94 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.593 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.723 ' HA ' ' CG ' ' A' ' 10' ' ' GLU . . . -75.45 -25.84 57.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.862 0.363 . . . . 0.0 111.226 176.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.443 ' O ' ' HG ' ' A' ' 12' ' ' LEU . . . -65.03 -39.94 94.11 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 167.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.652 ' HB ' ' O ' ' A' ' 6' ' ' LYS . 13.5 t -61.53 -36.39 72.97 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.363 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.826 170.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.724 ' HG3' ' O ' ' A' ' 6' ' ' LYS . 50.8 mt-10 -61.58 -35.18 77.09 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.515 178.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -72.66 -38.04 67.75 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.187 170.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 8' ' ' ALA . 76.0 mt -59.09 137.66 57.86 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-O 121.893 0.854 . . . . 0.0 109.279 173.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 52.0 p -96.42 160.56 14.34 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.217 -177.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -54.55 -24.03 19.16 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 177.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -69.54 -56.51 7.15 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.624 171.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -53.63 -57.05 12.18 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.869 0.842 . . . . 0.0 111.53 176.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -52.04 -43.92 63.99 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 114.21 -1.359 . . . . 0.0 111.92 174.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -58.61 -42.53 88.36 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-O 121.32 0.581 . . . . 0.0 110.341 176.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -57.94 -38.95 76.88 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 114.572 -1.194 . . . . 0.0 109.66 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.487 ' CD1' ' HG3' ' A' ' 81' ' ' MET . 26.4 m-85 -72.29 -32.32 66.51 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.119 178.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.674 ' O ' ' HB3' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -71.44 -50.29 33.21 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 122.056 0.932 . . . . 0.0 109.459 -179.403 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.745 ' O ' HG13 ' A' ' 26' ' ' ILE . . . -53.42 -47.51 69.53 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.177 -1.374 . . . . 0.0 110.23 175.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.483 ' HA ' HD13 ' A' ' 26' ' ' ILE . . . -71.29 -25.54 62.48 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.181 178.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.674 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 44.5 t80 -54.0 -54.72 35.15 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 169.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.438 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 23.3 t70 -53.42 -37.82 62.9 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 113.53 -1.668 . . . . 0.0 111.51 178.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.745 HG13 ' O ' ' A' ' 22' ' ' ALA . 8.1 mt -76.97 -41.58 31.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.774 -176.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.5 ' CZ ' ' HB ' ' A' ' 44' ' ' VAL . 0.5 OUTLIER -61.82 -21.93 65.04 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.515 179.016 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 24' ' ' PHE . 27.6 m -114.72 19.66 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.01 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.521 ' HG ' ' HA ' ' A' ' 26' ' ' ILE . 22.9 mt -70.17 117.99 12.43 Favored 'General case' 0 C--O 1.236 0.389 0 O-C-N 121.543 -0.723 . . . . 0.0 109.771 175.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.17 12.57 57.35 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.503 -173.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -90.41 158.16 17.23 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.256 0.55 . . . . 0.0 111.495 -179.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -80.1 -46.81 15.82 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.264 -178.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -91.76 -17.34 25.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.166 0.508 . . . . 0.0 111.188 -176.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.8 9.34 87.16 Favored Glycine 0 N--CA 1.449 -0.5 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -171.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.3 m -119.63 145.98 45.96 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 177.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.448 ' HB ' ' HB ' ' A' ' 72' ' ' VAL . 66.3 mt -68.93 106.84 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.674 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.314 -174.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.457 ' O ' HD13 ' A' ' 61' ' ' ILE . 88.9 p -87.31 -168.45 2.24 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 170.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.525 ' O ' HD13 ' A' ' 57' ' ' LEU . 72.0 p -69.62 -42.85 73.81 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 122.127 -0.358 . . . . 0.0 110.548 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -59.1 -49.19 78.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.573 177.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.676 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 0.9 OUTLIER -54.86 -50.64 68.18 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.131 -0.94 . . . . 0.0 112.975 172.84 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.563 HD13 HD21 ' A' ' 57' ' ' LEU . 0.8 OUTLIER -51.53 -58.14 7.12 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 175.886 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.802 ' O ' ' HG3' ' A' ' 46' ' ' ARG . . . -60.45 -31.73 75.27 Favored Glycine 0 C--O 1.219 -0.832 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.1 -178.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.676 ' HB3' ' O ' ' A' ' 40' ' ' GLU . 23.6 tttp -45.89 -50.42 14.48 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 123.282 0.633 . . . . 0.0 110.865 -176.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.5 ' HB ' ' CZ ' ' A' ' 27' ' ' PHE . 92.5 t -78.36 -41.52 25.98 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.977 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.773 178.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 37.9 mmm -54.59 -45.53 73.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 118.316 0.507 . . . . 0.0 109.914 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.802 ' HG3' ' O ' ' A' ' 42' ' ' GLY . 37.5 mtp180 -50.87 -57.56 8.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.426 0.632 . . . . 0.0 111.079 171.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.428 ' HE1' HG22 ' A' ' 44' ' ' VAL . 1.8 ttp -53.33 -34.39 57.3 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.35 174.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.507 ' HB3' ' OE1' ' A' ' 50' ' ' GLN . 6.5 mt -79.42 -5.02 53.75 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 124.061 0.944 . . . . 0.0 112.555 -174.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 107.19 -18.6 35.97 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.116 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.6 ' O ' ' HA ' ' A' ' 46' ' ' ARG . 26.6 mp0 -83.91 177.56 8.25 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 122.346 0.258 . . . . 0.0 110.371 177.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -160.38 59.92 1.3 Allowed Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.5 0.667 . . . . 0.0 111.732 169.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.549 ' HD3' ' HB3' ' A' ' 50' ' ' GLN . 40.0 Cg_endo -67.82 156.12 67.18 Favored 'Trans proline' 0 CA--C 1.519 -0.242 0 C-N-CA 123.578 2.852 . . . . 0.0 113.666 -176.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.577 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 1.0 OUTLIER -84.9 161.04 54.22 Favored Pre-proline 0 C--N 1.318 -0.803 0 CA-C-N 114.631 -1.168 . . . . 0.0 112.059 -177.948 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -41.24 -39.08 3.72 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 123.365 2.71 . . . . 0.0 112.906 170.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.478 ' O ' ' HG3' ' A' ' 59' ' ' GLU . 26.8 tt0 -58.42 -52.61 64.89 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.29 176.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -64.65 -35.97 82.75 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-O 121.992 0.901 . . . . 0.0 111.519 -178.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.667 ' O ' HG12 ' A' ' 61' ' ' ILE . 85.0 mt -76.02 -43.61 43.29 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 114.381 -1.281 . . . . 0.0 111.117 -175.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -65.65 -25.41 67.34 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 177.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.647 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 29.3 mt-10 -66.27 -54.02 29.88 Favored 'General case' 0 C--O 1.214 -0.779 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.548 172.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.561 ' HE2' ' NH1' ' A' ' 147' ' ' ARG . 8.9 tpt -60.14 -32.51 71.09 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.728 0.299 . . . . 0.0 110.581 176.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.667 HG12 ' O ' ' A' ' 57' ' ' LEU . 17.1 mm -62.64 -57.62 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 171.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -60.78 -30.11 69.84 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.965 -176.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.647 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 7.1 mm-40 -44.89 -38.74 4.84 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.125 -1.398 . . . . 0.0 111.275 177.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.697 HG11 ' CA ' ' A' ' 80' ' ' MET . 5.1 m -132.31 -15.84 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.428 -172.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -61.09 110.11 1.28 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 172.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -70.48 -21.8 62.74 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -173.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -115.58 -7.62 12.18 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.476 -0.489 . . . . 0.0 111.941 -173.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 77.25 25.27 64.1 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.537 -0.84 . . . . 0.0 111.53 -176.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 36.8 m -62.13 -40.7 96.8 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 122.953 0.501 . . . . 0.0 112.282 -175.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 109.35 11.28 22.17 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 -174.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 0.5 OUTLIER -149.18 131.72 15.78 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 121.28 0.562 . . . . 0.0 110.742 179.737 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.568 ' CG2' HG23 ' A' ' 64' ' ' VAL . 2.9 t -99.1 126.76 52.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.619 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.43 ' HA ' ' CZ ' ' A' ' 24' ' ' PHE . 0.7 OUTLIER -101.48 178.87 4.52 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 176.235 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -47.79 -51.35 22.82 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -170.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -66.92 -41.75 86.52 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.183 0.516 . . . . 0.0 110.816 -172.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -60.92 -47.41 86.53 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.268 174.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.579 ' O ' ' HG2' ' A' ' 81' ' ' MET . 15.4 t80 -57.45 -35.5 70.21 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.806 177.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.455 ' HG ' HG23 ' A' ' 9' ' ' VAL . 2.6 tp -72.62 -43.63 63.04 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.143 -178.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.809 ' O ' ' HG3' ' A' ' 83' ' ' ARG . 1.0 OUTLIER -59.06 -41.42 83.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 169.741 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.697 ' CA ' HG11 ' A' ' 64' ' ' VAL . 60.8 ttp -57.15 -46.03 83.08 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.521 178.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.623 ' O ' ' HG3' ' A' ' 85' ' ' MET . 24.9 mmt -55.18 -52.34 63.63 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 114.295 -1.32 . . . . 0.0 111.571 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.631 ' HA ' ' SD ' ' A' ' 85' ' ' MET . 2.5 m -69.48 -33.26 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.924 -176.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.809 ' HG3' ' O ' ' A' ' 79' ' ' VAL . 27.3 mtp-105 -58.22 -40.98 83.07 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.99 0.9 . . . . 0.0 108.695 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.709 ' HB3' ' O ' ' A' ' 148' ' ' ILE . 4.8 m -80.19 -8.48 59.46 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 113.79 -1.55 . . . . 0.0 111.658 -177.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.631 ' SD ' ' HA ' ' A' ' 82' ' ' VAL . 62.0 mtt -78.63 -45.34 21.77 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.653 ' HB3' ' HA ' ' A' ' 90' ' ' LYS . 35.3 tptt -58.11 -56.45 21.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.848 -169.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -172.69 170.42 4.73 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -170.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -48.65 -49.49 37.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.929 0.395 . . . . 0.0 110.348 175.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.5 t -100.8 8.06 43.43 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.97 -177.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.653 ' HA ' ' HB3' ' A' ' 86' ' ' LYS . 8.1 tmtt? 62.35 -77.92 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.016 0.526 . . . . 0.0 109.6 -174.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -162.93 21.96 0.18 Allowed Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 177.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -97.37 -166.29 1.37 Allowed 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.301 0.572 . . . . 0.0 110.757 -177.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.431 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 9.1 t80 -138.69 -176.83 4.61 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.023 -0.989 . . . . 0.0 108.426 177.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 138' ' ' PHE . 94.8 mttt 76.08 -65.25 0.32 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.222 0.609 . . . . 0.0 111.693 176.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 9.1 mtm180 -130.9 160.77 65.13 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-O 121.565 0.698 . . . . 0.0 110.009 176.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -87.22 55.88 3.07 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 124.24 3.294 . . . . 0.0 111.714 -178.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 1.4 m 53.22 74.57 0.29 Allowed 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.578 -176.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.446 ' HG ' HH21 ' A' ' 147' ' ' ARG . 25.4 mt 80.82 171.46 0.14 Allowed 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.283 -171.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -82.88 -66.42 0.89 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.127 0.489 . . . . 0.0 110.951 -177.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.456 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 0.1 OUTLIER -100.19 -39.38 8.09 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.568 -178.845 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -83.42 76.98 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.948 -164.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.561 ' NH1' ' HE2' ' A' ' 60' ' ' MET . 5.6 tpp180 -124.34 105.12 9.2 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.354 171.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.709 ' O ' ' HB3' ' A' ' 84' ' ' SER . 11.1 mt -71.99 131.53 34.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.624 -178.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.51 ' HB2' ' HB3' ' A' ' 152' ' ' ALA . 20.4 m -82.56 134.21 35.19 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 167.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.638 ' O ' ' HG2' ' A' ' 154' ' ' MET . . . -46.53 -63.37 1.03 Allowed 'General case' 0 N--CA 1.468 0.426 0 O-C-N 123.345 0.403 . . . . 0.0 112.011 -172.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.581 ' HA ' ' HB2' ' A' ' 154' ' ' MET . 4.3 p-10 -71.88 -24.16 61.62 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.647 -175.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.567 ' HA ' HE21 ' A' ' 155' ' ' GLN . . . -55.35 -45.26 76.45 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.277 177.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.513 ' O ' HD22 ' A' ' 157' ' ' LEU . 7.9 ptm -79.83 -31.98 40.61 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.155 175.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.638 ' HG2' ' O ' ' A' ' 150' ' ' ALA . 32.3 mmt -50.15 -50.35 49.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.028 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.567 HE21 ' HA ' ' A' ' 152' ' ' ALA . 13.1 pt20 -59.98 -56.23 24.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.877 0.37 . . . . 0.0 111.932 -178.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.532 ' H ' ' HG3' ' A' ' 155' ' ' GLN . . . -54.57 -40.88 69.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.14 -175.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.513 HD22 ' O ' ' A' ' 153' ' ' MET . 3.4 mm? -80.49 -60.84 2.17 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.39 0.614 . . . . 0.0 111.008 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.426 ' HB3' ' HB3' ' A' ' 161' ' ' ARG . 64.4 mt -65.81 -35.72 81.48 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.908 -1.042 . . . . 0.0 112.252 -169.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 76.14 -64.77 2.73 Favored Glycine 0 CA--C 1.499 -0.952 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.513 -176.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -148.15 45.66 1.07 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.333 0.587 . . . . 0.0 111.135 -175.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.719 ' HD3' ' O ' ' A' ' 161' ' ' ARG . 0.0 OUTLIER -133.13 -7.19 3.03 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.656 178.718 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -81.25 47.72 1.06 Allowed 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -172.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.53 164.69 2.57 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.731 0.3 . . . . 0.0 110.3 -178.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -101.63 37.99 3.38 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 175.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 49.4 p-80 . . . . . 0 C--O 1.246 0.894 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.233 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.7 ttt . . . . . 0 N--CA 1.477 0.885 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -65.14 110.58 2.58 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 175.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.457 ' HA ' ' CB ' ' A' ' 6' ' ' LYS . 4.2 p-10 -70.7 -6.95 41.07 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -172.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.48 HD13 ' NZ ' ' A' ' 90' ' ' LYS . 3.0 tt -61.36 -43.21 96.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 169.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.626 ' CE2' ' HG2' ' A' ' 83' ' ' ARG . 23.3 m-85 -80.63 -32.01 36.38 Favored 'General case' 0 N--CA 1.428 -1.57 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.694 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.634 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 19.3 ttpt -63.78 -35.95 82.3 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.648 172.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.74 -35.29 79.77 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.228 0.537 . . . . 0.0 110.22 176.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.516 ' O ' ' HG ' ' A' ' 12' ' ' LEU . . . -61.14 -39.74 91.22 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.562 171.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 5' ' ' TYR . 98.0 t -66.59 -35.61 75.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.291 175.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.634 ' HG2' ' O ' ' A' ' 6' ' ' LYS . 7.9 mm-40 -64.54 -27.38 68.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.421 178.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -82.77 -38.77 22.74 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.64 170.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.549 HD21 ' HB3' ' A' ' 16' ' ' GLN . 32.9 mt -52.3 134.38 33.84 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-O 121.448 0.642 . . . . 0.0 109.853 177.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.497 ' OG1' ' HG3' ' A' ' 16' ' ' GLN . 6.7 p -82.3 164.71 20.94 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -55.12 -44.5 75.06 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 177.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -53.37 -49.62 66.79 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.046 174.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.549 ' HB3' HD21 ' A' ' 12' ' ' LEU . 37.6 mt-30 -58.24 -54.3 48.49 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.029 0.442 . . . . 0.0 111.755 178.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -55.55 -45.17 77.28 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.444 175.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -59.86 -41.33 91.23 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.713 176.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.405 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 6.2 tt0 -59.95 -44.17 94.57 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.23 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.401 ' HB3' ' HG3' ' A' ' 81' ' ' MET . 23.5 m-85 -73.08 -25.54 60.93 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.46 176.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.507 ' O ' ' HB3' ' A' ' 24' ' ' PHE . 0.6 OUTLIER -69.82 -46.51 65.51 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 176.161 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.581 ' O ' HG13 ' A' ' 26' ' ' ILE . . . -51.82 -43.47 63.13 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 113.632 -1.622 . . . . 0.0 110.103 171.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.656 ' O ' ' HB2' ' A' ' 27' ' ' PHE . . . -64.58 -43.42 93.91 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.536 177.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.507 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 35.5 t80 -51.12 -52.25 45.63 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.707 0.765 . . . . 0.0 109.466 171.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -51.99 -55.57 19.65 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 113.98 -1.464 . . . . 0.0 112.168 -177.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.626 ' HA ' ' HG ' ' A' ' 29' ' ' LEU . 21.3 mt -67.77 -38.0 79.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.17 -178.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.656 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 0.3 OUTLIER -54.43 -32.01 56.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.988 177.568 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 24' ' ' PHE . 22.2 m -112.4 24.47 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.028 -177.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.626 ' HG ' ' HA ' ' A' ' 26' ' ' ILE . 91.0 mt -76.48 117.01 17.7 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 170.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.16 13.29 54.81 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.29 -0.957 . . . . 0.0 111.454 -169.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -86.6 144.54 27.13 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.626 0.727 . . . . 0.0 111.428 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -80.46 -39.84 27.35 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.319 -1.309 . . . . 0.0 111.129 -178.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -105.3 -16.46 14.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.676 -177.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.7 -3.2 83.17 Favored Glycine 0 C--O 1.222 -0.599 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.576 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.8 m -111.91 150.56 30.3 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 174.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.616 ' O ' ' HA ' ' A' ' 71' ' ' THR . 57.1 mt -68.42 107.44 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.015 -175.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 96.9 p -89.05 -174.34 4.41 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 169.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 32.0 p -76.49 -25.37 54.18 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.2 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 30.6 tttm -59.1 -57.13 14.43 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 169.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.426 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 2.1 mp0 -52.59 -52.73 53.88 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.244 -0.889 . . . . 0.0 113.06 173.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.532 HD11 HD13 ' A' ' 148' ' ' ILE . 16.8 tp -61.0 -55.31 34.41 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.889 -177.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.401 ' HA2' ' HB2' ' A' ' 45' ' ' MET . . . -61.09 -33.86 85.74 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.36 178.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.426 ' HB3' ' O ' ' A' ' 40' ' ' GLU . 6.3 tttp -52.14 -40.88 62.0 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.256 0.551 . . . . 0.0 110.124 169.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.538 HG23 ' CD2' ' A' ' 27' ' ' PHE . 33.9 t -76.0 -43.59 38.62 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.546 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.272 178.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.53 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 13.1 mmt -56.07 -34.53 66.03 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.473 178.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 65.6 mtp180 -62.28 -47.92 82.2 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.833 0.825 . . . . 0.0 110.098 172.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.469 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 2.5 mtm -61.58 -16.7 50.45 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 114.164 -1.38 . . . . 0.0 111.204 174.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.547 HD21 ' HA ' ' A' ' 153' ' ' MET . 17.9 mt -99.08 -8.2 25.62 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.901 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 106.0 -13.02 45.31 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 121.026 -0.606 . . . . 0.0 113.348 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.46 ' HB3' ' HD3' ' A' ' 52' ' ' PRO . 1.7 mp0 -99.62 -174.37 2.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.018 0.437 . . . . 0.0 110.506 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 29.1 p-10 -159.01 60.94 1.75 Allowed Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.057 167.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.668 ' CB ' ' HB ' ' A' ' 146' ' ' VAL . 43.7 Cg_endo -66.78 165.53 25.42 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.064 2.509 . . . . 0.0 112.066 -178.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.671 ' OG1' ' HG3' ' A' ' 56' ' ' GLU . 38.1 p -90.6 157.6 43.97 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.525 -172.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -50.21 -29.82 23.96 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.084 1.856 . . . . 0.0 111.223 173.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -59.3 -55.05 39.77 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.206 173.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.671 ' HG3' ' OG1' ' A' ' 53' ' ' THR . 40.5 mt-10 -59.34 -49.0 79.5 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.749 176.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.587 ' CD2' ' HG2' ' A' ' 52' ' ' PRO . 80.7 mt -67.89 -29.06 68.07 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 114.606 -1.179 . . . . 0.0 112.776 -171.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.418 ' O ' ' HB2' ' A' ' 62' ' ' ASP . 36.9 tt0 -75.24 -27.17 59.39 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.061 -0.655 . . . . 0.0 110.064 -172.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.82 -36.55 28.21 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.036 -178.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.538 ' HE2' ' HB ' ' A' ' 148' ' ' ILE . 2.1 ttt -66.91 -37.02 83.57 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.846 175.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.491 HG22 HG21 ' A' ' 72' ' ' VAL . 5.5 mt -65.28 -50.36 73.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.351 169.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.604 ' HA ' ' HB3' ' A' ' 65' ' ' ASP . 12.9 t70 -56.6 -32.96 65.76 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.783 -177.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.559 ' OE2' ' HG2' ' A' ' 137' ' ' LYS . 4.1 mt-10 -44.85 -48.63 11.08 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.453 178.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.618 HG11 ' CA ' ' A' ' 80' ' ' MET . 28.6 m -110.6 -15.31 9.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.987 -176.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.604 ' HB3' ' HA ' ' A' ' 62' ' ' ASP . 61.7 t0 -64.76 107.61 1.49 Allowed 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 173.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -64.82 -38.36 90.73 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.793 -175.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -94.34 -7.94 40.34 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -175.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.42 24.0 77.0 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.357 -0.925 . . . . 0.0 111.74 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 65.0 p -73.49 -7.6 52.47 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -171.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.51 16.77 67.82 Favored Glycine 0 C--N 1.311 -0.826 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -175.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.616 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 0.7 OUTLIER -146.22 131.17 18.18 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.996 0.903 . . . . 0.0 111.594 179.567 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.491 HG21 HG22 ' A' ' 61' ' ' ILE . 1.0 OUTLIER -104.39 119.03 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 CA-C-N 114.301 -1.318 . . . . 0.0 109.588 -179.05 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.507 ' CG ' ' H ' ' A' ' 74' ' ' PHE . 18.9 t70 -98.57 -169.08 1.74 Allowed 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 177.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.507 ' H ' ' CG ' ' A' ' 73' ' ' ASP . 8.8 t80 -55.52 -57.46 11.81 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -167.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -65.41 -43.37 90.78 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.768 -172.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.471 ' O ' ' HB ' ' A' ' 64' ' ' VAL . 2.5 mp0 -50.74 -55.17 17.93 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.481 0.657 . . . . 0.0 111.34 169.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.414 ' HZ ' ' SD ' ' A' ' 153' ' ' MET . 89.7 t80 -58.96 -43.28 91.26 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.104 -178.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.5 tp -60.62 -41.01 93.96 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.403 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.574 ' O ' ' HG3' ' A' ' 83' ' ' ARG . 46.9 t -54.21 -50.55 54.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 170.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.618 ' CA ' HG11 ' A' ' 64' ' ' VAL . 45.2 ttp -58.15 -38.06 75.85 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.56 -178.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.453 ' HA ' ' HE3' ' A' ' 81' ' ' MET . 23.9 mmt -61.4 -44.11 97.71 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 115.173 -0.922 . . . . 0.0 112.184 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.682 ' HA ' ' HB2' ' A' ' 85' ' ' MET . 1.7 m -69.34 -28.98 40.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 121.048 0.451 . . . . 0.0 110.487 178.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.626 ' HG2' ' CE2' ' A' ' 5' ' ' TYR . 21.3 mtp180 -67.31 -40.64 86.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.978 -178.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.4 m -80.8 -12.44 59.44 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.898 174.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.682 ' HB2' ' HA ' ' A' ' 82' ' ' VAL . 1.0 OUTLIER -75.62 -63.38 1.31 Allowed 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 123.768 0.827 . . . . 0.0 112.273 -179.763 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.2 tptm -59.99 -37.55 80.0 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.286 0.565 . . . . 0.0 110.64 -173.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -153.65 167.88 28.08 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -175.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -64.91 -21.92 66.9 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.104 178.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.519 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 51.9 m -131.42 -36.02 1.29 Allowed 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.48 ' NZ ' HD13 ' A' ' 4' ' ' ILE . 0.4 OUTLIER 69.93 -77.42 0.05 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.046 0.539 . . . . 0.0 110.321 -176.316 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -151.54 46.23 0.61 Allowed Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 178.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.559 ' HG2' ' OE2' ' A' ' 63' ' ' GLU . 56.8 mttm -90.31 -105.96 0.09 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.542 -0.329 . . . . 0.0 110.856 -178.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.545 ' O ' ' HG2' ' A' ' 141' ' ' PRO . 16.2 t80 56.12 -161.49 0.19 Allowed 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -177.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.43 ' HB3' ' H ' ' A' ' 140' ' ' ARG . 55.7 mtmt 58.22 -160.83 0.25 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 174.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.651 ' N ' ' HD2' ' A' ' 141' ' ' PRO . 92.2 mtt180 -55.87 -50.14 88.88 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 114.742 -1.117 . . . . 0.0 112.804 173.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.651 ' HD2' ' N ' ' A' ' 140' ' ' ARG . 1.7 Cg_endo -39.08 -63.2 0.28 Allowed 'Trans proline' 0 C--N 1.362 1.285 0 C-N-CA 124.068 3.179 . . . . 0.0 114.384 -177.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.525 ' OG1' ' HD3' ' A' ' 137' ' ' LYS . 97.5 m -100.92 117.39 34.88 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.475 0.655 . . . . 0.0 110.183 177.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.716 ' HB2' ' CG1' ' A' ' 146' ' ' VAL . 5.9 mp -92.05 176.06 6.64 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.381 -172.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 145' ' ' ARG . 89.0 mtm180 -88.77 57.76 4.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.836 -168.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.532 ' NE ' ' HA ' ' A' ' 52' ' ' PRO . 4.3 tmm_? 171.78 -58.57 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.791 0.805 . . . . 0.0 109.556 175.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.716 ' CG1' ' HB2' ' A' ' 143' ' ' LEU . 1.3 p -57.79 108.83 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 114.158 -1.383 . . . . 0.0 110.515 172.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.452 ' HA ' ' HD3' ' A' ' 147' ' ' ARG . 4.0 tpp180 -144.89 131.59 20.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.312 0.577 . . . . 0.0 112.39 -175.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.538 ' HB ' ' HE2' ' A' ' 60' ' ' MET . 4.2 mt -113.07 111.41 35.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.284 174.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 73.4 m -99.24 136.78 38.69 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 171.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.593 ' O ' ' HG2' ' A' ' 154' ' ' MET . . . -54.94 -58.31 8.14 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 118.295 0.498 . . . . 0.0 110.649 -173.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.495 ' O ' ' HG2' ' A' ' 155' ' ' GLN . 3.8 m-20 -52.46 -49.26 65.0 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 123.993 0.808 . . . . 0.0 110.587 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.13 -48.7 80.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.32 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.713 ' HE3' ' O ' ' A' ' 153' ' ' MET . 0.0 OUTLIER -58.08 -47.19 83.95 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.946 -179.804 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.602 ' O ' ' HB2' ' A' ' 158' ' ' LEU . 22.6 mmt -56.78 -31.73 64.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.054 0.454 . . . . 0.0 111.235 178.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' A' ' 151' ' ' ASP . 14.7 mm100 -77.2 -45.14 27.56 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.258 -0.428 . . . . 0.0 112.086 -177.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.469 ' HB3' ' HB3' ' A' ' 47' ' ' MET . . . -65.53 -47.55 75.54 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.947 -175.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.585 HD11 ' C ' ' A' ' 26' ' ' ILE . 3.1 mm? -86.28 -64.4 1.16 Allowed 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.193 0.521 . . . . 0.0 111.488 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.602 ' HB2' ' O ' ' A' ' 154' ' ' MET . 97.3 mt -62.24 -48.25 80.79 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.998 -167.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 34.54 -90.74 0.01 OUTLIER Glycine 0 C--N 1.343 0.956 0 O-C-N 124.857 1.348 . . . . 0.0 114.023 175.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -46.02 -46.47 16.57 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.914 0.886 . . . . 0.0 112.146 176.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 161' ' ' ARG . 0.0 OUTLIER -94.96 -6.75 41.72 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.575 -174.751 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.486 ' HB2' ' HB2' ' A' ' 158' ' ' LEU . . . -76.04 -78.89 0.11 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.294 -176.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 49.06 45.6 22.87 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.437 0.637 . . . . 0.0 109.846 -174.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -74.38 172.92 51.79 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.225 -0.898 . . . . 0.0 113.19 -172.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 86.3 t60 . . . . . 0 C--O 1.247 0.934 0 CA-C-O 118.515 -0.755 . . . . 0.0 110.33 -178.27 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.437 ' O ' ' HB2' ' A' ' 2' ' ' ASP . 19.1 ttt . . . . . 0 N--CA 1.481 1.077 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.522 ' HB3' HG23 ' A' ' 4' ' ' ILE . 7.1 m-20 72.52 106.91 0.07 Allowed 'General case' 0 C--O 1.237 0.435 0 O-C-N 123.72 0.637 . . . . 0.0 110.005 -170.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.437 ' HA ' ' HB3' ' A' ' 6' ' ' LYS . 5.0 p-10 -69.74 -5.41 24.98 Favored 'General case' 0 C--O 1.224 -0.284 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -175.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.522 HG23 ' HB3' ' A' ' 2' ' ' ASP . 3.5 tt -57.77 -44.66 86.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 170.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.648 ' CE2' ' HG2' ' A' ' 83' ' ' ARG . 27.1 m-85 -82.0 -33.12 30.25 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.513 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.604 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 26.1 ttpt -64.45 -39.29 93.53 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.584 176.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.27 -29.65 70.94 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.27 0.557 . . . . 0.0 110.053 176.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.542 ' O ' ' HG ' ' A' ' 12' ' ' LEU . . . -66.97 -39.6 87.24 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.413 172.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.486 ' HA ' ' HB2' ' A' ' 12' ' ' LEU . 52.7 t -67.03 -32.29 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 121.232 0.539 . . . . 0.0 110.312 174.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.604 ' HG2' ' O ' ' A' ' 6' ' ' LYS . 8.7 mm-40 -67.94 -27.74 66.88 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.517 177.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -85.1 -37.52 20.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.116 171.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 8' ' ' ALA . 49.5 mt -53.7 135.01 41.73 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 172.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.523 HG21 HE21 ' A' ' 16' ' ' GLN . 16.4 p -86.24 157.0 20.05 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 -178.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -52.95 -37.46 61.08 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 118.97 0.805 . . . . 0.0 108.928 177.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -53.7 -57.26 11.46 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.979 170.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.523 HE21 HG21 ' A' ' 13' ' ' THR . 35.4 mt-30 -52.8 -52.58 56.24 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 121.381 0.61 . . . . 0.0 111.708 176.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 34.2 mtpt -56.38 -39.46 72.98 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 123.898 0.879 . . . . 0.0 112.283 176.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -69.04 -32.88 72.69 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 121.343 0.592 . . . . 0.0 109.817 177.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.472 ' HB3' ' O ' ' A' ' 16' ' ' GLN . 21.0 tt0 -62.23 -35.81 80.05 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 176.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.423 ' CD2' ' HG3' ' A' ' 81' ' ' MET . 28.9 m-85 -78.9 -29.42 44.3 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.469 174.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.468 ' O ' ' HB3' ' A' ' 24' ' ' PHE . 40.5 tptt -59.78 -51.73 68.52 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-O 122.363 1.078 . . . . 0.0 109.319 172.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.495 ' O ' HG13 ' A' ' 26' ' ' ILE . . . -51.46 -37.62 49.71 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 112.898 -1.955 . . . . 0.0 110.96 173.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.502 ' O ' HD12 ' A' ' 157' ' ' LEU . . . -73.39 -42.04 62.6 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.283 177.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.722 ' O ' HG21 ' A' ' 28' ' ' VAL . 23.4 t80 -48.89 -51.34 30.43 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.685 0.755 . . . . 0.0 108.997 171.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.44 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 19.2 t70 -49.23 -54.99 14.02 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.62 -1.627 . . . . 0.0 112.204 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.565 ' HA ' ' HG ' ' A' ' 29' ' ' LEU . 24.3 mt -74.48 -31.17 27.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.67 -175.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.641 ' CD2' HD11 ' A' ' 157' ' ' LEU . 0.2 OUTLIER -56.11 -31.92 63.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.292 176.596 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.722 HG21 ' O ' ' A' ' 24' ' ' PHE . 30.7 m -121.54 23.35 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.564 -172.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.565 ' HG ' ' HA ' ' A' ' 26' ' ' ILE . 82.7 mt -69.83 118.05 12.18 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 175.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.87 12.38 59.23 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.961 -174.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -86.02 155.31 20.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.073 0.463 . . . . 0.0 111.006 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -79.54 -45.44 19.23 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.151 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -100.04 -15.46 18.23 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.865 -175.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.7 4.53 85.15 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.203 -0.999 . . . . 0.0 112.329 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.423 ' HB2' ' HB ' ' A' ' 71' ' ' THR . 0.8 OUTLIER -122.18 149.98 42.87 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 175.627 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.692 ' O ' ' HA ' ' A' ' 71' ' ' THR . 58.8 mt -63.29 107.34 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.569 -0.742 . . . . 0.0 112.01 -169.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 90.9 p -85.38 178.65 7.38 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 172.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.581 ' O ' HD11 ' A' ' 57' ' ' LEU . 16.9 p -71.74 -34.81 69.85 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.407 178.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -57.24 -56.12 25.98 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 171.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.626 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 0.9 OUTLIER -49.18 -48.44 45.12 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.592 -1.185 . . . . 0.0 113.456 172.181 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.558 ' HG ' HD22 ' A' ' 57' ' ' LEU . 24.5 tp -64.5 -51.3 63.67 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 121.029 -0.269 . . . . 0.0 110.531 -178.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.33 -40.11 74.96 Favored Glycine 0 C--O 1.224 -0.509 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.224 174.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.626 ' HB3' ' O ' ' A' ' 40' ' ' GLU . 14.7 tttp -48.31 -50.54 29.7 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.524 0.73 . . . . 0.0 110.812 172.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.565 ' HA ' ' SD ' ' A' ' 47' ' ' MET . 2.6 t -71.83 -45.59 64.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.947 178.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.515 ' SD ' HG13 ' A' ' 146' ' ' VAL . 1.1 mmt -54.23 -37.71 64.93 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 176.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.702 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 97.1 mtt180 -61.32 -48.69 80.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.324 171.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.565 ' SD ' ' HA ' ' A' ' 44' ' ' VAL . 81.2 mtp -51.6 -29.19 16.49 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.907 0.86 . . . . 0.0 110.533 171.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 16.6 mt -94.87 7.96 44.28 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 114.023 -1.444 . . . . 0.0 112.404 -172.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.34 -9.47 77.31 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.741 -0.663 . . . . 0.0 113.207 174.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.702 ' O ' ' HA ' ' A' ' 46' ' ' ARG . 74.8 mt-30 -102.12 -179.66 4.06 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -160.77 69.72 2.71 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-O 121.395 0.617 . . . . 0.0 109.577 167.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.466 ' HG2' ' CD2' ' A' ' 57' ' ' LEU . 9.8 Cg_endo -65.23 170.93 9.87 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.7 2.267 . . . . 0.0 111.564 176.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.604 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 4.4 p -96.21 157.1 36.19 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.023 -177.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.436 ' HA ' ' HB2' ' A' ' 57' ' ' LEU . 8.8 Cg_endo -50.68 -34.03 42.14 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.575 2.184 . . . . 0.0 111.348 175.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.476 ' O ' ' HG2' ' A' ' 59' ' ' GLU . 19.5 tt0 -54.67 -45.71 73.94 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.993 173.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.504 ' HB3' HG22 ' A' ' 146' ' ' VAL . 57.4 mt-10 -79.11 -28.43 42.97 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.408 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.604 ' HG ' ' O ' ' A' ' 53' ' ' THR . 65.4 mt -79.93 -35.58 37.55 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.147 -177.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -68.04 -32.89 73.56 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.609 -178.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 55' ' ' GLU . 2.8 mm-40 -67.12 -49.88 63.36 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.351 0.596 . . . . 0.0 110.112 176.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.688 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 31.6 ttm -58.37 -37.9 76.16 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.931 -1.031 . . . . 0.0 112.201 175.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.3 mt -66.7 -47.88 81.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 174.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.563 ' HA ' ' HB3' ' A' ' 65' ' ' ASP . 23.4 t70 -58.08 -29.38 65.38 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.386 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.688 ' HB2' ' O ' ' A' ' 60' ' ' MET . 14.2 mt-10 -44.44 -51.5 8.64 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.674 177.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.641 HG11 ' CA ' ' A' ' 80' ' ' MET . 4.2 m -111.45 -18.34 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 CA-C-N 114.559 -1.201 . . . . 0.0 111.384 -175.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.563 ' HB3' ' HA ' ' A' ' 62' ' ' ASP . 44.0 t0 -60.01 122.59 14.71 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 172.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -85.69 -37.47 19.38 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.598 -177.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -91.03 -8.52 48.83 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.125 0.488 . . . . 0.0 110.974 -175.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 73.43 25.03 73.79 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.508 -0.853 . . . . 0.0 111.24 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 86.2 p -71.26 -8.86 56.44 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -170.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.68 11.61 83.8 Favored Glycine 0 C--N 1.316 -0.575 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -176.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.692 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 1.1 p -144.43 132.52 21.62 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.93 -0.635 . . . . 0.0 110.222 178.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.477 HG23 ' CG2' ' A' ' 64' ' ' VAL . 1.2 t -102.74 127.66 56.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.385 -178.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.505 ' HA ' ' CE2' ' A' ' 24' ' ' PHE . 20.1 t70 -105.05 -172.32 2.08 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.465 ' H ' ' CG ' ' A' ' 73' ' ' ASP . 19.3 t80 -58.1 -43.09 86.94 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -165.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -70.45 -48.47 55.76 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.246 -175.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.484 ' HG2' ' HA ' ' A' ' 65' ' ' ASP . 2.0 mp0 -50.0 -52.4 34.22 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.52 0.676 . . . . 0.0 111.677 169.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.514 ' HE2' ' CE2' ' A' ' 27' ' ' PHE . 89.6 t80 -60.01 -39.28 85.24 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.224 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.402 ' HG ' ' CG2' ' A' ' 9' ' ' VAL . 0.1 OUTLIER -61.21 -41.53 97.0 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.737 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.444 ' O ' ' HG3' ' A' ' 83' ' ' ARG . 53.3 t -60.24 -46.28 94.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.55 174.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.641 ' CA ' HG11 ' A' ' 64' ' ' VAL . 5.7 tmm? -63.82 -28.96 70.22 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.543 0.687 . . . . 0.0 109.926 -178.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.474 ' O ' ' HB2' ' A' ' 85' ' ' MET . 4.1 mmt -71.93 -37.69 69.97 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.675 -177.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.613 ' HA ' ' HB2' ' A' ' 85' ' ' MET . 2.0 m -76.72 -31.99 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-O 120.997 0.427 . . . . 0.0 110.528 177.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.648 ' HG2' ' CE2' ' A' ' 5' ' ' TYR . 24.9 mtp180 -62.42 -43.59 98.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.713 -176.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.401 ' HB2' ' HB2' ' A' ' 150' ' ' ALA . 13.2 m -81.05 -19.46 43.75 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.119 0.485 . . . . 0.0 111.334 174.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.613 ' HB2' ' HA ' ' A' ' 82' ' ' VAL . 0.1 OUTLIER -67.65 -49.43 62.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.867 -176.602 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.457 ' HB3' ' HG2' ' A' ' 90' ' ' LYS . 27.4 tptp -68.2 -44.76 75.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.857 0.361 . . . . 0.0 110.538 -176.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -175.77 158.03 2.07 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -62.72 -29.36 70.61 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.1 0.476 . . . . 0.0 110.542 177.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.5 m -96.06 5.95 49.95 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.711 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.573 ' HB3' ' O ' ' A' ' 83' ' ' ARG . 55.7 tptt -68.62 -68.65 0.38 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.925 0.393 . . . . 0.0 110.527 178.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.504 ' HA3' ' HB3' ' A' ' 83' ' ' ARG . . . -115.77 10.6 18.59 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.302 -0.951 . . . . 0.0 111.944 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.481 ' C ' ' H ' ' A' ' 139' ' ' LYS . 58.1 mttm -133.15 -163.12 1.31 Allowed 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 177.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.444 ' HB3' ' O ' ' A' ' 137' ' ' LYS . 81.5 t80 75.89 -30.56 0.19 Allowed 'General case' 0 N--CA 1.473 0.675 0 O-C-N 123.46 0.475 . . . . 0.0 110.95 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.481 ' H ' ' C ' ' A' ' 137' ' ' LYS . 94.9 mttt -74.88 -167.44 0.59 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.855 177.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.654 ' N ' ' HD2' ' A' ' 141' ' ' PRO . 99.3 mtt180 -48.76 -48.72 69.54 Favored Pre-proline 0 CA--C 1.54 0.581 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.986 172.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.654 ' HD2' ' N ' ' A' ' 140' ' ' ARG . 3.5 Cg_exo -37.95 -58.76 0.61 Allowed 'Trans proline' 0 C--N 1.366 1.463 0 C-N-CA 124.051 3.167 . . . . 0.0 113.775 -178.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.407 ' HG1' ' CD ' ' A' ' 63' ' ' GLU . 1.7 m -93.93 123.73 37.48 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.079 0.466 . . . . 0.0 110.186 179.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.548 HD21 ' H ' ' A' ' 143' ' ' LEU . 0.3 OUTLIER -74.03 -172.9 1.46 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.23 -178.816 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 4.0 tpp180 -69.34 -51.98 31.68 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -170.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.95 -65.06 0.72 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.18 0.514 . . . . 0.0 110.305 -178.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.521 HG23 HD23 ' A' ' 143' ' ' LEU . 0.0 OUTLIER -47.6 137.26 3.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 114.382 -1.281 . . . . 0.0 112.261 -174.586 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.417 ' NH2' ' HA ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -170.12 101.23 0.28 Allowed 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 120.529 -0.469 . . . . 0.0 111.898 177.27 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.502 HG12 ' SD ' ' A' ' 60' ' ' MET . 27.2 mm -86.13 102.16 11.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 174.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.446 ' HB2' ' HB1' ' A' ' 152' ' ' ALA . 41.8 m -89.2 115.17 26.51 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 175.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.609 ' O ' ' HG2' ' A' ' 154' ' ' MET . . . -49.38 -57.86 6.15 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -169.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.635 ' O ' ' HG3' ' A' ' 155' ' ' GLN . 6.8 p-10 -55.37 -41.07 72.09 Favored 'General case' 0 C--N 1.323 -0.571 0 O-C-N 123.451 0.469 . . . . 0.0 110.622 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.486 ' HA ' ' HG3' ' A' ' 155' ' ' GLN . . . -71.54 -34.47 70.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.053 0.454 . . . . 0.0 111.269 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.607 ' CE ' ' HG ' ' A' ' 157' ' ' LEU . 3.2 tpt -61.61 -40.87 96.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 122.008 0.909 . . . . 0.0 109.599 177.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.609 ' HG2' ' O ' ' A' ' 150' ' ' ALA . 13.2 mmt -66.07 -28.78 69.1 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.319 -1.309 . . . . 0.0 109.951 178.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.635 ' HG3' ' O ' ' A' ' 151' ' ' ASP . 39.5 mt-30 -73.77 -57.92 3.65 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.428 177.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.96 -52.11 61.73 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.9 -176.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.641 HD11 ' CD2' ' A' ' 27' ' ' PHE . 85.2 mt -78.99 -65.76 0.95 Allowed 'General case' 0 CA--C 1.501 -0.919 0 CA-C-O 121.026 0.441 . . . . 0.0 111.979 -176.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.459 HD21 ' N ' ' A' ' 23' ' ' ALA . 86.3 mt -66.74 -50.33 63.11 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.157 -0.929 . . . . 0.0 112.527 -159.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.484 ' O ' ' HE3' ' A' ' 163' ' ' LYS . . . 44.91 -95.28 0.01 OUTLIER Glycine 0 C--N 1.338 0.653 0 O-C-N 124.11 0.881 . . . . 0.0 112.035 -177.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.416 ' HB3' ' HG3' ' A' ' 161' ' ' ARG . . . -36.98 -54.78 0.94 Allowed 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 122.401 1.096 . . . . 0.0 111.472 168.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.445 ' HD3' HD11 ' A' ' 26' ' ' ILE . 45.0 mtp180 -89.97 5.27 47.19 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 113.358 -1.746 . . . . 0.0 111.051 -169.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -83.77 -15.14 49.6 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.98 0.419 . . . . 0.0 110.717 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.484 ' HE3' ' O ' ' A' ' 159' ' ' GLY . 0.0 OUTLIER -144.42 177.88 8.33 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.48 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -134.17 58.37 0.69 Allowed Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.127 -1.035 . . . . 0.0 112.525 178.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 23.7 p80 . . . . . 0 C--O 1.245 0.857 0 CA-C-O 118.729 -0.653 . . . . 0.0 109.347 176.925 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.773 ' SD ' ' HB2' ' A' ' 6' ' ' LYS . 1.1 tmt? . . . . . 0 N--CA 1.48 1.043 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -63.25 119.17 9.1 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 120.866 0.365 . . . . 0.0 110.785 -178.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.531 ' HA ' ' HB3' ' A' ' 6' ' ' LYS . 5.2 p-10 -71.73 -7.4 47.87 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -173.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.4 tt -60.4 -43.51 94.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 169.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.583 ' CZ ' ' HG2' ' A' ' 83' ' ' ARG . 25.3 m-85 -81.54 -30.7 33.04 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.455 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.773 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 24.5 ttpt -65.06 -37.07 86.34 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.337 172.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.51 -28.31 69.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.336 0.588 . . . . 0.0 110.402 176.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.441 ' HB1' ' O ' ' A' ' 5' ' ' TYR . . . -67.76 -46.03 73.22 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.475 170.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.472 ' HA ' ' HB2' ' A' ' 12' ' ' LEU . 50.0 t -60.32 -32.38 50.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.571 174.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.577 ' HG2' ' O ' ' A' ' 6' ' ' LYS . 55.1 mm-40 -64.39 -29.43 70.49 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.722 177.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -82.06 -38.62 24.64 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.223 170.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.684 ' HA ' ' OE1' ' A' ' 16' ' ' GLN . 57.0 mt -55.74 135.86 51.3 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 121.942 0.877 . . . . 0.0 110.132 175.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.463 ' OG1' ' HG3' ' A' ' 16' ' ' GLN . 6.1 p -86.42 155.2 20.67 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -47.17 -42.95 20.68 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 118.629 0.65 . . . . 0.0 109.395 177.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -54.6 -56.74 15.8 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.447 173.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.684 ' OE1' ' HA ' ' A' ' 12' ' ' LEU . 88.4 mt-30 -52.37 -54.11 36.14 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 121.184 0.516 . . . . 0.0 111.626 176.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.416 ' HG3' ' HB3' ' A' ' 12' ' ' LEU . 32.8 mtpt -53.15 -48.92 67.56 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.748 175.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.415 ' O ' ' HB3' ' A' ' 21' ' ' LYS . 56.6 t30 -60.47 -34.75 74.48 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.839 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -66.75 -34.92 78.9 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.191 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -72.96 -31.64 64.7 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.622 174.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.55 ' HD3' ' CG ' ' A' ' 74' ' ' PHE . 29.3 tptp -61.13 -38.14 85.33 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.433 0.635 . . . . 0.0 110.187 172.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.454 ' O ' HG13 ' A' ' 26' ' ' ILE . . . -62.0 -38.37 88.34 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.493 173.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.548 ' O ' ' HB2' ' A' ' 27' ' ' PHE . . . -71.38 -38.38 71.53 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 177.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.623 ' O ' HG21 ' A' ' 28' ' ' VAL . 28.2 t80 -51.24 -53.75 32.37 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.878 0.846 . . . . 0.0 109.069 170.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -51.99 -53.59 39.87 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 113.646 -1.615 . . . . 0.0 112.239 -178.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.536 ' HA ' ' HG ' ' A' ' 29' ' ' LEU . 40.0 mt -70.79 -33.36 52.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.329 -177.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.548 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 0.4 OUTLIER -53.85 -42.87 69.0 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.356 175.461 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.623 HG21 ' O ' ' A' ' 24' ' ' PHE . 35.5 m -111.07 23.03 4.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.809 -174.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.536 ' HG ' ' HA ' ' A' ' 26' ' ' ILE . 19.7 mt -61.99 117.08 5.49 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.34 -0.944 . . . . 0.0 109.319 177.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.29 12.99 72.04 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.508 -176.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.41 154.13 38.92 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 117.129 0.464 . . . . 0.0 111.221 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -69.33 -46.43 67.1 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.868 -176.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -101.58 -16.62 16.69 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.899 -176.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.06 -0.58 86.16 Favored Glycine 0 C--O 1.224 -0.51 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.34 -175.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 52.5 m -108.49 151.25 26.32 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 174.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.538 ' O ' ' HA ' ' A' ' 71' ' ' THR . 61.3 mt -65.95 106.92 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.972 0 O-C-N 123.342 0.401 . . . . 0.0 110.311 -175.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 61.9 p -90.39 170.67 10.04 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 170.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.451 HG23 ' HG3' ' A' ' 58' ' ' GLN . 32.1 p -65.79 -21.82 66.52 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.359 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -60.28 -55.49 33.09 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.801 172.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.505 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 18.5 mm-40 -65.76 -38.16 88.3 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 177.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.58 ' HG ' ' CD2' ' A' ' 57' ' ' LEU . 4.1 tp -65.8 -49.82 66.9 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.729 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.657 ' O ' ' HG3' ' A' ' 46' ' ' ARG . . . -58.96 -42.4 96.81 Favored Glycine 0 C--N 1.315 -0.603 0 C-N-CA 120.295 -0.955 . . . . 0.0 111.525 173.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.505 ' HB3' ' O ' ' A' ' 40' ' ' GLU . 24.4 tttt -48.75 -47.96 41.22 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 123.623 0.769 . . . . 0.0 110.96 173.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.639 ' O ' ' HB2' ' A' ' 47' ' ' MET . 0.9 OUTLIER -74.6 -35.58 38.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.966 -178.48 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.459 ' HE3' HG12 ' A' ' 148' ' ' ILE . 11.8 mmt -63.7 -38.14 89.97 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 175.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.657 ' HG3' ' O ' ' A' ' 42' ' ' GLY . 62.0 mtp180 -55.74 -49.45 73.05 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.211 169.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.639 ' HB2' ' O ' ' A' ' 44' ' ' VAL . 0.4 OUTLIER -53.79 -28.78 36.99 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.638 -1.164 . . . . 0.0 111.686 173.281 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.436 ' HB2' ' HA ' ' A' ' 45' ' ' MET . 11.0 mt -97.18 -3.25 41.29 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-N 114.494 -1.23 . . . . 0.0 112.094 -171.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 105.55 -15.9 45.16 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 121.07 -0.586 . . . . 0.0 113.423 175.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.463 ' HB3' ' HD3' ' A' ' 52' ' ' PRO . 1.7 mp0 -91.33 -176.69 4.63 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.466 ' N ' ' HD3' ' A' ' 52' ' ' PRO . 6.9 p30 -155.4 60.32 2.51 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.665 0.745 . . . . 0.0 110.521 168.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.579 ' HB3' HG21 ' A' ' 146' ' ' VAL . 74.6 Cg_exo -53.19 173.12 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.948 3.099 . . . . 0.0 114.254 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.8 p -109.19 162.26 20.77 Favored Pre-proline 0 C--N 1.316 -0.849 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.891 176.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.62 -33.54 98.27 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 121.829 1.686 . . . . 0.0 110.557 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -48.53 -52.38 22.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.427 172.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.578 ' HB3' HG21 ' A' ' 146' ' ' VAL . 47.3 mt-10 -73.19 -45.72 54.76 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 113.869 -1.514 . . . . 0.0 112.879 -178.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.621 ' O ' HG13 ' A' ' 61' ' ' ILE . 21.8 mt -64.36 -37.38 87.31 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.707 -177.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.451 ' HG3' HG23 ' A' ' 38' ' ' THR . 56.0 mt-30 -57.26 -33.49 67.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.418 0.151 . . . . 0.0 111.259 178.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.448 ' HG3' HD11 ' A' ' 143' ' ' LEU . 4.7 mm-40 -65.62 -48.72 71.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.145 0.498 . . . . 0.0 110.386 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.538 ' CE ' ' HB ' ' A' ' 148' ' ' ILE . 31.4 mmm -65.6 -37.1 85.68 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.202 178.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.621 HG13 ' O ' ' A' ' 57' ' ' LEU . 2.4 mt -65.28 -56.95 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 176.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.562 ' HA ' ' HB3' ' A' ' 65' ' ' ASP . 19.4 t70 -55.96 -35.93 67.26 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.484 -176.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.56 ' CD ' ' HZ3' ' A' ' 137' ' ' LYS . 9.9 mt-10 -47.94 -50.22 27.75 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.311 0.576 . . . . 0.0 111.915 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.61 HG13 ' CA ' ' A' ' 80' ' ' MET . 9.3 m -99.95 -20.03 5.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.39 -177.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.562 ' HB3' ' HA ' ' A' ' 62' ' ' ASP . 66.7 t0 -59.82 130.3 46.11 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.312 174.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -89.64 -32.87 16.87 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -175.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -105.32 -7.35 18.93 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -174.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 73.86 25.64 71.22 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.052 -1.071 . . . . 0.0 112.741 174.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 78.0 p -78.73 -1.54 35.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.217 0.532 . . . . 0.0 111.28 -176.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.31 17.67 70.95 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.38 -178.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 0.8 OUTLIER -141.41 133.15 27.23 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.74 0.781 . . . . 0.0 111.265 178.584 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.514 ' CG2' HG22 ' A' ' 64' ' ' VAL . 0.9 OUTLIER -101.17 117.0 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.736 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.502 ' CG ' ' H ' ' A' ' 74' ' ' PHE . 20.4 t70 -96.75 -165.99 1.35 Allowed 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.55 ' CG ' ' HD3' ' A' ' 21' ' ' LYS . 10.3 t80 -56.01 -60.42 3.51 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -167.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.512 ' OD2' ' HG3' ' A' ' 1' ' ' MET . 13.9 t70 -63.27 -43.35 98.19 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.816 -173.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.524 ' O ' ' HB ' ' A' ' 64' ' ' VAL . 2.6 mp0 -50.85 -53.79 29.37 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.35 0.595 . . . . 0.0 111.422 170.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.401 ' HE2' ' CE2' ' A' ' 27' ' ' PHE . 73.0 t80 -56.59 -46.99 80.54 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.138 178.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.408 HD23 ' CE1' ' A' ' 74' ' ' PHE . 2.1 tp -60.73 -39.83 90.1 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.379 -178.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.564 ' O ' ' HG3' ' A' ' 83' ' ' ARG . 54.9 t -56.7 -50.93 72.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 170.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.61 ' CA ' HG13 ' A' ' 64' ' ' VAL . 44.8 ttp -56.89 -35.22 68.7 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.667 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 27.3 mmt -63.76 -48.73 75.78 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.175 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.657 ' HA ' ' HB2' ' A' ' 85' ' ' MET . 0.6 OUTLIER -66.59 -31.49 53.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.524 177.434 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.583 ' HG2' ' CZ ' ' A' ' 5' ' ' TYR . 29.9 mtp180 -62.13 -46.62 88.21 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.356 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 51.7 p -79.1 -6.47 56.53 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.014 0.435 . . . . 0.0 111.034 176.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.657 ' HB2' ' HA ' ' A' ' 82' ' ' VAL . 0.6 OUTLIER -83.31 -46.27 12.81 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.964 -177.364 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.49 ' CB ' ' HG2' ' A' ' 90' ' ' LYS . 0.9 OUTLIER -60.96 -46.98 88.52 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 121.361 0.6 . . . . 0.0 110.055 177.546 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.435 ' HB3' ' HA ' ' A' ' 90' ' ' LYS . 30.0 t70 -159.7 164.39 34.0 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -177.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -63.82 -28.54 69.93 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.96 178.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.2 t -113.85 -35.96 4.97 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.14 177.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.49 ' HG2' ' CB ' ' A' ' 86' ' ' LYS . 0.0 OUTLIER 68.52 -67.76 0.19 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.397 0.679 . . . . 0.0 111.969 176.162 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 158.17 43.5 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -173.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.56 ' HZ3' ' CD ' ' A' ' 63' ' ' GLU . 6.0 mtpm? -74.47 -35.51 63.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.766 -0.717 . . . . 0.0 111.638 -170.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -167.63 -50.52 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.827 0.346 . . . . 0.0 110.518 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -137.58 -69.2 0.46 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.408 176.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.637 ' N ' ' HD2' ' A' ' 141' ' ' PRO . 21.8 tpt180 175.4 -53.72 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.904 -173.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.637 ' HD2' ' N ' ' A' ' 140' ' ' ARG . 10.1 Cg_endo -51.54 -38.58 64.98 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 123.036 2.491 . . . . 0.0 113.083 -176.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.546 ' HB ' ' NE ' ' A' ' 147' ' ' ARG . 91.8 m 52.43 64.8 1.71 Allowed 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.756 0.788 . . . . 0.0 110.13 -177.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.503 ' HB2' ' HB ' ' A' ' 146' ' ' VAL . 2.8 mm? 58.43 15.97 3.85 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.656 179.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.465 ' NE ' ' HA ' ' A' ' 144' ' ' ARG . 5.1 tpm_? 63.29 -81.02 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.632 0.773 . . . . 0.0 112.191 175.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -85.79 -17.63 35.22 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.465 0.65 . . . . 0.0 110.746 -174.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.579 HG21 ' HB3' ' A' ' 52' ' ' PRO . 19.7 t -96.21 75.07 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 121.68 0.752 . . . . 0.0 110.806 -171.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.546 ' NE ' ' HB ' ' A' ' 142' ' ' THR . 14.7 mmt85 -109.57 120.02 41.2 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 114.849 -1.069 . . . . 0.0 112.737 -174.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.538 ' HB ' ' CE ' ' A' ' 60' ' ' MET . 5.5 mm -95.69 120.93 45.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 169.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.42 ' HB2' ' HB2' ' A' ' 152' ' ' ALA . 42.6 m -119.43 113.98 21.61 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 119.447 -0.311 . . . . 0.0 110.296 -178.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.782 ' O ' ' HG2' ' A' ' 154' ' ' MET . . . -44.29 -59.59 2.31 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 123.702 0.626 . . . . 0.0 112.185 -172.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.632 ' O ' ' HG3' ' A' ' 155' ' ' GLN . 5.0 m-20 -50.84 -53.69 30.11 Favored 'General case' 0 CA--C 1.518 -0.265 0 O-C-N 123.28 0.362 . . . . 0.0 110.74 179.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.42 ' HB2' ' HB2' ' A' ' 149' ' ' SER . . . -59.84 -34.44 73.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.18 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.588 ' CE ' ' HA ' ' A' ' 153' ' ' MET . 2.2 tpt -68.02 -36.17 79.49 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.777 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.782 ' HG2' ' O ' ' A' ' 150' ' ' ALA . 14.9 mmt -69.67 -27.77 65.3 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.516 178.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.632 ' HG3' ' O ' ' A' ' 151' ' ' ASP . 8.8 mt-30 -72.42 -57.94 3.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.225 177.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -62.52 -45.59 92.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.036 -174.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.495 ' HB3' ' HB ' ' A' ' 26' ' ' ILE . 22.6 mt -85.63 -66.62 0.88 Allowed 'General case' 0 CA--C 1.504 -0.814 0 CA-C-O 121.48 0.657 . . . . 0.0 111.768 -177.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.534 HD21 ' N ' ' A' ' 23' ' ' ALA . 83.7 mt -68.32 -48.43 64.89 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.954 -166.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 36.6 -90.05 0.01 OUTLIER Glycine 0 C--N 1.342 0.913 0 O-C-N 125.121 1.513 . . . . 0.0 113.582 174.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -36.62 -52.45 0.88 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 123.955 0.902 . . . . 0.0 111.785 171.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 44.2 ttt180 -86.19 -17.86 33.72 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.396 -176.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -64.25 -33.13 75.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.869 0.366 . . . . 0.0 111.254 -175.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.48 ' HD2' ' H ' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -116.16 6.82 14.0 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.034 0.445 . . . . 0.0 110.471 177.16 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -125.26 68.32 0.51 Allowed Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.359 -176.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 81.1 t60 . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.541 -0.743 . . . . 0.0 109.753 175.915 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.453 ' HB2' ' HG2' ' A' ' 66' ' ' GLU . 27.1 ttm . . . . . 0 N--CA 1.479 0.991 0 N-CA-C 110.264 -0.272 . . . . 0.0 110.264 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -73.18 109.23 6.56 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 174.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -66.39 -13.06 60.12 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -173.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.3 tt -55.79 -41.07 64.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.572 0.701 . . . . 0.0 109.322 172.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.663 ' HB3' ' CG1' ' A' ' 82' ' ' VAL . 55.2 m-85 -83.37 -27.0 29.96 Favored 'General case' 0 C--O 1.215 -0.75 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.162 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.576 ' O ' ' HG3' ' A' ' 10' ' ' GLU . 8.6 ttpt -65.17 -32.36 74.0 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 174.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.68 ' HA ' ' CG ' ' A' ' 10' ' ' GLU . . . -79.15 -23.76 43.76 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.976 173.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.539 ' O ' ' HG ' ' A' ' 12' ' ' LEU . . . -71.42 -27.34 63.23 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 166.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.475 ' HB ' ' O ' ' A' ' 6' ' ' LYS . 54.3 t -72.5 -29.92 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 121.183 0.516 . . . . 0.0 109.82 167.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.68 ' CG ' ' HA ' ' A' ' 7' ' ' ALA . 45.3 mt-10 -69.81 -27.27 64.75 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 122.195 0.998 . . . . 0.0 108.802 171.012 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.489 ' HB3' ' O ' ' A' ' 8' ' ' ALA . 37.7 tp60 -79.94 -34.91 38.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 113.622 -1.626 . . . . 0.0 110.19 178.092 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' A' ' 8' ' ' ALA . 51.2 mt -58.82 135.36 57.48 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.85 172.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.593 ' OG1' ' HG3' ' A' ' 16' ' ' GLN . 17.5 p -77.08 166.72 22.91 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -58.54 -35.11 71.8 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 175.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -63.7 -48.28 77.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.736 176.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.593 ' HG3' ' OG1' ' A' ' 13' ' ' THR . 35.2 mt-30 -58.07 -54.08 50.96 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 121.396 0.617 . . . . 0.0 111.176 177.257 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.462 ' HA ' HD21 ' A' ' 78' ' ' LEU . 55.0 mtpt -55.55 -42.51 74.73 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.363 176.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -58.64 -37.52 76.12 Favored 'General case' 0 CA--C 1.51 -0.596 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.315 177.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -65.7 -37.47 86.52 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-O 121.255 0.55 . . . . 0.0 110.036 -176.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.443 ' HD1' ' CD2' ' A' ' 78' ' ' LEU . 21.4 m-85 -78.56 -23.09 46.32 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.496 176.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.485 ' HD3' ' CD1' ' A' ' 74' ' ' PHE . 22.4 tptp -65.17 -52.79 52.83 Favored 'General case' 0 CA--C 1.499 -1.013 0 CA-C-O 122.031 0.919 . . . . 0.0 109.028 174.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.15 -36.74 31.35 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 113.476 -1.693 . . . . 0.0 110.403 173.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.504 ' O ' ' HB2' ' A' ' 27' ' ' PHE . . . -71.94 -46.54 57.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.381 175.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.722 ' O ' HG22 ' A' ' 28' ' ' VAL . 20.8 t80 -47.87 -49.52 29.35 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 124.091 0.869 . . . . 0.0 109.597 175.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -49.44 -52.5 28.53 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 113.892 -1.504 . . . . 0.0 112.527 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.449 HG23 HD12 ' A' ' 29' ' ' LEU . 21.7 mt -77.82 -33.51 18.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.206 -177.369 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.66 ' HE1' ' SD ' ' A' ' 153' ' ' MET . 0.7 OUTLIER -56.25 -36.7 68.83 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 114.506 -1.225 . . . . 0.0 109.302 177.73 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.722 HG22 ' O ' ' A' ' 24' ' ' PHE . 29.1 m -114.65 23.68 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.634 -178.371 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.449 HD12 HG23 ' A' ' 26' ' ' ILE . 4.6 mt -64.04 118.19 8.13 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 173.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.97 12.78 67.74 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.442 -0.885 . . . . 0.0 111.936 -175.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -84.64 143.38 29.27 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.583 0.706 . . . . 0.0 111.014 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -78.73 -45.53 20.97 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.134 -178.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -87.25 -17.24 33.03 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.345 -177.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.07 1.89 75.8 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.766 -178.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.448 ' HB2' ' HB ' ' A' ' 71' ' ' THR . 2.5 m -119.74 155.09 33.14 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 173.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.71 ' O ' ' HA ' ' A' ' 71' ' ' THR . 69.9 mt -64.45 107.84 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.049 -171.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 84.4 p -82.73 175.93 9.74 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 169.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.587 ' O ' HD13 ' A' ' 57' ' ' LEU . 12.9 p -69.76 -45.14 68.74 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.303 -178.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -51.76 -40.98 61.25 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.434 0.635 . . . . 0.0 109.807 171.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.17 -42.35 93.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.98 176.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.753 HD21 ' SD ' ' A' ' 60' ' ' MET . 0.5 OUTLIER -71.02 -36.23 72.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.859 0.838 . . . . 0.0 109.711 -179.113 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.48 -21.52 76.14 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 114.705 -1.134 . . . . 0.0 112.014 178.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.615 ' O ' ' HG3' ' A' ' 47' ' ' MET . 8.1 ptmt -55.4 -50.3 70.12 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.462 ' N ' ' CG ' ' A' ' 43' ' ' LYS . 5.6 p -78.01 -28.11 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 CA-C-N 116.793 -0.185 . . . . 0.0 110.944 -174.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.634 ' CB ' ' HG3' ' A' ' 52' ' ' PRO . 9.1 mmt -64.08 -41.83 97.18 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 174.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -59.47 -43.95 93.12 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.977 172.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.615 ' HG3' ' O ' ' A' ' 43' ' ' LYS . 37.0 mtm -66.0 -9.97 35.26 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.541 175.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.516 HD11 ' HG3' ' A' ' 153' ' ' MET . 8.9 mt -108.56 3.15 22.68 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.914 -173.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 95.41 -1.51 64.39 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.994 -0.622 . . . . 0.0 113.015 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -93.02 177.21 6.14 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 120.952 0.406 . . . . 0.0 111.264 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -145.87 66.23 11.59 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-O 121.989 0.9 . . . . 0.0 110.177 165.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.675 ' HB3' HG11 ' A' ' 146' ' ' VAL . 59.3 Cg_endo -66.9 143.82 68.09 Favored 'Trans proline' 0 C--N 1.327 -0.566 0 C-N-CA 123.379 2.72 . . . . 0.0 113.604 -174.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 22.0 p -82.59 144.08 48.49 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.143 174.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.448 ' HA ' ' HB2' ' A' ' 57' ' ' LEU . 13.6 Cg_endo -58.46 -18.94 41.52 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.699 2.266 . . . . 0.0 111.628 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -70.51 -49.23 50.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.932 174.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.606 ' CG ' HG22 ' A' ' 146' ' ' VAL . 0.9 OUTLIER -63.38 -40.28 96.82 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 121.772 0.796 . . . . 0.0 109.833 177.367 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.587 HD13 ' O ' ' A' ' 38' ' ' THR . 52.5 mt -67.05 -36.1 81.32 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.542 178.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.439 ' HB2' ' O ' ' A' ' 54' ' ' PRO . 25.8 tt0 -64.07 -44.34 92.71 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 121.235 -0.186 . . . . 0.0 110.894 -174.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.571 ' O ' ' HG3' ' A' ' 63' ' ' GLU . 12.1 mm-40 -61.97 -44.0 97.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.74 -0.209 . . . . 0.0 110.659 175.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.753 ' SD ' HD21 ' A' ' 41' ' ' LEU . 20.9 ttm -53.33 -49.16 67.65 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 174.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.648 HG23 HG23 ' A' ' 72' ' ' VAL . 1.0 OUTLIER -54.99 -56.9 8.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.869 177.372 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -50.01 -40.57 45.03 Favored 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 124.532 1.133 . . . . 0.0 112.154 -176.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.589 ' HB2' ' O ' ' A' ' 60' ' ' MET . 80.4 mt-10 -46.54 -42.17 15.37 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 113.729 -1.578 . . . . 0.0 111.894 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.722 HG21 ' HB2' ' A' ' 80' ' ' MET . 3.4 m -116.46 -14.64 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.591 -173.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -65.96 116.92 7.61 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 170.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.453 ' HG2' ' HB2' ' A' ' 1' ' ' MET . 44.6 mt-10 -76.9 -18.38 58.34 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -174.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -112.3 -8.43 13.94 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.133 0.492 . . . . 0.0 111.34 -174.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 73.8 19.61 79.74 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.785 -0.722 . . . . 0.0 111.495 -178.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 76.1 p -68.38 -32.44 72.51 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 121.25 0.548 . . . . 0.0 112.329 -172.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 107.77 16.35 13.01 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.429 -178.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.71 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 2.0 p -145.41 132.06 19.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.121 0.486 . . . . 0.0 110.76 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.65 HG12 HD12 ' A' ' 36' ' ' ILE . 2.7 t -100.05 118.79 47.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.155 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.443 ' HA ' ' CE1' ' A' ' 24' ' ' PHE . 15.6 t70 -98.87 -172.03 2.21 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.333 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.485 ' CD1' ' HD3' ' A' ' 21' ' ' LYS . 12.7 t80 -58.14 -54.23 49.34 Favored 'General case' 0 C--O 1.219 -0.546 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -162.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.443 ' HA ' ' HB2' ' A' ' 78' ' ' LEU . 34.7 t70 -71.82 -34.12 69.07 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.073 0.463 . . . . 0.0 110.44 -174.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -59.74 -44.64 93.69 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.813 169.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.422 ' HZ ' ' HE1' ' A' ' 153' ' ' MET . 60.1 t80 -65.22 -35.67 81.78 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.412 176.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.496 ' O ' ' HB ' ' A' ' 82' ' ' VAL . 17.0 mt -63.9 -43.93 94.49 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 122.297 0.239 . . . . 0.0 110.68 176.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.542 HG12 HG12 ' A' ' 64' ' ' VAL . 5.0 t -64.39 -45.78 94.92 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.608 0 C-N-CA 120.449 -0.501 . . . . 0.0 109.777 174.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.722 ' HB2' HG21 ' A' ' 64' ' ' VAL . 43.4 ttp -61.05 -39.04 88.32 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.144 0.497 . . . . 0.0 111.343 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 8.6 mmt -68.43 -51.16 46.82 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.946 174.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.663 ' CG1' ' HB3' ' A' ' 5' ' ' TYR . 0.4 OUTLIER -63.86 -29.49 47.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.114 -177.759 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.418 HH11 HG13 ' A' ' 64' ' ' VAL . 26.9 mtp180 -58.48 -35.55 72.38 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.462 -178.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.4 m -79.4 -17.46 54.33 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.849 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.417 ' HE2' ' CD2' ' A' ' 12' ' ' LEU . 2.7 ptt? -93.88 -9.6 36.7 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.543 -0.463 . . . . 0.0 112.104 -175.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -61.94 -40.79 96.75 Favored 'General case' 0 C--N 1.339 0.136 0 CA-C-O 121.616 0.722 . . . . 0.0 109.976 -178.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -136.55 -159.0 0.91 Allowed 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 172.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -55.92 -58.49 7.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 118.363 0.529 . . . . 0.0 110.365 174.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.7 m -134.19 -7.89 2.64 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.823 175.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.459 ' HE2' ' OH ' ' A' ' 5' ' ' TYR . 16.3 mmmt 68.25 137.31 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.753 -174.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -102.11 -86.97 1.97 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.534 -177.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.406 ' HD3' ' HA ' ' A' ' 137' ' ' LYS . 43.0 mmtm -100.79 -174.9 2.74 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.641 0.258 . . . . 0.0 111.374 -178.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 9.9 t80 58.98 36.47 24.47 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -167.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 140' ' ' ARG . 37.5 tttt -171.32 143.76 1.9 Allowed 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 112.891 -1.959 . . . . 0.0 108.35 -170.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.421 ' O ' ' HG2' ' A' ' 139' ' ' LYS . 23.4 mmm180 -77.45 151.11 80.39 Favored Pre-proline 0 C--N 1.325 -0.5 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 175.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -86.96 -5.32 7.83 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 124.017 3.145 . . . . 0.0 113.079 -168.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.412 HG22 HG23 ' A' ' 146' ' ' VAL . 3.9 m 58.21 50.3 10.01 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.682 0.753 . . . . 0.0 109.841 -177.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.7 mm? 64.55 -89.04 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.125 -175.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.425 ' HD3' ' N ' ' A' ' 144' ' ' ARG . 0.0 OUTLIER 174.7 -27.05 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.499 0.72 . . . . 0.0 109.246 178.09 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -72.83 -59.88 2.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.9 -176.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.675 HG11 ' HB3' ' A' ' 52' ' ' PRO . 3.2 m -98.87 155.82 3.85 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.823 0 C-N-CA 120.48 -0.488 . . . . 0.0 112.301 -177.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.507 ' HD2' ' H ' ' A' ' 148' ' ' ILE . 17.7 tpt180 -169.94 133.01 1.15 Allowed 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.03 161.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.727 HG13 ' SD ' ' A' ' 60' ' ' MET . 13.5 mt -65.35 111.65 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 114.838 -1.073 . . . . 0.0 112.197 177.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 48.7 m -82.82 99.78 9.92 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 167.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.627 ' O ' ' HG2' ' A' ' 154' ' ' MET . . . -44.93 -62.64 1.15 Allowed 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.824 0.702 . . . . 0.0 112.812 -168.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.429 ' O ' ' HG3' ' A' ' 155' ' ' GLN . 26.9 t70 -62.2 -43.26 99.24 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.114 -175.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.06 -34.77 79.22 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.609 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' MET . . . . . 0.66 ' SD ' ' HE1' ' A' ' 27' ' ' PHE . 34.7 ttp -76.42 -33.13 58.81 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.754 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.627 ' HG2' ' O ' ' A' ' 150' ' ' ALA . 4.8 mmt -53.57 -37.92 63.4 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 173.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.429 ' HG3' ' O ' ' A' ' 151' ' ' ASP . 24.6 mt-30 -61.85 -44.98 95.74 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.63 -179.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -65.02 -33.35 75.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.421 -0.808 . . . . 0.0 112.568 -173.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.42 ' HG ' ' CG2' ' A' ' 44' ' ' VAL . 9.4 mt -93.72 -63.55 1.19 Allowed 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.831 0.824 . . . . 0.0 112.257 -178.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.575 HD22 ' HD2' ' A' ' 161' ' ' ARG . 68.2 mt -63.44 -42.22 98.67 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 113.468 -1.696 . . . . 0.0 112.837 -161.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.527 ' O ' ' HB3' ' A' ' 160' ' ' ALA . . . 54.01 94.37 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.602 -178.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 159' ' ' GLY . . . 87.41 -51.7 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.897 0.879 . . . . 0.0 111.356 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.677 ' HD3' ' O ' ' A' ' 161' ' ' ARG . 0.0 OUTLIER -60.06 -25.71 65.58 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.583 -178.057 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.2 -11.3 59.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.477 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.499 ' HD2' ' N ' ' A' ' 163' ' ' LYS . 0.2 OUTLIER -92.81 119.97 32.7 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.063 0.459 . . . . 0.0 110.022 178.045 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 167.11 -47.15 0.25 Allowed Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.251 -178.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 18.9 p-80 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.855 -0.593 . . . . 0.0 110.557 178.214 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.608 ' SD ' ' HG3' ' A' ' 6' ' ' LYS . 24.0 ttm . . . . . 0 N--CA 1.479 1.022 0 CA-C-O 120.859 0.361 . . . . 0.0 111.294 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.474 ' H ' HG21 ' A' ' 79' ' ' VAL . 1.0 OUTLIER -89.84 143.2 27.0 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 175.746 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.534 ' HA ' ' CB ' ' A' ' 6' ' ' LYS . 4.5 p30 -77.53 -11.53 59.87 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.689 -0.405 . . . . 0.0 112.034 -173.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.461 HG22 ' OD2' ' A' ' 2' ' ' ASP . 2.7 tp -62.13 -44.83 99.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 122.311 1.053 . . . . 0.0 108.864 169.078 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.792 ' HB2' HG22 ' A' ' 79' ' ' VAL . 25.1 m-85 -81.5 -29.1 33.75 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 114.143 -1.389 . . . . 0.0 109.995 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.746 ' O ' ' HG3' ' A' ' 10' ' ' GLU . 15.6 ttpt -67.3 -31.5 71.84 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.016 176.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.686 ' HA ' ' HG3' ' A' ' 10' ' ' GLU . . . -76.46 -26.44 55.4 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.163 0.506 . . . . 0.0 110.821 176.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.41 -40.99 94.08 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 167.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.687 ' HB ' ' O ' ' A' ' 6' ' ' LYS . 17.8 t -60.02 -29.18 42.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 114.3 -1.318 . . . . 0.0 111.412 171.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.746 ' HG3' ' O ' ' A' ' 6' ' ' LYS . 75.0 mt-10 -69.52 -30.39 68.21 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.635 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -78.1 -36.07 48.53 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 170.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.564 HD12 ' HA ' ' A' ' 9' ' ' VAL . 81.6 mt -56.76 143.89 34.93 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 169.117 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 61.6 p -104.24 165.46 11.04 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 120.074 -0.65 . . . . 0.0 109.696 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -54.55 -29.09 49.94 Favored 'General case' 0 C--O 1.212 -0.919 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 177.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -69.04 -51.48 38.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.469 175.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -55.78 -57.08 13.53 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.943 0.878 . . . . 0.0 111.37 174.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -53.21 -40.83 64.77 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 114.13 -1.395 . . . . 0.0 111.732 175.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -59.51 -47.45 85.48 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 121.02 0.438 . . . . 0.0 110.657 174.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -58.12 -38.61 76.84 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.754 -179.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.524 ' CD1' ' HG3' ' A' ' 81' ' ' MET . 18.2 m-85 -70.24 -34.44 72.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.51 177.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.617 ' O ' ' HD2' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -70.87 -53.13 16.31 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.589 ' O ' HG13 ' A' ' 26' ' ' ILE . . . -48.3 -45.66 35.15 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.29 -1.323 . . . . 0.0 110.211 175.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.551 ' HB2' HD21 ' A' ' 158' ' ' LEU . . . -70.54 -31.7 68.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.36 178.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.641 ' O ' HG22 ' A' ' 28' ' ' VAL . 55.6 t80 -52.63 -52.86 53.56 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 173.287 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -48.23 -39.62 21.83 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 113.605 -1.634 . . . . 0.0 111.439 177.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.591 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 1.8 mt -83.04 -35.89 12.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.101 -174.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.683 ' CE2' ' HA ' ' A' ' 41' ' ' LEU . 7.8 t80 -62.04 -29.71 70.47 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 177.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.641 HG22 ' O ' ' A' ' 24' ' ' PHE . 30.8 m -108.73 26.0 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.638 175.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.591 ' HB2' ' O ' ' A' ' 26' ' ' ILE . 0.2 OUTLIER -71.67 116.34 11.92 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -178.471 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.28 9.34 60.55 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.93 -174.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -85.7 148.93 25.64 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.047 0.451 . . . . 0.0 111.28 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -77.1 -45.86 25.5 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.54 -178.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -91.52 -17.91 24.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.879 0.371 . . . . 0.0 111.176 -176.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.96 5.75 85.8 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.745 177.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.562 ' HB2' ' HB ' ' A' ' 71' ' ' THR . 3.9 m -120.11 154.14 35.13 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 176.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.583 ' HB ' ' HB ' ' A' ' 72' ' ' VAL . 54.5 mt -68.97 107.72 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-O 121.119 0.485 . . . . 0.0 111.27 -172.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 96.3 p -90.4 -176.67 4.86 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 171.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.605 ' O ' HD13 ' A' ' 57' ' ' LEU . 47.1 p -69.26 -34.03 74.15 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -61.32 -56.08 24.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.832 176.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.506 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 0.7 OUTLIER -49.22 -44.58 43.51 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.938 174.888 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.683 ' HA ' ' CE2' ' A' ' 27' ' ' PHE . 4.6 tt -74.91 -37.53 62.04 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.371 -0.532 . . . . 0.0 109.709 -175.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -67.77 -35.77 85.98 Favored Glycine 0 C--N 1.333 0.366 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 175.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.506 ' HB3' ' O ' ' A' ' 40' ' ' GLU . 9.3 tttp -46.83 -53.22 12.48 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.498 0.719 . . . . 0.0 110.634 172.213 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.754 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 77.1 t -72.7 -44.06 60.41 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.7 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.759 -178.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.56 ' HE2' ' HA ' ' A' ' 45' ' ' MET . 31.5 mmt -53.44 -45.29 69.41 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 123.047 0.217 . . . . 0.0 111.306 178.033 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.549 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 29.2 mtt180 -60.35 -49.61 76.89 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.26 0.552 . . . . 0.0 110.989 176.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.27 -25.89 49.71 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.622 173.256 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.754 ' HB2' ' O ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -99.98 6.1 45.14 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.104 -169.316 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 107.12 -18.64 36.12 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 120.726 -0.75 . . . . 0.0 114.025 177.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.549 ' O ' ' HA ' ' A' ' 46' ' ' ARG . 1.7 mp0 -86.47 -177.97 6.31 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 117.649 0.724 . . . . 0.0 111.139 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.9 p-10 -156.01 62.12 2.97 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.845 169.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.688 ' HB3' HG11 ' A' ' 146' ' ' VAL . 72.9 Cg_endo -69.03 161.84 44.17 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 123.404 2.736 . . . . 0.0 113.855 -174.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.54 156.39 35.27 Favored Pre-proline 0 N--CA 1.441 -0.896 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.652 169.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -44.86 -37.6 12.19 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.885 2.39 . . . . 0.0 112.645 176.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.494 ' O ' ' HG2' ' A' ' 59' ' ' GLU . 1.3 tt0 -54.89 -51.82 64.8 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.636 178.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.736 ' HG3' HG22 ' A' ' 146' ' ' VAL . 7.5 tp10 -67.63 -41.93 83.13 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.689 0.757 . . . . 0.0 110.191 177.32 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.723 ' O ' HG12 ' A' ' 61' ' ' ILE . 73.6 mt -62.71 -41.39 99.11 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.079 -0.964 . . . . 0.0 112.057 -174.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -67.25 -23.39 65.7 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.759 0.314 . . . . 0.0 110.317 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.592 ' HG3' HH12 ' A' ' 144' ' ' ARG . 9.7 mm-40 -73.07 -37.2 66.89 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.974 0.416 . . . . 0.0 110.274 176.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.422 ' O ' ' HB3' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -71.9 -37.19 70.15 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 174.253 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.723 HG12 ' O ' ' A' ' 57' ' ' LEU . 51.2 mm -57.69 -54.12 35.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.453 171.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.559 ' HA ' ' HB3' ' A' ' 65' ' ' ASP . 9.3 t70 -60.86 -29.82 69.76 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.074 -176.127 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.422 ' HB3' ' O ' ' A' ' 60' ' ' MET . 13.9 tp10 -43.44 -49.46 7.17 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-O 122.309 1.052 . . . . 0.0 109.639 175.017 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.912 HG11 ' HB2' ' A' ' 80' ' ' MET . 0.0 OUTLIER -116.03 -1.9 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.722 0 CA-C-N 113.628 -1.623 . . . . 0.0 111.96 -172.169 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.559 ' HB3' ' HA ' ' A' ' 62' ' ' ASP . 21.6 t0 -88.69 82.59 6.81 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.036 0.446 . . . . 0.0 110.003 175.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -83.16 -26.25 31.08 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.742 -176.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -80.59 -8.53 59.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.224 0.535 . . . . 0.0 110.514 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 74.68 25.61 69.45 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.498 177.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.0 m -78.44 -8.7 58.8 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.948 0.404 . . . . 0.0 111.499 -175.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 72.59 9.96 75.0 Favored Glycine 0 C--N 1.323 -0.166 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.892 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.562 ' HB ' ' HB2' ' A' ' 35' ' ' SER . 0.6 OUTLIER -152.3 133.39 14.26 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.236 0.541 . . . . 0.0 110.136 -177.832 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.676 HG21 HG23 ' A' ' 64' ' ' VAL . 3.6 t -91.63 118.1 36.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.248 -177.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.401 ' HA ' ' CE1' ' A' ' 24' ' ' PHE . 1.9 p30 -94.39 179.04 5.42 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.405 176.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.434 ' CE1' HD22 ' A' ' 78' ' ' LEU . 10.9 t80 -53.42 -48.89 68.34 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -171.183 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -68.74 -35.94 77.76 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.732 0.301 . . . . 0.0 110.54 -173.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.417 ' OE2' ' HA ' ' A' ' 76' ' ' GLU . 3.8 mm-40 -64.03 -49.99 70.19 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.854 0.835 . . . . 0.0 109.752 172.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.409 ' O ' ' HG2' ' A' ' 81' ' ' MET . 5.2 t80 -57.62 -33.79 68.61 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 113.931 -1.486 . . . . 0.0 111.394 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.434 HD22 ' CE1' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -62.72 -51.37 67.43 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 177.221 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.906 HG12 HG12 ' A' ' 64' ' ' VAL . 1.2 t -53.24 -44.34 52.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.687 169.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.912 ' HB2' HG11 ' A' ' 64' ' ' VAL . 62.1 ttp -56.83 -44.87 82.49 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 122.002 0.906 . . . . 0.0 109.783 -179.044 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.618 ' O ' ' HG3' ' A' ' 85' ' ' MET . 18.5 mmt -60.85 -40.4 92.71 Favored 'General case' 0 N--CA 1.424 -1.766 0 CA-C-N 113.741 -1.572 . . . . 0.0 112.555 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.692 ' HA ' ' SD ' ' A' ' 85' ' ' MET . 0.8 OUTLIER -77.41 -28.53 16.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.448 178.203 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.705 ' HG3' ' O ' ' A' ' 79' ' ' VAL . 23.8 mtp180 -62.17 -36.36 81.63 Favored 'General case' 0 CA--C 1.522 -0.13 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.7 p -80.35 -6.92 58.77 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.334 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.692 ' SD ' ' HA ' ' A' ' 82' ' ' VAL . 61.4 mtt -76.0 -63.64 1.27 Allowed 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -177.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.614 ' HB3' ' HA ' ' A' ' 90' ' ' LYS . 17.6 tptp -61.2 -67.14 0.43 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.791 0.805 . . . . 0.0 110.857 -174.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -125.11 -164.6 1.3 Allowed 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 -177.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.503 ' HB3' HG21 ' A' ' 142' ' ' THR . 9.0 m-20 -66.05 -36.11 82.34 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 173.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.9 p -119.89 3.09 11.06 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.917 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.614 ' HA ' ' HB3' ' A' ' 86' ' ' LYS . 9.7 tmtt? 66.46 -68.59 0.13 Allowed 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -171.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -163.27 84.86 0.11 Allowed Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 176.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.7 175.67 4.07 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -173.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -90.8 -64.02 1.19 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.624 -174.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -142.03 -53.85 0.43 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.909 0.385 . . . . 0.0 110.943 -173.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -68.61 159.5 81.33 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.561 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -72.97 168.48 24.59 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.349 2.033 . . . . 0.0 110.627 176.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.503 HG21 ' HB3' ' A' ' 88' ' ' ASP . 6.2 m -75.92 67.26 2.27 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.085 0.469 . . . . 0.0 110.943 -177.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 19.6 mt 63.86 -171.63 0.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.017 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.592 HH12 ' HG3' ' A' ' 59' ' ' GLU . 0.7 OUTLIER -118.63 -65.09 1.21 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.082 0.468 . . . . 0.0 110.493 -176.673 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -85.46 -56.64 3.42 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.649 -175.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.736 HG22 ' HG3' ' A' ' 56' ' ' GLU . 14.6 m -101.64 156.07 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -170.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 19.5 tpt180 -163.99 135.67 4.72 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 114.395 -1.275 . . . . 0.0 110.106 164.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 13.7 mt -87.22 127.62 40.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.153 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.509 ' HB2' ' CB ' ' A' ' 152' ' ' ALA . 31.2 m -93.82 141.15 28.83 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 163.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.619 ' O ' ' HG2' ' A' ' 154' ' ' MET . . . -46.9 -62.96 1.16 Allowed 'General case' 0 N--CA 1.467 0.379 0 O-C-N 123.249 0.343 . . . . 0.0 111.908 -173.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.619 ' HA ' ' HB2' ' A' ' 154' ' ' MET . 3.9 p30 -73.99 -24.56 59.61 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.524 -174.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.509 ' CB ' ' HB2' ' A' ' 149' ' ' SER . . . -58.24 -42.35 86.16 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.899 177.432 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' MET . . . . . 0.507 ' HG2' HD23 ' A' ' 157' ' ' LEU . 1.1 tmt? -80.57 -35.17 34.64 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.179 174.121 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.619 ' HG2' ' O ' ' A' ' 150' ' ' ALA . 28.4 mmt -47.86 -56.61 7.1 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.104 177.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.537 ' HG2' ' O ' ' A' ' 151' ' ' ASP . 11.3 pt20 -56.92 -46.17 82.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.469 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.452 ' N ' ' HG3' ' A' ' 155' ' ' GLN . . . -51.62 -44.1 62.79 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.727 -177.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.507 HD23 ' HG2' ' A' ' 153' ' ' MET . 3.9 mm? -91.27 -52.45 4.81 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.485 0.66 . . . . 0.0 111.767 -174.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.564 ' HB2' ' HB2' ' A' ' 162' ' ' ALA . 4.7 mt -85.71 -47.87 9.37 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.021 -0.991 . . . . 0.0 112.966 -170.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 66.32 -97.09 0.3 Allowed Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 111.229 -0.749 . . . . 0.0 111.229 -170.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.405 ' O ' ' HG2' ' A' ' 163' ' ' LYS . . . -67.82 -33.46 74.83 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.536 0.684 . . . . 0.0 111.479 177.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.458 ' HB3' ' HB3' ' A' ' 158' ' ' LEU . 0.2 OUTLIER -84.72 23.47 1.16 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.384 -172.935 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.564 ' HB2' ' HB2' ' A' ' 158' ' ' LEU . . . -126.99 23.06 6.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.381 178.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.405 ' HG2' ' O ' ' A' ' 160' ' ' ALA . 16.1 ptpt -155.85 -172.91 4.3 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.948 -176.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 88.0 29.86 19.16 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.629 178.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 56.7 m-70 . . . . . 0 C--O 1.245 0.86 0 CA-C-O 118.369 -0.824 . . . . 0.0 109.475 179.623 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.2 ttt . . . . . 0 N--CA 1.48 1.063 0 CA-C-O 120.75 0.31 . . . . 0.0 110.548 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.443 ' HB2' ' CD1' ' A' ' 5' ' ' TYR . 9.9 m-20 -69.53 115.19 8.49 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 176.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.413 ' HA ' ' CB ' ' A' ' 6' ' ' LYS . 7.8 p-10 -76.84 -12.56 59.99 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -173.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.3 tp -57.89 -40.99 78.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 122.195 0.998 . . . . 0.0 108.649 167.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.636 ' CB ' HG22 ' A' ' 79' ' ' VAL . 22.9 m-85 -82.82 -34.22 26.99 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.934 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.736 ' O ' ' HG3' ' A' ' 10' ' ' GLU . 14.1 ttpt -66.39 -30.85 71.32 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.36 176.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.705 ' HA ' ' CG ' ' A' ' 10' ' ' GLU . . . -77.64 -27.25 51.01 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.058 0.456 . . . . 0.0 111.046 176.178 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.448 ' O ' ' HG ' ' A' ' 12' ' ' LEU . . . -63.15 -41.0 99.2 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 167.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.625 ' HB ' ' O ' ' A' ' 6' ' ' LYS . 16.8 t -61.5 -33.11 55.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.246 171.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.736 ' HG3' ' O ' ' A' ' 6' ' ' LYS . 71.5 mt-10 -65.1 -27.22 68.61 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.035 178.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -85.61 -36.27 20.48 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.831 172.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.53 ' HA ' ' OE1' ' A' ' 16' ' ' GLN . 73.4 mt -56.78 141.51 44.06 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-O 121.78 0.8 . . . . 0.0 109.644 172.079 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.519 HG23 ' OE1' ' A' ' 16' ' ' GLN . 3.3 p -100.61 164.95 11.65 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.511 -176.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -57.4 -25.9 60.27 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.343 -0.543 . . . . 0.0 109.954 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -73.09 -51.67 17.14 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.475 173.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.53 ' OE1' ' HA ' ' A' ' 12' ' ' LEU . 38.4 mt-30 -54.31 -58.0 9.08 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-O 121.727 0.775 . . . . 0.0 111.054 174.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.448 ' HG2' HD21 ' A' ' 78' ' ' LEU . 57.2 mtpt -50.79 -45.5 59.26 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.581 -1.19 . . . . 0.0 111.969 174.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -60.12 -43.38 95.68 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 120.951 0.405 . . . . 0.0 110.691 175.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -57.77 -40.24 79.34 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.025 -177.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.434 ' CD2' ' HG3' ' A' ' 81' ' ' MET . 40.8 m-85 -70.57 -38.57 74.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.901 176.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.708 ' O ' ' HB3' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -62.7 -51.54 66.78 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 122.121 0.962 . . . . 0.0 109.579 178.846 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.642 ' O ' HG13 ' A' ' 26' ' ' ILE . . . -50.52 -49.54 55.44 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.06 -1.427 . . . . 0.0 110.643 177.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.496 ' HB2' HD21 ' A' ' 158' ' ' LEU . . . -67.32 -33.37 75.12 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.172 177.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.708 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 40.2 t80 -48.98 -55.51 11.68 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 172.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.525 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 23.9 t70 -51.68 -36.77 47.75 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 113.705 -1.589 . . . . 0.0 111.914 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.642 HG13 ' O ' ' A' ' 22' ' ' ALA . 2.8 mt -80.38 -41.19 20.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.93 -175.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.588 ' CE2' ' HA ' ' A' ' 41' ' ' LEU . 2.8 t80 -56.72 -30.86 63.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.324 177.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.553 HG22 ' O ' ' A' ' 24' ' ' PHE . 27.0 m -107.71 16.41 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.96 -176.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.526 ' HG ' ' HA ' ' A' ' 26' ' ' ILE . 33.8 mt -72.78 121.2 19.51 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 173.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.46 5.71 58.92 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.268 -171.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.45 149.44 21.7 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.338 0.589 . . . . 0.0 110.692 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -78.98 -45.61 19.94 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.219 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -94.66 -18.33 21.43 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.088 0.471 . . . . 0.0 111.302 -175.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.4 3.28 84.51 Favored Glycine 0 C--O 1.225 -0.436 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.043 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.514 ' HB2' ' HB ' ' A' ' 71' ' ' THR . 5.1 m -111.57 148.01 34.19 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 174.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.572 HD11 ' HD2' ' A' ' 77' ' ' PHE . 53.0 mt -68.15 107.17 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 C-N-CA 121.313 -0.155 . . . . 0.0 111.059 -175.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 82.0 p -90.88 -175.43 4.35 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 170.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.59 ' O ' HD13 ' A' ' 57' ' ' LEU . 55.5 p -64.15 -36.24 83.41 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 120.992 0.425 . . . . 0.0 110.132 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -59.46 -56.11 26.15 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.094 177.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -48.98 -49.62 39.74 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 114.647 -1.16 . . . . 0.0 112.489 175.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.588 ' HA ' ' CE2' ' A' ' 27' ' ' PHE . 2.3 tt -71.07 -34.39 71.13 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 120.42 -0.512 . . . . 0.0 109.993 -174.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.9 ' O ' ' HG3' ' A' ' 46' ' ' ARG . . . -64.23 -46.93 89.53 Favored Glycine 0 C--O 1.218 -0.872 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 173.14 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 35.0 tttt -46.31 -47.79 18.33 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.328 0.651 . . . . 0.0 111.138 -178.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.481 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 92.1 t -74.44 -38.65 47.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.151 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.578 ' HG3' ' HG3' ' A' ' 52' ' ' PRO . 34.2 mmt -55.03 -49.72 70.85 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 174.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.9 ' HG3' ' O ' ' A' ' 42' ' ' GLY . 41.1 mtt180 -50.16 -59.41 3.95 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.682 0.753 . . . . 0.0 110.286 174.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 4.9 ttp -52.27 -23.87 6.43 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.074 -1.421 . . . . 0.0 112.534 174.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.518 HD21 ' O ' ' A' ' 152' ' ' ALA . 5.2 mt -97.68 0.29 46.85 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -175.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 105.92 -2.59 38.49 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.8 -0.714 . . . . 0.0 113.089 177.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.725 ' HB3' ' HD3' ' A' ' 52' ' ' PRO . 1.2 mp0 -99.77 -179.6 4.23 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 120.747 0.308 . . . . 0.0 111.037 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -159.36 58.23 1.17 Allowed Pre-proline 0 CA--C 1.536 0.426 0 CA-C-O 121.544 0.687 . . . . 0.0 111.223 166.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.725 ' HD3' ' HB3' ' A' ' 50' ' ' GLN . 43.7 Cg_endo -63.41 157.72 49.0 Favored 'Trans proline' 0 N--CA 1.476 0.499 0 C-N-CA 123.964 3.109 . . . . 0.0 113.473 -177.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.99 156.48 57.81 Favored Pre-proline 0 CA--C 1.504 -0.816 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.376 175.003 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -46.29 -35.5 15.69 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 122.641 2.227 . . . . 0.0 113.048 174.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -63.23 -51.11 67.57 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.581 177.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.58 ' O ' HG21 ' A' ' 146' ' ' VAL . 7.5 tt0 -65.01 -32.48 74.23 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.662 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.684 ' O ' HG12 ' A' ' 61' ' ' ILE . 65.7 mt -76.12 -37.72 57.74 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.811 178.054 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.53 -36.21 75.69 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-O 120.563 0.22 . . . . 0.0 110.792 -178.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.463 ' HG3' ' CD1' ' A' ' 143' ' ' LEU . 7.6 pt-20 -77.88 -27.31 49.65 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.578 -177.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.472 ' SD ' ' HG ' ' A' ' 143' ' ' LEU . 10.5 tpt -71.68 -39.98 69.87 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 169.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.684 HG12 ' O ' ' A' ' 57' ' ' LEU . 47.6 mm -58.55 -54.13 37.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.275 172.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -62.63 -30.22 71.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.331 -172.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.643 ' OE2' HG23 ' A' ' 142' ' ' THR . 2.6 tt0 -56.03 -37.6 69.43 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 121.875 0.845 . . . . 0.0 109.329 177.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 1.009 HG11 ' HB2' ' A' ' 80' ' ' MET . 0.1 OUTLIER -100.3 -33.36 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.722 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.702 -173.067 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -58.28 111.71 1.3 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.297 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -70.48 -31.85 69.14 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.146 -177.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -107.35 -6.33 17.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.807 -173.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 75.16 26.06 67.24 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.654 175.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.7 m -75.29 -26.77 58.99 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.219 0.533 . . . . 0.0 111.621 -175.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 104.97 20.04 10.23 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -176.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.544 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 0.8 OUTLIER -149.89 131.48 14.87 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.345 0.593 . . . . 0.0 111.147 -178.63 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.476 HG22 ' HB ' ' A' ' 64' ' ' VAL . 18.0 t -101.36 113.05 36.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.777 178.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.559 ' HA ' ' CE2' ' A' ' 24' ' ' PHE . 3.2 t70 -99.62 174.18 6.36 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.418 ' O ' ' HB3' ' A' ' 77' ' ' PHE . 17.7 t80 -42.94 -55.64 3.65 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -167.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -62.13 -41.14 97.95 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 118.15 0.432 . . . . 0.0 110.766 -176.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.422 ' CB ' HG13 ' A' ' 72' ' ' VAL . 1.6 mp0 -56.99 -56.32 23.26 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.593 0.711 . . . . 0.0 109.287 169.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.572 ' HD2' HD11 ' A' ' 36' ' ' ILE . 20.7 t80 -47.73 -35.62 10.08 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.21 -1.359 . . . . 0.0 111.445 -176.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.46 ' HG ' HG22 ' A' ' 9' ' ' VAL . 3.0 tp -75.36 -42.82 53.28 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.239 -177.022 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.798 ' O ' ' HG3' ' A' ' 83' ' ' ARG . 1.0 OUTLIER -55.5 -44.96 78.19 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.523 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 167.052 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' MET . . . . . 1.009 ' HB2' HG11 ' A' ' 64' ' ' VAL . 55.2 ttp -59.2 -44.02 92.24 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.134 0.492 . . . . 0.0 110.785 177.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.623 ' O ' ' HB2' ' A' ' 85' ' ' MET . 24.5 mmt -57.87 -55.1 39.25 Favored 'General case' 0 N--CA 1.426 -1.669 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.078 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.594 ' HA ' ' HB2' ' A' ' 85' ' ' MET . 18.8 m -63.0 -29.16 46.55 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.635 0 C-N-CA 120.729 -0.388 . . . . 0.0 111.026 176.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.798 ' HG3' ' O ' ' A' ' 79' ' ' VAL . 57.9 mtt-85 -58.77 -42.39 88.81 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.951 0.405 . . . . 0.0 110.55 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.506 ' HG ' ' HA ' ' A' ' 149' ' ' SER . 29.1 t -79.4 -44.21 21.89 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.533 0.682 . . . . 0.0 109.759 174.374 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.623 ' HB2' ' O ' ' A' ' 81' ' ' MET . 0.2 OUTLIER -50.36 -40.52 49.66 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 124.563 1.145 . . . . 0.0 113.998 177.869 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.534 ' HA ' ' HE2' ' A' ' 86' ' ' LYS . 3.5 mmpt? -54.31 -61.47 2.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.918 0.389 . . . . 0.0 111.716 -176.047 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -174.12 151.25 1.66 Allowed 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -175.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.405 ' O ' ' HD3' ' A' ' 137' ' ' LYS . 11.7 t70 -69.55 -15.78 63.3 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.92 0.39 . . . . 0.0 110.417 -178.279 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 56.3 m -100.71 -9.78 21.49 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.323 174.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 22.1 tptp -57.63 -41.56 81.6 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 176.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.672 ' C ' HG21 ' A' ' 142' ' ' THR . . . -151.55 115.1 0.68 Allowed Glycine 0 N--CA 1.435 -1.41 0 CA-C-N 114.616 -1.175 . . . . 0.0 110.889 174.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.464 ' O ' ' HB ' ' A' ' 142' ' ' THR . 4.6 tptm -152.94 -80.2 0.1 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.765 0.317 . . . . 0.0 110.281 177.137 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -104.01 -43.22 5.34 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.517 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 99.6 mttt -68.05 148.75 50.56 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 172.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.517 ' HB2' ' O ' ' A' ' 139' ' ' LYS . 0.2 OUTLIER 68.77 162.21 0.14 Allowed Pre-proline 0 C--O 1.234 0.259 0 O-C-N 124.02 0.825 . . . . 0.0 110.229 -168.903 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -64.75 57.15 0.26 Allowed 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 123.996 3.13 . . . . 0.0 111.463 171.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.672 HG21 ' C ' ' A' ' 136' ' ' GLY . 1.4 m -98.1 -159.4 0.74 Allowed 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.78 -175.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.669 ' H ' HG22 ' A' ' 142' ' ' THR . 3.2 mm? -125.0 122.25 36.77 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -160.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 22.0 tpt180 -90.72 127.73 36.42 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 167.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.495 ' CZ ' ' HG3' ' A' ' 50' ' ' GLN . 0.0 OUTLIER 76.14 -51.35 0.61 Allowed 'General case' 0 N--CA 1.471 0.6 0 O-C-N 123.775 0.672 . . . . 0.0 111.714 178.312 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.58 HG21 ' O ' ' A' ' 56' ' ' GLU . 0.9 OUTLIER -87.98 27.24 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.662 0 CA-C-O 121.049 0.452 . . . . 0.0 111.716 -178.022 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.412 HH22 ' HB3' ' A' ' 83' ' ' ARG . 32.7 tpt180 -88.09 95.54 10.19 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 120.214 -0.594 . . . . 0.0 109.412 177.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 32.2 mt -54.32 116.43 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.322 -0.853 . . . . 0.0 111.129 176.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.51 ' HB2' ' CB ' ' A' ' 152' ' ' ALA . 21.2 m -80.89 134.61 35.77 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 167.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.672 ' O ' ' HG2' ' A' ' 154' ' ' MET . . . -44.63 -63.48 0.89 Allowed 'General case' 0 N--CA 1.465 0.284 0 O-C-N 123.805 0.69 . . . . 0.0 112.297 -173.076 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.536 ' HA ' ' HB2' ' A' ' 154' ' ' MET . 5.5 m-20 -75.34 -22.71 57.4 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.318 -175.003 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.518 ' O ' HD21 ' A' ' 48' ' ' LEU . . . -59.09 -46.14 89.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.791 0.329 . . . . 0.0 111.169 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' MET . . . . . 0.447 ' HA ' HD11 ' A' ' 48' ' ' LEU . 7.7 ptm -79.74 -26.42 40.77 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 119.916 -0.714 . . . . 0.0 110.175 176.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.672 ' HG2' ' O ' ' A' ' 150' ' ' ALA . 27.8 mmt -51.66 -56.97 10.6 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.224 177.049 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.551 ' HG3' ' N ' ' A' ' 156' ' ' ALA . 10.6 pt20 -58.91 -48.45 81.43 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.791 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.551 ' N ' ' HG3' ' A' ' 155' ' ' GLN . . . -53.31 -42.37 66.6 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.025 -0.989 . . . . 0.0 112.44 -176.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.517 ' HB3' ' HB ' ' A' ' 26' ' ' ILE . 3.3 mm? -91.51 -44.03 9.33 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.951 0.405 . . . . 0.0 111.805 -177.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.598 HD22 ' HB3' ' A' ' 161' ' ' ARG . 16.3 mt -85.56 -48.08 9.27 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.127 -171.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 67.05 3.28 22.41 Favored Glycine 0 CA--C 1.508 -0.353 0 CA-C-N 115.686 -0.688 . . . . 0.0 113.98 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.517 ' C ' ' H ' ' A' ' 162' ' ' ALA . . . 177.81 -48.06 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.687 0.756 . . . . 0.0 110.613 -169.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.598 ' HB3' HD22 ' A' ' 158' ' ' LEU . 0.0 OUTLIER -75.34 32.16 0.1 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.707 179.081 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.517 ' H ' ' C ' ' A' ' 160' ' ' ALA . . . -114.08 -8.78 13.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.12 171.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.438 ' N ' ' HD3' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -129.05 -48.84 1.21 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.961 -1.018 . . . . 0.0 108.707 179.063 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 143.54 -106.18 0.41 Allowed Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.503 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 45.7 m80 . . . . . 0 C--O 1.246 0.904 0 CA-C-O 118.554 -0.736 . . . . 0.0 109.733 176.977 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.1 ttt . . . . . 0 N--CA 1.477 0.877 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.463 ' HB2' ' CD2' ' A' ' 5' ' ' TYR . 11.0 m-20 -65.08 118.72 9.58 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -75.48 -10.59 59.58 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -171.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.2 tt -59.27 -38.47 74.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 122.0 0.905 . . . . 0.0 108.775 169.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.645 ' CB ' HG22 ' A' ' 79' ' ' VAL . 18.1 m-85 -83.06 -30.38 28.07 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.57 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.413 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 33.8 tttt -70.01 -33.5 72.1 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.094 177.187 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.2 -34.73 78.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.995 0.426 . . . . 0.0 110.321 176.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.52 ' O ' ' HG ' ' A' ' 12' ' ' LEU . . . -62.05 -46.95 86.87 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.163 171.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.513 ' HA ' ' HB2' ' A' ' 12' ' ' LEU . 1.5 t -54.42 -37.88 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.683 172.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -69.5 -27.79 65.5 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.014 -0.994 . . . . 0.0 112.097 -178.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -85.59 -29.71 23.9 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.529 170.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 8' ' ' ALA . 22.6 mt -59.86 135.75 57.79 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.129 172.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.465 ' H ' ' HB2' ' A' ' 16' ' ' GLN . 31.6 p -98.89 165.51 11.73 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.566 -176.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -55.63 -28.7 56.74 Favored 'General case' 0 C--O 1.212 -0.875 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 179.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -70.67 -48.72 53.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.649 176.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.465 ' HB2' ' H ' ' A' ' 13' ' ' THR . 69.9 mm-40 -57.83 -57.9 10.74 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.816 0.817 . . . . 0.0 111.355 174.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.449 ' HG3' ' HB3' ' A' ' 12' ' ' LEU . 58.4 mtpt -54.71 -44.07 73.14 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 113.971 -1.468 . . . . 0.0 111.577 178.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -59.39 -45.44 91.48 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.755 174.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -56.96 -41.3 78.06 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.539 -177.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.431 ' CD1' ' HG3' ' A' ' 81' ' ' MET . 32.2 m-85 -68.55 -36.92 79.46 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.112 176.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.656 ' O ' ' HB3' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -65.37 -51.14 62.49 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 122.037 0.922 . . . . 0.0 108.865 179.602 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.767 ' O ' HG13 ' A' ' 26' ' ' ILE . . . -48.73 -49.04 40.03 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.127 -1.397 . . . . 0.0 110.351 175.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.45 ' HA ' HD12 ' A' ' 26' ' ' ILE . . . -67.85 -33.67 75.2 Favored 'General case' 0 CA--C 1.518 -0.265 0 O-C-N 123.054 0.221 . . . . 0.0 110.959 178.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.656 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 64.8 t80 -51.29 -56.17 14.41 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 171.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.463 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 35.7 t70 -49.53 -43.48 45.77 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 113.835 -1.529 . . . . 0.0 111.921 178.052 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.767 HG13 ' O ' ' A' ' 22' ' ' ALA . 4.5 mt -72.06 -43.97 66.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.68 0.753 . . . . 0.0 109.922 -177.059 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.663 ' CE2' ' HA ' ' A' ' 41' ' ' LEU . 3.7 t80 -58.6 -29.66 66.63 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.286 -1.325 . . . . 0.0 109.628 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.552 HG22 ' O ' ' A' ' 24' ' ' PHE . 30.2 m -109.7 18.66 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.119 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.487 ' HG ' ' HA ' ' A' ' 26' ' ' ILE . 18.3 mt -67.53 117.24 9.22 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 119.808 -0.757 . . . . 0.0 109.46 177.189 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.21 11.97 53.05 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.814 -174.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -85.78 151.76 23.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.23 0.538 . . . . 0.0 111.052 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -77.95 -45.66 23.33 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.486 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -95.24 -17.55 21.61 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.109 -176.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.54 -2.04 86.05 Favored Glycine 0 C--O 1.221 -0.665 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.065 -176.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.403 ' CB ' ' HB ' ' A' ' 71' ' ' THR . 69.8 m -105.81 157.04 17.74 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 176.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.49 ' HB ' ' HB ' ' A' ' 72' ' ' VAL . 66.1 mt -72.74 107.69 3.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.954 -175.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 62.7 p -90.62 -175.97 4.58 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 170.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.544 ' O ' HD13 ' A' ' 57' ' ' LEU . 62.8 p -66.69 -38.82 87.54 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 120.655 -0.418 . . . . 0.0 109.938 178.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 58.6 tttp -58.31 -51.35 70.17 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.42 176.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.705 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 0.6 OUTLIER -51.96 -43.87 63.72 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.782 175.511 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.663 ' HA ' ' CE2' ' A' ' 27' ' ' PHE . 4.5 tt -75.26 -33.5 61.29 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.9 -175.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.788 ' O ' ' HG3' ' A' ' 46' ' ' ARG . . . -66.27 -33.61 85.58 Favored Glycine 0 C--O 1.222 -0.602 0 C-N-CA 120.324 -0.941 . . . . 0.0 111.182 173.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.705 ' HB3' ' O ' ' A' ' 40' ' ' GLU . 0.6 OUTLIER -45.92 -47.84 16.3 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.598 0.713 . . . . 0.0 109.949 175.412 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.612 HG21 ' CD1' ' A' ' 27' ' ' PHE . 98.3 t -80.14 -42.08 21.5 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.922 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.51 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 4.9 mmt -59.64 -51.48 69.63 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 117.826 0.285 . . . . 0.0 111.043 -177.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.788 ' HG3' ' O ' ' A' ' 42' ' ' GLY . 76.3 mtt180 -50.97 -56.64 11.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.406 0.622 . . . . 0.0 110.346 172.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.405 ' CE ' ' HA ' ' A' ' 44' ' ' VAL . 6.1 ttp -51.35 -29.7 16.17 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.778 -1.101 . . . . 0.0 112.82 173.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.575 ' HB2' ' O ' ' A' ' 44' ' ' VAL . 4.3 mt -92.57 -2.27 56.29 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 123.152 0.581 . . . . 0.0 112.085 -172.018 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 103.01 -9.51 54.95 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.339 177.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.599 ' HB3' ' HD3' ' A' ' 52' ' ' PRO . 10.8 mp0 -84.64 175.54 9.16 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 175.005 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -158.31 63.54 2.63 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-O 122.035 0.922 . . . . 0.0 109.708 172.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.738 ' HB3' HG11 ' A' ' 146' ' ' VAL . 48.9 Cg_endo -68.89 161.93 43.61 Favored 'Trans proline' 0 CA--C 1.512 -0.623 0 C-N-CA 123.673 2.915 . . . . 0.0 113.087 -178.025 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.9 p -87.87 161.49 44.15 Favored Pre-proline 0 CA--C 1.499 -0.989 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.905 166.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -47.78 -26.38 6.92 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 122.846 2.364 . . . . 0.0 112.576 169.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -65.65 -53.8 36.33 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.813 177.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -65.25 -41.4 94.36 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.586 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.707 ' O ' HG12 ' A' ' 61' ' ' ILE . 98.5 mt -59.34 -45.6 90.92 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.091 175.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -65.38 -29.84 70.59 Favored 'General case' 0 C--O 1.216 -0.671 0 C-N-CA 121.077 -0.249 . . . . 0.0 110.485 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -68.52 -39.97 81.0 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.829 0.347 . . . . 0.0 111.037 176.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.48 ' HG2' ' O ' ' A' ' 146' ' ' VAL . 0.0 OUTLIER -71.15 -37.39 72.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.945 175.727 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.707 HG12 ' O ' ' A' ' 57' ' ' LEU . 47.4 mm -59.12 -49.92 81.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.636 0.732 . . . . 0.0 109.149 171.158 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.437 ' HA ' ' HB3' ' A' ' 65' ' ' ASP . 15.6 t70 -65.15 -25.34 67.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.873 -174.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.448 ' HB2' ' O ' ' A' ' 60' ' ' MET . 2.6 mm-40 -49.43 -33.16 13.36 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-O 121.712 0.768 . . . . 0.0 110.102 173.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.997 HG11 ' HB2' ' A' ' 80' ' ' MET . 0.0 OUTLIER -130.5 -14.46 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.568 0 CA-C-N 114.318 -1.31 . . . . 0.0 113.431 -167.768 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.437 ' HB3' ' HA ' ' A' ' 62' ' ' ASP . 25.3 t70 -63.21 92.03 0.05 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.079 0.466 . . . . 0.0 111.301 176.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -91.18 -35.74 14.36 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.405 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -78.88 -8.74 59.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.169 0.509 . . . . 0.0 110.783 -176.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.408 ' HA2' ' OD1' ' A' ' 65' ' ' ASP . . . 74.27 18.17 79.78 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.947 -0.57 . . . . 0.0 113.07 174.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 57.5 m -90.87 6.86 42.77 Favored 'General case' 0 C--N 1.321 -0.64 0 O-C-N 122.585 -0.362 . . . . 0.0 111.661 -176.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 71.31 19.81 77.76 Favored Glycine 0 CA--C 1.507 -0.464 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.216 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 0.8 OUTLIER -146.6 139.67 25.51 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 114.802 -0.699 . . . . 0.0 110.496 -175.89 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.582 HG21 HG23 ' A' ' 64' ' ' VAL . 6.7 t -96.52 121.66 47.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.458 176.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -96.69 179.27 5.04 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 177.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.434 ' CZ ' HD22 ' A' ' 78' ' ' LEU . 12.0 t80 -53.1 -54.33 37.19 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -170.129 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -67.44 -34.05 76.41 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.636 -172.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.404 ' OE2' ' HA ' ' A' ' 72' ' ' VAL . 82.0 mt-10 -62.34 -54.14 44.89 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-O 121.6 0.714 . . . . 0.0 109.749 171.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.47 ' O ' ' HG2' ' A' ' 81' ' ' MET . 4.1 t80 -55.55 -30.59 61.05 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.577 178.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.499 ' O ' HG13 ' A' ' 82' ' ' VAL . 0.9 OUTLIER -69.78 -47.78 61.63 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 178.116 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.799 HG12 HG12 ' A' ' 64' ' ' VAL . 0.5 OUTLIER -54.52 -43.48 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 168.768 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.997 ' HB2' HG11 ' A' ' 64' ' ' VAL . 64.0 ttp -56.24 -47.65 78.06 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.459 0.647 . . . . 0.0 110.122 177.075 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.636 ' O ' ' HG3' ' A' ' 85' ' ' MET . 23.7 mmt -60.42 -37.49 81.05 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 114.785 -1.098 . . . . 0.0 112.158 -177.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.591 ' HA ' ' SD ' ' A' ' 85' ' ' MET . 1.3 m -79.95 -28.87 12.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 119.934 -0.706 . . . . 0.0 110.319 176.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.794 ' HG3' ' O ' ' A' ' 79' ' ' VAL . 54.6 mtp85 -62.33 -34.56 76.87 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 177.075 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.486 ' HB3' ' O ' ' A' ' 148' ' ' ILE . 3.9 p -80.15 -16.98 53.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.054 -0.976 . . . . 0.0 112.394 177.071 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.636 ' HG3' ' O ' ' A' ' 81' ' ' MET . 57.0 mtt -69.37 -46.19 67.55 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 121.319 0.581 . . . . 0.0 111.366 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.444 ' HB2' ' HG2' ' A' ' 90' ' ' LYS . 64.9 mmtt -60.0 -37.99 81.31 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.051 -0.977 . . . . 0.0 112.11 -175.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.43 ' OD2' ' HD3' ' A' ' 137' ' ' LYS . 21.1 t70 -178.97 165.15 1.53 Allowed 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -178.067 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -47.91 -43.95 29.34 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 123.372 0.42 . . . . 0.0 109.897 175.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.402 ' OG ' ' HB3' ' A' ' 137' ' ' LYS . 0.1 OUTLIER -123.17 23.94 9.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.853 -179.062 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.444 ' HG2' ' HB2' ' A' ' 86' ' ' LYS . 0.4 OUTLIER 52.12 -95.03 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.226 0.61 . . . . 0.0 110.367 -179.396 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.432 ' H ' ' HB3' ' A' ' 90' ' ' LYS . . . -94.8 61.03 1.69 Allowed Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 178.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.43 ' HD3' ' OD2' ' A' ' 87' ' ' ASP . 49.9 pttt -56.99 139.37 52.33 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.607 -0.297 . . . . 0.0 110.884 -178.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 61.3 t80 76.91 -24.18 0.23 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.658 -177.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -95.72 -30.12 13.91 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.28 0.562 . . . . 0.0 110.682 178.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.435 ' NE ' ' HA ' ' A' ' 140' ' ' ARG . 2.4 mmp_? -121.31 155.15 59.04 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-O 121.342 0.592 . . . . 0.0 110.342 177.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -80.62 53.36 4.73 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 123.585 2.857 . . . . 0.0 111.169 174.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.08 60.05 2.33 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.389 -175.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.579 ' HB3' ' O ' ' A' ' 145' ' ' ARG . 6.4 mp 70.14 138.99 0.04 OUTLIER 'General case' 0 C--N 1.334 -0.094 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.753 169.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 20.7 ptp180 -88.76 -4.89 58.4 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.443 173.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.579 ' O ' ' HB3' ' A' ' 143' ' ' LEU . 0.1 OUTLIER -160.09 170.69 20.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.485 -179.707 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.738 HG11 ' HB3' ' A' ' 52' ' ' PRO . 28.1 m 44.82 37.94 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 N-CA-C 114.684 1.365 . . . . 0.0 114.684 173.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.539 ' NH2' ' HB3' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -84.36 94.14 8.41 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 169.872 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.486 ' O ' ' HB3' ' A' ' 84' ' ' SER . 35.3 mt -51.37 132.51 12.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.414 -176.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 74.2 m -92.89 144.57 25.14 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 165.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.583 ' O ' ' HG2' ' A' ' 154' ' ' MET . . . -50.12 -62.73 1.41 Allowed 'General case' 0 C--N 1.33 -0.28 0 O-C-N 123.306 0.379 . . . . 0.0 111.653 -172.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.6 ' HA ' ' HB2' ' A' ' 154' ' ' MET . 4.2 p-10 -72.76 -24.87 61.01 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.706 -174.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -55.09 -48.37 73.64 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.757 176.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' MET . . . . . 0.489 ' O ' HD23 ' A' ' 157' ' ' LEU . 3.7 ppp? -80.85 -28.1 36.22 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.591 177.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.6 ' HB2' ' HA ' ' A' ' 151' ' ' ASP . 26.9 mmt -50.76 -55.95 14.34 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.002 0.429 . . . . 0.0 110.777 177.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.519 ' HG2' ' O ' ' A' ' 151' ' ' ASP . 7.0 pt20 -58.38 -50.88 72.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.113 -176.102 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -55.19 -40.97 71.33 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.098 -0.956 . . . . 0.0 112.298 -175.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.489 HD23 ' O ' ' A' ' 153' ' ' MET . 3.8 mm? -86.02 -53.08 5.3 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.403 0.62 . . . . 0.0 111.434 -177.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.751 HD22 ' HG2' ' A' ' 161' ' ' ARG . 57.4 mt -79.17 -47.59 15.75 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.003 -0.999 . . . . 0.0 112.573 -169.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.43 ' O ' ' HE3' ' A' ' 163' ' ' LYS . . . 68.5 -107.16 1.97 Allowed Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.3 -172.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.433 ' O ' ' HG2' ' A' ' 163' ' ' LYS . . . -61.06 -43.38 98.97 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.558 0.694 . . . . 0.0 111.559 177.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.751 ' HG2' HD22 ' A' ' 158' ' ' LEU . 1.8 tpm_? -62.88 -20.81 65.49 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.023 -0.99 . . . . 0.0 111.674 -177.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.549 ' HB2' ' HB2' ' A' ' 158' ' ' LEU . . . -71.21 -45.25 63.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.236 0.541 . . . . 0.0 110.685 178.19 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.433 ' HG2' ' O ' ' A' ' 160' ' ' ALA . 9.8 ptpt -85.73 -31.3 22.51 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.137 -175.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 79.79 -47.94 3.4 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.791 177.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 54.3 m80 . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.703 -0.665 . . . . 0.0 110.454 -178.418 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.427 ' CE ' HG23 ' A' ' 79' ' ' VAL . 21.6 ttt . . . . . 0 N--CA 1.478 0.941 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -69.84 116.05 9.78 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 178.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.456 ' HA ' ' CB ' ' A' ' 6' ' ' LYS . 5.0 p-10 -76.38 -12.61 60.09 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.98 -172.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 7.1 tt -59.36 -40.56 81.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 121.686 0.755 . . . . 0.0 109.439 169.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.775 ' HB2' HG22 ' A' ' 79' ' ' VAL . 23.1 m-85 -82.39 -32.44 29.17 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.246 177.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.748 ' O ' ' HG3' ' A' ' 10' ' ' GLU . 18.4 ttpt -66.95 -34.52 77.94 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.593 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.729 ' HA ' ' CG ' ' A' ' 10' ' ' GLU . . . -75.45 -25.84 57.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.862 0.363 . . . . 0.0 111.226 176.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.452 ' O ' ' HG ' ' A' ' 12' ' ' LEU . . . -65.03 -39.94 94.11 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 167.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.663 ' HB ' ' O ' ' A' ' 6' ' ' LYS . 13.5 t -61.53 -36.39 72.97 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.363 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.826 170.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.748 ' HG3' ' O ' ' A' ' 6' ' ' LYS . 50.8 mt-10 -61.58 -35.18 77.09 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.515 178.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -72.66 -38.04 67.75 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.187 170.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' A' ' 8' ' ' ALA . 76.0 mt -59.09 137.66 57.86 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-O 121.893 0.854 . . . . 0.0 109.279 173.009 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 52.0 p -96.42 160.56 14.34 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.217 -177.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -54.55 -24.03 19.16 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 177.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -69.54 -56.51 7.15 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.624 171.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -53.63 -57.05 12.18 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.869 0.842 . . . . 0.0 111.53 176.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.483 ' HG2' HD21 ' A' ' 78' ' ' LEU . 50.3 mtpt -52.04 -43.92 63.99 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 114.21 -1.359 . . . . 0.0 111.92 174.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -58.61 -42.53 88.36 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-O 121.32 0.581 . . . . 0.0 110.341 176.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -57.94 -38.95 76.88 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 114.572 -1.194 . . . . 0.0 109.66 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.488 ' CD1' ' HG3' ' A' ' 81' ' ' MET . 26.4 m-85 -72.29 -32.32 66.51 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.119 178.291 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.687 ' O ' ' HB3' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -71.44 -50.29 33.21 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 122.056 0.932 . . . . 0.0 109.459 -179.403 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.758 ' O ' HG13 ' A' ' 26' ' ' ILE . . . -53.42 -47.51 69.53 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.177 -1.374 . . . . 0.0 110.23 175.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.508 ' HA ' HD12 ' A' ' 26' ' ' ILE . . . -71.29 -25.54 62.48 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.181 178.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.687 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 44.5 t80 -54.0 -54.72 35.15 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 169.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.451 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 23.3 t70 -53.42 -37.82 62.9 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 113.53 -1.668 . . . . 0.0 111.51 178.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.758 HG13 ' O ' ' A' ' 22' ' ' ALA . 8.1 mt -76.97 -41.58 31.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.774 -176.283 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.513 ' HD1' ' HE3' ' A' ' 153' ' ' MET . 0.5 OUTLIER -61.82 -21.93 65.04 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.515 179.016 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.577 HG22 ' O ' ' A' ' 24' ' ' PHE . 27.6 m -114.72 19.66 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.01 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.546 ' HG ' ' HA ' ' A' ' 26' ' ' ILE . 22.9 mt -70.17 117.99 12.43 Favored 'General case' 0 C--O 1.236 0.389 0 O-C-N 121.543 -0.723 . . . . 0.0 109.771 175.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.17 12.57 57.35 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.503 -173.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -90.41 158.16 17.23 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.256 0.55 . . . . 0.0 111.495 -179.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -80.1 -46.81 15.82 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.264 -178.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -91.76 -17.34 25.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.166 0.508 . . . . 0.0 111.188 -176.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.8 9.34 87.16 Favored Glycine 0 N--CA 1.449 -0.5 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -171.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.3 m -119.63 145.98 45.96 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 177.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.482 ' HB ' ' HB ' ' A' ' 72' ' ' VAL . 66.3 mt -68.93 106.84 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.674 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.314 -174.062 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.449 ' H ' ' HB2' ' A' ' 40' ' ' GLU . 88.9 p -87.31 -168.45 2.24 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 170.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.519 ' O ' HD13 ' A' ' 57' ' ' LEU . 72.0 p -69.62 -42.85 73.81 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 122.127 -0.358 . . . . 0.0 110.548 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -59.1 -49.19 78.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.573 177.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.688 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 0.9 OUTLIER -54.86 -50.64 68.18 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.131 -0.94 . . . . 0.0 112.975 172.84 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.868 HD12 HD22 ' A' ' 57' ' ' LEU . 0.8 OUTLIER -51.53 -58.14 7.12 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 175.886 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.816 ' O ' ' HG3' ' A' ' 46' ' ' ARG . . . -60.45 -31.73 75.27 Favored Glycine 0 C--O 1.219 -0.832 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.1 -178.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.688 ' HB3' ' O ' ' A' ' 40' ' ' GLU . 23.6 tttp -45.89 -50.42 14.48 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 123.282 0.633 . . . . 0.0 110.865 -176.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.512 ' HB ' ' CZ ' ' A' ' 27' ' ' PHE . 92.5 t -78.36 -41.52 25.98 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.977 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.773 178.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 37.9 mmm -54.59 -45.53 73.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 118.316 0.507 . . . . 0.0 109.914 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.816 ' HG3' ' O ' ' A' ' 42' ' ' GLY . 37.5 mtp180 -50.87 -57.56 8.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.426 0.632 . . . . 0.0 111.079 171.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.456 ' HE3' HG22 ' A' ' 44' ' ' VAL . 1.8 ttp -53.33 -34.39 57.3 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.35 174.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.511 ' HB3' ' OE1' ' A' ' 50' ' ' GLN . 6.5 mt -79.42 -5.02 53.75 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 124.061 0.944 . . . . 0.0 112.555 -174.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 107.19 -18.6 35.97 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.116 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.63 ' O ' ' HA ' ' A' ' 46' ' ' ARG . 26.6 mp0 -83.91 177.56 8.25 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 122.346 0.258 . . . . 0.0 110.371 177.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -160.38 59.92 1.3 Allowed Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.5 0.667 . . . . 0.0 111.732 169.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.894 ' HG2' HD21 ' A' ' 57' ' ' LEU . 40.0 Cg_endo -67.82 156.12 67.18 Favored 'Trans proline' 0 CA--C 1.519 -0.242 0 C-N-CA 123.578 2.852 . . . . 0.0 113.666 -176.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.618 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 1.0 OUTLIER -84.9 161.04 54.22 Favored Pre-proline 0 C--N 1.318 -0.803 0 CA-C-N 114.631 -1.168 . . . . 0.0 112.059 -177.948 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -41.24 -39.08 3.72 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 123.365 2.71 . . . . 0.0 112.906 170.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 59' ' ' GLU . 26.8 tt0 -58.42 -52.61 64.89 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.29 176.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -64.65 -35.97 82.75 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-O 121.992 0.901 . . . . 0.0 111.519 -178.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.894 HD21 ' HG2' ' A' ' 52' ' ' PRO . 85.0 mt -76.02 -43.61 43.29 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 114.381 -1.281 . . . . 0.0 111.117 -175.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -65.65 -25.41 67.34 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 177.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.653 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 29.3 mt-10 -66.27 -54.02 29.88 Favored 'General case' 0 C--O 1.214 -0.779 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.548 172.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.46 ' CG ' HD21 ' A' ' 41' ' ' LEU . 8.9 tpt -60.14 -32.51 71.09 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.728 0.299 . . . . 0.0 110.581 176.135 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.679 HG12 ' O ' ' A' ' 57' ' ' LEU . 17.1 mm -62.64 -57.62 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 171.291 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -60.78 -30.11 69.84 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.965 -176.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.653 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 7.1 mm-40 -44.89 -38.74 4.84 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.125 -1.398 . . . . 0.0 111.275 177.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.837 HG12 HG12 ' A' ' 79' ' ' VAL . 5.1 m -132.31 -15.84 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.428 -172.044 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -61.09 110.11 1.28 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 172.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -70.48 -21.8 62.74 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -173.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -115.58 -7.62 12.18 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.476 -0.489 . . . . 0.0 111.941 -173.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 77.25 25.27 64.1 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.537 -0.84 . . . . 0.0 111.53 -176.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 36.8 m -62.13 -40.7 96.8 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 122.953 0.501 . . . . 0.0 112.282 -175.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 109.35 11.28 22.17 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 -174.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 0.5 OUTLIER -149.18 131.72 15.78 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 121.28 0.562 . . . . 0.0 110.742 179.737 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.582 ' CG2' HG23 ' A' ' 64' ' ' VAL . 2.9 t -99.1 126.76 52.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.619 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.445 ' HA ' ' CZ ' ' A' ' 24' ' ' PHE . 0.7 OUTLIER -101.48 178.87 4.52 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 176.235 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -47.79 -51.35 22.82 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -170.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -66.92 -41.75 86.52 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.183 0.516 . . . . 0.0 110.816 -172.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -60.92 -47.41 86.53 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.268 174.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.578 ' O ' ' HG2' ' A' ' 81' ' ' MET . 15.4 t80 -57.45 -35.5 70.21 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.806 177.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.592 ' HG ' HG22 ' A' ' 9' ' ' VAL . 2.6 tp -72.62 -43.63 63.04 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.143 -178.228 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.837 HG12 HG12 ' A' ' 64' ' ' VAL . 1.0 OUTLIER -59.06 -41.42 83.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 169.741 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.746 ' CA ' HG11 ' A' ' 64' ' ' VAL . 60.8 ttp -57.15 -46.03 83.08 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.521 178.192 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.637 ' O ' ' HG3' ' A' ' 85' ' ' MET . 24.9 mmt -55.18 -52.34 63.63 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 114.295 -1.32 . . . . 0.0 111.571 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.65 ' HA ' ' SD ' ' A' ' 85' ' ' MET . 2.5 m -69.48 -33.26 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.924 -176.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.819 ' HG3' ' O ' ' A' ' 79' ' ' VAL . 27.3 mtp-105 -58.22 -40.98 83.07 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.99 0.9 . . . . 0.0 108.695 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.725 ' HB3' ' O ' ' A' ' 148' ' ' ILE . 4.8 m -80.19 -8.48 59.46 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 113.79 -1.55 . . . . 0.0 111.658 -177.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.65 ' SD ' ' HA ' ' A' ' 82' ' ' VAL . 62.0 mtt -78.63 -45.34 21.77 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.69 ' HB3' ' HA ' ' A' ' 90' ' ' LYS . 35.3 tptt -58.11 -56.45 21.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.848 -169.097 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -172.69 170.42 4.73 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -170.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -48.65 -49.49 37.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.929 0.395 . . . . 0.0 110.348 175.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.5 t -100.8 8.06 43.43 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.97 -177.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.69 ' HA ' ' HB3' ' A' ' 86' ' ' LYS . 8.1 tmtt? 62.35 -77.92 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.016 0.526 . . . . 0.0 109.6 -174.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -162.93 21.96 0.18 Allowed Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 177.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -97.37 -166.29 1.37 Allowed 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.301 0.572 . . . . 0.0 110.757 -177.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.422 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 9.1 t80 -138.69 -176.83 4.61 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.023 -0.989 . . . . 0.0 108.426 177.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 138' ' ' PHE . 94.8 mttt 76.08 -65.25 0.32 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.222 0.609 . . . . 0.0 111.693 176.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 9.1 mtm180 -130.9 160.77 65.13 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-O 121.565 0.698 . . . . 0.0 110.009 176.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -87.22 55.88 3.07 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 124.24 3.294 . . . . 0.0 111.714 -178.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 1.4 m 53.22 74.57 0.29 Allowed 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.578 -176.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.462 ' HG ' HH21 ' A' ' 147' ' ' ARG . 25.4 mt 80.82 171.46 0.14 Allowed 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.283 -171.184 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -82.88 -66.42 0.89 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.127 0.489 . . . . 0.0 110.951 -177.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.472 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 0.1 OUTLIER -100.19 -39.38 8.09 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.568 -178.845 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -83.42 76.98 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.948 -164.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.462 HH21 ' HG ' ' A' ' 143' ' ' LEU . 5.6 tpp180 -124.34 105.12 9.2 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.354 171.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.725 ' O ' ' HB3' ' A' ' 84' ' ' SER . 11.1 mt -71.99 131.53 34.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.624 -178.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.539 ' HB2' ' HB2' ' A' ' 152' ' ' ALA . 20.4 m -82.56 134.21 35.19 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 167.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.661 ' O ' ' HG2' ' A' ' 154' ' ' MET . . . -46.53 -63.37 1.03 Allowed 'General case' 0 N--CA 1.468 0.426 0 O-C-N 123.345 0.403 . . . . 0.0 112.011 -172.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.589 ' HA ' ' HB2' ' A' ' 154' ' ' MET . 4.3 p-10 -71.88 -24.16 61.62 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.647 -175.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.539 ' HB2' ' HB2' ' A' ' 149' ' ' SER . . . -55.35 -45.26 76.45 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.277 177.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' MET . . . . . 0.533 ' HE1' ' HZ ' ' A' ' 77' ' ' PHE . 7.9 ptm -79.83 -31.98 40.61 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.155 175.011 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.661 ' HG2' ' O ' ' A' ' 150' ' ' ALA . 32.3 mmt -50.15 -50.35 49.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.028 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.513 ' HG3' ' H ' ' A' ' 156' ' ' ALA . 1.8 pt20 -59.98 -56.23 24.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.877 0.37 . . . . 0.0 111.932 -178.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.513 ' H ' ' HG3' ' A' ' 155' ' ' GLN . . . -54.57 -40.88 69.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.14 -175.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.536 HD12 HG22 ' A' ' 26' ' ' ILE . 3.4 mm? -80.49 -60.84 2.17 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.39 0.614 . . . . 0.0 111.008 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.568 HD12 ' HB2' ' A' ' 162' ' ' ALA . 64.4 mt -65.81 -35.72 81.48 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.908 -1.042 . . . . 0.0 112.252 -169.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 76.14 -64.77 2.73 Favored Glycine 0 CA--C 1.499 -0.952 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.513 -176.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -148.15 45.66 1.07 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.333 0.587 . . . . 0.0 111.135 -175.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.713 ' HD3' ' O ' ' A' ' 161' ' ' ARG . 0.0 OUTLIER -133.13 -7.19 3.03 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.656 178.718 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.568 ' HB2' HD12 ' A' ' 158' ' ' LEU . . . -81.25 47.72 1.06 Allowed 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -172.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.53 164.69 2.57 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.731 0.3 . . . . 0.0 110.3 -178.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -101.63 37.99 3.38 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 175.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 49.4 p-80 . . . . . 0 C--O 1.246 0.894 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.233 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.7 ttt . . . . . 0 N--CA 1.477 0.885 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -65.14 110.58 2.58 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 175.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.463 ' HA ' ' CB ' ' A' ' 6' ' ' LYS . 4.2 p-10 -70.7 -6.95 41.07 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -172.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.478 HD11 ' NZ ' ' A' ' 90' ' ' LYS . 3.0 tt -61.36 -43.21 96.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 169.039 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.646 ' CE2' ' HG2' ' A' ' 83' ' ' ARG . 23.3 m-85 -80.63 -32.01 36.38 Favored 'General case' 0 N--CA 1.428 -1.57 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.694 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.643 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 19.3 ttpt -63.78 -35.95 82.3 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.648 172.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.74 -35.29 79.77 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.228 0.537 . . . . 0.0 110.22 176.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.527 ' O ' ' HG ' ' A' ' 12' ' ' LEU . . . -61.14 -39.74 91.22 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.562 171.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 5' ' ' TYR . 98.0 t -66.59 -35.61 75.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.291 175.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.643 ' HG2' ' O ' ' A' ' 6' ' ' LYS . 7.9 mm-40 -64.54 -27.38 68.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.421 178.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -82.77 -38.77 22.74 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.64 170.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.602 HD21 ' HE1' ' A' ' 85' ' ' MET . 32.9 mt -52.3 134.38 33.84 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-O 121.448 0.642 . . . . 0.0 109.853 177.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.529 HG23 ' OE1' ' A' ' 16' ' ' GLN . 6.7 p -82.3 164.71 20.94 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -55.12 -44.5 75.06 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 177.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -53.37 -49.62 66.79 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.046 174.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.553 ' HB3' HD22 ' A' ' 12' ' ' LEU . 37.6 mt-30 -58.24 -54.3 48.49 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.029 0.442 . . . . 0.0 111.755 178.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -55.55 -45.17 77.28 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.444 175.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -59.86 -41.33 91.23 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.713 176.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.412 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 6.2 tt0 -59.95 -44.17 94.57 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.23 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.41 ' HB3' ' HG3' ' A' ' 81' ' ' MET . 23.5 m-85 -73.08 -25.54 60.93 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.46 176.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.526 ' O ' ' HB3' ' A' ' 24' ' ' PHE . 0.6 OUTLIER -69.82 -46.51 65.51 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 176.161 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.583 ' O ' HG13 ' A' ' 26' ' ' ILE . . . -51.82 -43.47 63.13 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 113.632 -1.622 . . . . 0.0 110.103 171.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.672 ' O ' ' HB2' ' A' ' 27' ' ' PHE . . . -64.58 -43.42 93.91 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.536 177.191 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.526 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 35.5 t80 -51.12 -52.25 45.63 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.707 0.765 . . . . 0.0 109.466 171.215 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -51.99 -55.57 19.65 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 113.98 -1.464 . . . . 0.0 112.168 -177.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.641 ' HA ' ' HG ' ' A' ' 29' ' ' LEU . 21.3 mt -67.77 -38.0 79.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.17 -178.075 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.672 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 0.3 OUTLIER -54.43 -32.01 56.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.988 177.568 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 24' ' ' PHE . 22.2 m -112.4 24.47 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.028 -177.038 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.641 ' HG ' ' HA ' ' A' ' 26' ' ' ILE . 91.0 mt -76.48 117.01 17.7 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 170.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.16 13.29 54.81 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.29 -0.957 . . . . 0.0 111.454 -169.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -86.6 144.54 27.13 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.626 0.727 . . . . 0.0 111.428 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -80.46 -39.84 27.35 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.319 -1.309 . . . . 0.0 111.129 -178.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -105.3 -16.46 14.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.676 -177.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.7 -3.2 83.17 Favored Glycine 0 C--O 1.222 -0.599 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.576 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.8 m -111.91 150.56 30.3 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 174.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.6 ' O ' ' HA ' ' A' ' 71' ' ' THR . 57.1 mt -68.42 107.44 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.015 -175.227 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 96.9 p -89.05 -174.34 4.41 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 169.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 32.0 p -76.49 -25.37 54.18 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.2 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 30.6 tttm -59.1 -57.13 14.43 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 169.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.426 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 2.1 mp0 -52.59 -52.73 53.88 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.244 -0.889 . . . . 0.0 113.06 173.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.934 ' HG ' HD22 ' A' ' 57' ' ' LEU . 16.8 tp -61.0 -55.31 34.41 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.889 -177.049 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.09 -33.86 85.74 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.36 178.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.426 ' HB3' ' O ' ' A' ' 40' ' ' GLU . 6.3 tttp -52.14 -40.88 62.0 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.256 0.551 . . . . 0.0 110.124 169.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.596 HG21 ' CD2' ' A' ' 27' ' ' PHE . 33.9 t -76.0 -43.59 38.62 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.546 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.272 178.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.845 ' HE1' HG13 ' A' ' 148' ' ' ILE . 13.1 mmt -56.07 -34.53 66.03 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.473 178.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 65.6 mtp180 -62.28 -47.92 82.2 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.833 0.825 . . . . 0.0 110.098 172.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.512 ' HB3' ' HB1' ' A' ' 156' ' ' ALA . 2.5 mtm -61.58 -16.7 50.45 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 114.164 -1.38 . . . . 0.0 111.204 174.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.595 ' HB2' ' HA ' ' A' ' 45' ' ' MET . 17.9 mt -99.08 -8.2 25.62 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.901 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 106.0 -13.02 45.31 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 121.026 -0.606 . . . . 0.0 113.348 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.527 ' HB3' ' HD3' ' A' ' 52' ' ' PRO . 1.7 mp0 -99.62 -174.37 2.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.018 0.437 . . . . 0.0 110.506 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 29.1 p-10 -159.01 60.94 1.75 Allowed Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.057 167.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 1.13 ' HG2' HD21 ' A' ' 57' ' ' LEU . 43.7 Cg_endo -66.78 165.53 25.42 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.064 2.509 . . . . 0.0 112.066 -178.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.671 ' OG1' ' HG3' ' A' ' 56' ' ' GLU . 38.1 p -90.6 157.6 43.97 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.525 -172.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -50.21 -29.82 23.96 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.084 1.856 . . . . 0.0 111.223 173.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -59.3 -55.05 39.77 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.206 173.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.763 ' HB3' HG11 ' A' ' 146' ' ' VAL . 40.5 mt-10 -59.34 -49.0 79.5 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.749 176.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 1.13 HD21 ' HG2' ' A' ' 52' ' ' PRO . 80.7 mt -67.89 -29.06 68.07 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 114.606 -1.179 . . . . 0.0 112.776 -171.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.428 ' O ' ' HB2' ' A' ' 62' ' ' ASP . 36.9 tt0 -75.24 -27.17 59.39 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.061 -0.655 . . . . 0.0 110.064 -172.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.82 -36.55 28.21 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.036 -178.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.592 ' HE2' ' HB ' ' A' ' 148' ' ' ILE . 2.1 ttt -66.91 -37.02 83.57 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.846 175.274 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.6 HG23 HG23 ' A' ' 72' ' ' VAL . 5.5 mt -65.28 -50.36 73.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.351 169.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.677 ' HA ' ' HB3' ' A' ' 65' ' ' ASP . 12.9 t70 -56.6 -32.96 65.76 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.783 -177.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.566 ' OE2' ' HG2' ' A' ' 137' ' ' LYS . 4.1 mt-10 -44.85 -48.63 11.08 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.453 178.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.695 HG21 ' HB2' ' A' ' 80' ' ' MET . 28.6 m -110.6 -15.31 9.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.987 -176.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.677 ' HB3' ' HA ' ' A' ' 62' ' ' ASP . 61.7 t0 -64.76 107.61 1.49 Allowed 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 173.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -64.82 -38.36 90.73 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.793 -175.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -94.34 -7.94 40.34 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -175.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.42 24.0 77.0 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.357 -0.925 . . . . 0.0 111.74 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 65.0 p -73.49 -7.6 52.47 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -171.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.51 16.77 67.82 Favored Glycine 0 C--N 1.311 -0.826 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -175.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.6 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 0.7 OUTLIER -146.22 131.17 18.18 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.996 0.903 . . . . 0.0 111.594 179.567 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.6 HG23 HG23 ' A' ' 61' ' ' ILE . 1.0 OUTLIER -104.39 119.03 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 CA-C-N 114.301 -1.318 . . . . 0.0 109.588 -179.05 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.467 ' CG ' ' H ' ' A' ' 74' ' ' PHE . 18.9 t70 -98.57 -169.08 1.74 Allowed 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 177.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.467 ' H ' ' CG ' ' A' ' 73' ' ' ASP . 8.8 t80 -55.52 -57.46 11.81 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -167.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -65.41 -43.37 90.78 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.768 -172.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.482 ' HG2' ' HA ' ' A' ' 65' ' ' ASP . 2.5 mp0 -50.74 -55.17 17.93 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.481 0.657 . . . . 0.0 111.34 169.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.415 ' HZ ' ' SD ' ' A' ' 153' ' ' MET . 89.7 t80 -58.96 -43.28 91.26 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.104 -178.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.5 tp -60.62 -41.01 93.96 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.403 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.575 ' O ' ' HG3' ' A' ' 83' ' ' ARG . 46.9 t -54.21 -50.55 54.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 170.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.695 ' HB2' HG21 ' A' ' 64' ' ' VAL . 45.2 ttp -58.15 -38.06 75.85 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.56 -178.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.415 ' O ' ' HG3' ' A' ' 85' ' ' MET . 23.9 mmt -61.4 -44.11 97.71 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 115.173 -0.922 . . . . 0.0 112.184 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.673 ' HA ' ' HB2' ' A' ' 85' ' ' MET . 1.7 m -69.34 -28.98 40.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 121.048 0.451 . . . . 0.0 110.487 178.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.646 ' HG2' ' CE2' ' A' ' 5' ' ' TYR . 21.3 mtp180 -67.31 -40.64 86.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.978 -178.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.4 m -80.8 -12.44 59.44 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.898 174.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.673 ' HB2' ' HA ' ' A' ' 82' ' ' VAL . 1.0 OUTLIER -75.62 -63.38 1.31 Allowed 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 123.768 0.827 . . . . 0.0 112.273 -179.763 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.2 tptm -59.99 -37.55 80.0 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.286 0.565 . . . . 0.0 110.64 -173.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -153.65 167.88 28.08 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -175.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -64.91 -21.92 66.9 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.104 178.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.542 ' HA ' ' HD2' ' A' ' 137' ' ' LYS . 51.9 m -131.42 -36.02 1.29 Allowed 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.478 ' NZ ' HD11 ' A' ' 4' ' ' ILE . 0.4 OUTLIER 69.93 -77.42 0.05 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.046 0.539 . . . . 0.0 110.321 -176.316 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -151.54 46.23 0.61 Allowed Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 178.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.566 ' HG2' ' OE2' ' A' ' 63' ' ' GLU . 56.8 mttm -90.31 -105.96 0.09 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.542 -0.329 . . . . 0.0 110.856 -178.008 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.537 ' O ' ' HG2' ' A' ' 141' ' ' PRO . 16.2 t80 56.12 -161.49 0.19 Allowed 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -177.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.413 ' HB3' ' HD2' ' A' ' 141' ' ' PRO . 55.7 mtmt 58.22 -160.83 0.25 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 174.159 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.651 ' N ' ' HD2' ' A' ' 141' ' ' PRO . 92.2 mtt180 -55.87 -50.14 88.88 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 114.742 -1.117 . . . . 0.0 112.804 173.377 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.651 ' HD2' ' N ' ' A' ' 140' ' ' ARG . 1.7 Cg_endo -39.08 -63.2 0.28 Allowed 'Trans proline' 0 C--N 1.362 1.285 0 C-N-CA 124.068 3.179 . . . . 0.0 114.384 -177.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.522 ' OG1' ' HD3' ' A' ' 137' ' ' LYS . 97.5 m -100.92 117.39 34.88 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.475 0.655 . . . . 0.0 110.183 177.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.721 ' HB2' ' CG1' ' A' ' 146' ' ' VAL . 5.9 mp -92.05 176.06 6.64 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.381 -172.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.475 ' O ' ' HB2' ' A' ' 145' ' ' ARG . 89.0 mtm180 -88.77 57.76 4.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.836 -168.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.498 ' NE ' ' HA ' ' A' ' 52' ' ' PRO . 4.3 tmm_? 171.78 -58.57 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.791 0.805 . . . . 0.0 109.556 175.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.763 HG11 ' HB3' ' A' ' 56' ' ' GLU . 1.3 p -57.79 108.83 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 114.158 -1.383 . . . . 0.0 110.515 172.079 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.427 ' HA ' ' HD3' ' A' ' 147' ' ' ARG . 4.0 tpp180 -144.89 131.59 20.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.312 0.577 . . . . 0.0 112.39 -175.274 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.845 HG13 ' HE1' ' A' ' 45' ' ' MET . 4.2 mt -113.07 111.41 35.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.284 174.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 73.4 m -99.24 136.78 38.69 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 171.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.613 ' O ' ' HG2' ' A' ' 154' ' ' MET . . . -54.94 -58.31 8.14 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 118.295 0.498 . . . . 0.0 110.649 -173.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.523 ' O ' ' HG2' ' A' ' 155' ' ' GLN . 3.8 m-20 -52.46 -49.26 65.0 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 123.993 0.808 . . . . 0.0 110.587 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.13 -48.7 80.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.32 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' MET . . . . . 0.87 ' HE2' HD23 ' A' ' 157' ' ' LEU . 0.0 OUTLIER -58.08 -47.19 83.95 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.946 -179.804 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.613 ' HG2' ' O ' ' A' ' 150' ' ' ALA . 22.6 mmt -56.78 -31.73 64.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.054 0.454 . . . . 0.0 111.235 178.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.523 ' HG2' ' O ' ' A' ' 151' ' ' ASP . 14.7 mm100 -77.2 -45.14 27.56 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.258 -0.428 . . . . 0.0 112.086 -177.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.512 ' HB1' ' HB3' ' A' ' 47' ' ' MET . . . -65.53 -47.55 75.54 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.947 -175.206 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.87 HD23 ' HE2' ' A' ' 153' ' ' MET . 3.1 mm? -86.28 -64.4 1.16 Allowed 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.193 0.521 . . . . 0.0 111.488 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.605 ' HB2' ' O ' ' A' ' 154' ' ' MET . 97.3 mt -62.24 -48.25 80.79 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.998 -167.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 34.54 -90.74 0.01 OUTLIER Glycine 0 C--N 1.343 0.956 0 O-C-N 124.857 1.348 . . . . 0.0 114.023 175.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -46.02 -46.47 16.57 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.914 0.886 . . . . 0.0 112.146 176.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.442 HH11 ' HD3' ' A' ' 161' ' ' ARG . 0.0 OUTLIER -94.96 -6.75 41.72 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.575 -174.751 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.565 ' HB2' ' HB2' ' A' ' 158' ' ' LEU . . . -76.04 -78.89 0.11 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.294 -176.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 49.06 45.6 22.87 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.437 0.637 . . . . 0.0 109.846 -174.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -74.38 172.92 51.79 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.225 -0.898 . . . . 0.0 113.19 -172.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 86.3 t60 . . . . . 0 C--O 1.247 0.934 0 CA-C-O 118.515 -0.755 . . . . 0.0 110.33 -178.27 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.442 ' O ' ' HB2' ' A' ' 2' ' ' ASP . 19.1 ttt . . . . . 0 N--CA 1.481 1.077 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.567 ' HB3' HG22 ' A' ' 4' ' ' ILE . 7.1 m-20 72.52 106.91 0.07 Allowed 'General case' 0 C--O 1.237 0.435 0 O-C-N 123.72 0.637 . . . . 0.0 110.005 -170.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.453 ' HA ' ' HB3' ' A' ' 6' ' ' LYS . 5.0 p-10 -69.74 -5.41 24.98 Favored 'General case' 0 C--O 1.224 -0.284 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -175.148 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.567 HG22 ' HB3' ' A' ' 2' ' ' ASP . 3.5 tt -57.77 -44.66 86.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 170.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.669 ' CE2' ' HG2' ' A' ' 83' ' ' ARG . 27.1 m-85 -82.0 -33.12 30.25 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.513 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.609 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 26.1 ttpt -64.45 -39.29 93.53 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.584 176.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.27 -29.65 70.94 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.27 0.557 . . . . 0.0 110.053 176.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.554 ' O ' ' HG ' ' A' ' 12' ' ' LEU . . . -66.97 -39.6 87.24 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.413 172.116 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.531 HG22 ' HG ' ' A' ' 78' ' ' LEU . 52.7 t -67.03 -32.29 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 121.232 0.539 . . . . 0.0 110.312 174.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.609 ' HG2' ' O ' ' A' ' 6' ' ' LYS . 8.7 mm-40 -67.94 -27.74 66.88 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.517 177.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -85.1 -37.52 20.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.116 171.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.658 HD21 ' HE1' ' A' ' 85' ' ' MET . 49.5 mt -53.7 135.01 41.73 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 172.13 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.448 ' OG1' ' HG3' ' A' ' 16' ' ' GLN . 16.4 p -86.24 157.0 20.05 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 -178.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -52.95 -37.46 61.08 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 118.97 0.805 . . . . 0.0 108.928 177.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -53.7 -57.26 11.46 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.979 170.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.484 ' O ' ' HB3' ' A' ' 19' ' ' GLU . 32.7 mt-30 -52.8 -52.58 56.24 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 121.381 0.61 . . . . 0.0 111.708 176.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 34.2 mtpt -56.38 -39.46 72.98 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 123.898 0.879 . . . . 0.0 112.283 176.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -69.04 -32.88 72.69 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 121.343 0.592 . . . . 0.0 109.817 177.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.484 ' HB3' ' O ' ' A' ' 16' ' ' GLN . 21.0 tt0 -62.23 -35.81 80.05 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 176.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.419 ' CD2' ' HG3' ' A' ' 81' ' ' MET . 28.9 m-85 -78.9 -29.42 44.3 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.469 174.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.494 ' O ' ' HB3' ' A' ' 24' ' ' PHE . 40.5 tptt -59.78 -51.73 68.52 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-O 122.363 1.078 . . . . 0.0 109.319 172.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.49 ' O ' HG13 ' A' ' 26' ' ' ILE . . . -51.46 -37.62 49.71 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 112.898 -1.955 . . . . 0.0 110.96 173.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.496 ' O ' HD13 ' A' ' 157' ' ' LEU . . . -73.39 -42.04 62.6 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.283 177.062 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.705 ' O ' HG22 ' A' ' 28' ' ' VAL . 23.4 t80 -48.89 -51.34 30.43 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.685 0.755 . . . . 0.0 108.997 171.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.452 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 19.2 t70 -49.23 -54.99 14.02 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.62 -1.627 . . . . 0.0 112.204 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.612 ' HB ' HD22 ' A' ' 157' ' ' LEU . 24.3 mt -74.48 -31.17 27.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.67 -175.211 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.66 ' CD2' HD11 ' A' ' 157' ' ' LEU . 0.2 OUTLIER -56.11 -31.92 63.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.292 176.596 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.705 HG22 ' O ' ' A' ' 24' ' ' PHE . 30.7 m -121.54 23.35 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.564 -172.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.579 ' HG ' ' HA ' ' A' ' 26' ' ' ILE . 82.7 mt -69.83 118.05 12.18 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 175.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.87 12.38 59.23 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.961 -174.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -86.02 155.31 20.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.073 0.463 . . . . 0.0 111.006 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -79.54 -45.44 19.23 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.151 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -100.04 -15.46 18.23 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.865 -175.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.7 4.53 85.15 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.203 -0.999 . . . . 0.0 112.329 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.446 ' HB2' ' HB ' ' A' ' 71' ' ' THR . 0.8 OUTLIER -122.18 149.98 42.87 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 175.627 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.678 ' O ' ' HA ' ' A' ' 71' ' ' THR . 58.8 mt -63.29 107.34 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.569 -0.742 . . . . 0.0 112.01 -169.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.443 ' H ' ' HB2' ' A' ' 40' ' ' GLU . 90.9 p -85.38 178.65 7.38 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 172.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.566 ' O ' HD13 ' A' ' 57' ' ' LEU . 16.9 p -71.74 -34.81 69.85 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.407 178.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -57.24 -56.12 25.98 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 171.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.629 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 0.9 OUTLIER -49.18 -48.44 45.12 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.592 -1.185 . . . . 0.0 113.456 172.181 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.801 ' HG ' HD22 ' A' ' 57' ' ' LEU . 24.5 tp -64.5 -51.3 63.67 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 121.029 -0.269 . . . . 0.0 110.531 -178.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.33 -40.11 74.96 Favored Glycine 0 C--O 1.224 -0.509 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.224 174.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.629 ' HB3' ' O ' ' A' ' 40' ' ' GLU . 14.7 tttp -48.31 -50.54 29.7 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.524 0.73 . . . . 0.0 110.812 172.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.601 HG21 ' CD1' ' A' ' 27' ' ' PHE . 2.6 t -71.83 -45.59 64.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.947 178.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.568 ' SD ' HG12 ' A' ' 146' ' ' VAL . 1.1 mmt -54.23 -37.71 64.93 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 176.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.707 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 97.1 mtt180 -61.32 -48.69 80.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.324 171.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.558 ' SD ' ' HA ' ' A' ' 44' ' ' VAL . 81.2 mtp -51.6 -29.19 16.49 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.907 0.86 . . . . 0.0 110.533 171.263 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.405 ' HB2' ' HA ' ' A' ' 45' ' ' MET . 16.6 mt -94.87 7.96 44.28 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 114.023 -1.444 . . . . 0.0 112.404 -172.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.34 -9.47 77.31 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.741 -0.663 . . . . 0.0 113.207 174.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.707 ' O ' ' HA ' ' A' ' 46' ' ' ARG . 74.8 mt-30 -102.12 -179.66 4.06 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -160.77 69.72 2.71 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-O 121.395 0.617 . . . . 0.0 109.577 167.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.881 ' HG2' HD21 ' A' ' 57' ' ' LEU . 9.8 Cg_endo -65.23 170.93 9.87 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.7 2.267 . . . . 0.0 111.564 176.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.624 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 4.4 p -96.21 157.1 36.19 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.023 -177.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.487 ' HA ' ' HB2' ' A' ' 57' ' ' LEU . 8.8 Cg_endo -50.68 -34.03 42.14 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.575 2.184 . . . . 0.0 111.348 175.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.507 ' O ' ' HG2' ' A' ' 59' ' ' GLU . 19.5 tt0 -54.67 -45.71 73.94 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.993 173.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.544 ' HB3' HG22 ' A' ' 146' ' ' VAL . 57.4 mt-10 -79.11 -28.43 42.97 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.408 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.881 HD21 ' HG2' ' A' ' 52' ' ' PRO . 65.4 mt -79.93 -35.58 37.55 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.147 -177.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -68.04 -32.89 73.56 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.609 -178.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.613 ' HB2' HD21 ' A' ' 143' ' ' LEU . 2.8 mm-40 -67.12 -49.88 63.36 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.351 0.596 . . . . 0.0 110.112 176.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.694 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 31.6 ttm -58.37 -37.9 76.16 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.931 -1.031 . . . . 0.0 112.201 175.027 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.538 HG13 HD22 ' A' ' 41' ' ' LEU . 47.3 mt -66.7 -47.88 81.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 174.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.63 ' HA ' ' HB3' ' A' ' 65' ' ' ASP . 23.4 t70 -58.08 -29.38 65.38 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.386 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.694 ' HB2' ' O ' ' A' ' 60' ' ' MET . 14.2 mt-10 -44.44 -51.5 8.64 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.674 177.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.874 HG21 ' HB2' ' A' ' 80' ' ' MET . 4.2 m -111.45 -18.34 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 CA-C-N 114.559 -1.201 . . . . 0.0 111.384 -175.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.63 ' HB3' ' HA ' ' A' ' 62' ' ' ASP . 44.0 t0 -60.01 122.59 14.71 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 172.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -85.69 -37.47 19.38 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.598 -177.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -91.03 -8.52 48.83 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.125 0.488 . . . . 0.0 110.974 -175.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 73.43 25.03 73.79 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.508 -0.853 . . . . 0.0 111.24 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 86.2 p -71.26 -8.86 56.44 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -170.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.68 11.61 83.8 Favored Glycine 0 C--N 1.316 -0.575 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -176.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.678 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 1.1 p -144.43 132.52 21.62 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.93 -0.635 . . . . 0.0 110.222 178.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.844 HG21 HG23 ' A' ' 64' ' ' VAL . 1.2 t -102.74 127.66 56.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.385 -178.319 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.523 ' HA ' ' CE2' ' A' ' 24' ' ' PHE . 20.1 t70 -105.05 -172.32 2.08 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.431 ' H ' ' CG ' ' A' ' 73' ' ' ASP . 19.3 t80 -58.1 -43.09 86.94 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -165.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -70.45 -48.47 55.76 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.246 -175.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.727 ' HB3' HG22 ' A' ' 72' ' ' VAL . 2.0 mp0 -50.0 -52.4 34.22 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.52 0.676 . . . . 0.0 111.677 169.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.516 ' HE2' ' CE2' ' A' ' 27' ' ' PHE . 89.6 t80 -60.01 -39.28 85.24 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.224 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.531 ' HG ' HG22 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -61.21 -41.53 97.0 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.737 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.478 HG12 HG12 ' A' ' 64' ' ' VAL . 53.3 t -60.24 -46.28 94.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.55 174.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.874 ' HB2' HG21 ' A' ' 64' ' ' VAL . 5.7 tmm? -63.82 -28.96 70.22 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.543 0.687 . . . . 0.0 109.926 -178.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.456 ' O ' ' HB2' ' A' ' 85' ' ' MET . 4.1 mmt -71.93 -37.69 69.97 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.675 -177.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.637 ' HA ' ' HB2' ' A' ' 85' ' ' MET . 2.0 m -76.72 -31.99 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-O 120.997 0.427 . . . . 0.0 110.528 177.016 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.669 ' HG2' ' CE2' ' A' ' 5' ' ' TYR . 24.9 mtp180 -62.42 -43.59 98.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.713 -176.152 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.409 ' HB2' ' HB2' ' A' ' 150' ' ' ALA . 13.2 m -81.05 -19.46 43.75 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.119 0.485 . . . . 0.0 111.334 174.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.658 ' HE1' HD21 ' A' ' 12' ' ' LEU . 0.1 OUTLIER -67.65 -49.43 62.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.867 -176.602 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.483 ' HB3' ' HG2' ' A' ' 90' ' ' LYS . 27.4 tptp -68.2 -44.76 75.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.857 0.361 . . . . 0.0 110.538 -176.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -175.77 158.03 2.07 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -62.72 -29.36 70.61 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.1 0.476 . . . . 0.0 110.542 177.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.5 m -96.06 5.95 49.95 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.711 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.581 ' HB3' ' O ' ' A' ' 83' ' ' ARG . 55.7 tptt -68.62 -68.65 0.38 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.925 0.393 . . . . 0.0 110.527 178.387 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.497 ' HA3' ' HB3' ' A' ' 83' ' ' ARG . . . -115.77 10.6 18.59 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.302 -0.951 . . . . 0.0 111.944 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.488 ' HE3' ' HB ' ' A' ' 148' ' ' ILE . 58.1 mttm -133.15 -163.12 1.31 Allowed 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 177.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.457 ' HB3' ' O ' ' A' ' 137' ' ' LYS . 81.5 t80 75.89 -30.56 0.19 Allowed 'General case' 0 N--CA 1.473 0.675 0 O-C-N 123.46 0.475 . . . . 0.0 110.95 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.468 ' CB ' ' HD2' ' A' ' 141' ' ' PRO . 94.9 mttt -74.88 -167.44 0.59 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.855 177.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.659 ' N ' ' HD2' ' A' ' 141' ' ' PRO . 99.3 mtt180 -48.76 -48.72 69.54 Favored Pre-proline 0 CA--C 1.54 0.581 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.986 172.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.659 ' HD2' ' N ' ' A' ' 140' ' ' ARG . 3.5 Cg_exo -37.95 -58.76 0.61 Allowed 'Trans proline' 0 C--N 1.366 1.463 0 C-N-CA 124.051 3.167 . . . . 0.0 113.775 -178.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 1.7 m -93.93 123.73 37.48 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.079 0.466 . . . . 0.0 110.186 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.71 HD22 ' H ' ' A' ' 143' ' ' LEU . 0.3 OUTLIER -74.03 -172.9 1.46 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.23 -178.816 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 4.0 tpp180 -69.34 -51.98 31.68 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -170.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.95 -65.06 0.72 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.18 0.514 . . . . 0.0 110.305 -178.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.568 HG12 ' SD ' ' A' ' 45' ' ' MET . 0.0 OUTLIER -47.6 137.26 3.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 114.382 -1.281 . . . . 0.0 112.261 -174.586 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.421 ' NH2' ' HA ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -170.12 101.23 0.28 Allowed 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 120.529 -0.469 . . . . 0.0 111.898 177.27 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.522 HG12 ' SD ' ' A' ' 60' ' ' MET . 27.2 mm -86.13 102.16 11.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 174.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.466 ' HB2' ' HB3' ' A' ' 152' ' ' ALA . 41.8 m -89.2 115.17 26.51 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 175.084 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.638 ' O ' ' HG2' ' A' ' 154' ' ' MET . . . -49.38 -57.86 6.15 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -169.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.665 ' O ' ' HG3' ' A' ' 155' ' ' GLN . 6.8 p-10 -55.37 -41.07 72.09 Favored 'General case' 0 C--N 1.323 -0.571 0 O-C-N 123.451 0.469 . . . . 0.0 110.622 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.491 ' HA ' ' HG3' ' A' ' 155' ' ' GLN . . . -71.54 -34.47 70.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.053 0.454 . . . . 0.0 111.269 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' MET . . . . . 0.617 ' CE ' ' HG ' ' A' ' 157' ' ' LEU . 3.2 tpt -61.61 -40.87 96.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 122.008 0.909 . . . . 0.0 109.599 177.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.638 ' HG2' ' O ' ' A' ' 150' ' ' ALA . 13.2 mmt -66.07 -28.78 69.1 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.319 -1.309 . . . . 0.0 109.951 178.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.665 ' HG3' ' O ' ' A' ' 151' ' ' ASP . 39.5 mt-30 -73.77 -57.92 3.65 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.428 177.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.96 -52.11 61.73 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.9 -176.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.66 HD11 ' CD2' ' A' ' 27' ' ' PHE . 85.2 mt -78.99 -65.76 0.95 Allowed 'General case' 0 CA--C 1.501 -0.919 0 CA-C-O 121.026 0.441 . . . . 0.0 111.979 -176.147 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.459 HD21 ' N ' ' A' ' 23' ' ' ALA . 86.3 mt -66.74 -50.33 63.11 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.157 -0.929 . . . . 0.0 112.527 -159.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.501 ' O ' ' HE3' ' A' ' 163' ' ' LYS . . . 44.91 -95.28 0.01 OUTLIER Glycine 0 C--N 1.338 0.653 0 O-C-N 124.11 0.881 . . . . 0.0 112.035 -177.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -36.98 -54.78 0.94 Allowed 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 122.401 1.096 . . . . 0.0 111.472 168.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.458 ' HD3' HD11 ' A' ' 26' ' ' ILE . 45.0 mtp180 -89.97 5.27 47.19 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 113.358 -1.746 . . . . 0.0 111.051 -169.015 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -83.77 -15.14 49.6 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.98 0.419 . . . . 0.0 110.717 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.501 ' HE3' ' O ' ' A' ' 159' ' ' GLY . 0.0 OUTLIER -144.42 177.88 8.33 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.48 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -134.17 58.37 0.69 Allowed Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.127 -1.035 . . . . 0.0 112.525 178.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 23.7 p80 . . . . . 0 C--O 1.245 0.857 0 CA-C-O 118.729 -0.653 . . . . 0.0 109.347 176.925 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.759 ' SD ' ' HB2' ' A' ' 6' ' ' LYS . 1.1 tmt? . . . . . 0 N--CA 1.48 1.043 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -63.25 119.17 9.1 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 120.866 0.365 . . . . 0.0 110.785 -178.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.55 ' HA ' ' HB3' ' A' ' 6' ' ' LYS . 5.2 p-10 -71.73 -7.4 47.87 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -173.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.4 tt -60.4 -43.51 94.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 169.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.646 ' HA ' HG21 ' A' ' 82' ' ' VAL . 25.3 m-85 -81.54 -30.7 33.04 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.455 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.759 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 24.5 ttpt -65.06 -37.07 86.34 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.337 172.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.51 -28.31 69.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.336 0.588 . . . . 0.0 110.402 176.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 5' ' ' TYR . . . -67.76 -46.03 73.22 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.475 170.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.495 ' HA ' ' HB2' ' A' ' 12' ' ' LEU . 50.0 t -60.32 -32.38 50.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.571 174.177 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.582 ' HG2' ' O ' ' A' ' 6' ' ' LYS . 55.1 mm-40 -64.39 -29.43 70.49 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.722 177.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -82.06 -38.62 24.64 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.223 170.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.695 ' HA ' ' OE1' ' A' ' 16' ' ' GLN . 57.0 mt -55.74 135.86 51.3 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 121.942 0.877 . . . . 0.0 110.132 175.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.468 ' OG1' ' HG3' ' A' ' 16' ' ' GLN . 6.1 p -86.42 155.2 20.67 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -47.17 -42.95 20.68 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 118.629 0.65 . . . . 0.0 109.395 177.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -54.6 -56.74 15.8 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.447 173.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.695 ' OE1' ' HA ' ' A' ' 12' ' ' LEU . 88.4 mt-30 -52.37 -54.11 36.14 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 121.184 0.516 . . . . 0.0 111.626 176.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.469 ' HG3' ' HB3' ' A' ' 12' ' ' LEU . 32.8 mtpt -53.15 -48.92 67.56 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.748 175.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.427 ' O ' ' HB3' ' A' ' 21' ' ' LYS . 56.6 t30 -60.47 -34.75 74.48 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.839 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -66.75 -34.92 78.9 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.191 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -72.96 -31.64 64.7 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.622 174.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.568 ' HD3' ' CG ' ' A' ' 74' ' ' PHE . 29.3 tptp -61.13 -38.14 85.33 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.433 0.635 . . . . 0.0 110.187 172.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.449 ' O ' HG13 ' A' ' 26' ' ' ILE . . . -62.0 -38.37 88.34 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.493 173.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.565 ' O ' ' HB2' ' A' ' 27' ' ' PHE . . . -71.38 -38.38 71.53 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 177.008 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.648 ' O ' HG22 ' A' ' 28' ' ' VAL . 28.2 t80 -51.24 -53.75 32.37 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.878 0.846 . . . . 0.0 109.069 170.255 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -51.99 -53.59 39.87 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 113.646 -1.615 . . . . 0.0 112.239 -178.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.546 ' HA ' ' HG ' ' A' ' 29' ' ' LEU . 40.0 mt -70.79 -33.36 52.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.329 -177.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.565 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 0.4 OUTLIER -53.85 -42.87 69.0 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.356 175.461 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.648 HG22 ' O ' ' A' ' 24' ' ' PHE . 35.5 m -111.07 23.03 4.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.809 -174.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.546 ' HG ' ' HA ' ' A' ' 26' ' ' ILE . 19.7 mt -61.99 117.08 5.49 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.34 -0.944 . . . . 0.0 109.319 177.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.29 12.99 72.04 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.508 -176.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.41 154.13 38.92 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 117.129 0.464 . . . . 0.0 111.221 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -69.33 -46.43 67.1 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.868 -176.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -101.58 -16.62 16.69 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.899 -176.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.06 -0.58 86.16 Favored Glycine 0 C--O 1.224 -0.51 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.34 -175.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 52.5 m -108.49 151.25 26.32 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 174.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.575 HD12 HG12 ' A' ' 72' ' ' VAL . 61.3 mt -65.95 106.92 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.972 0 O-C-N 123.342 0.401 . . . . 0.0 110.311 -175.155 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 61.9 p -90.39 170.67 10.04 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 170.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.617 HG21 ' HG3' ' A' ' 58' ' ' GLN . 32.1 p -65.79 -21.82 66.52 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.359 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -60.28 -55.49 33.09 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.801 172.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.505 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 18.5 mm-40 -65.76 -38.16 88.3 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 177.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.942 ' HG ' HD22 ' A' ' 57' ' ' LEU . 4.1 tp -65.8 -49.82 66.9 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.729 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.651 ' O ' ' HG3' ' A' ' 46' ' ' ARG . . . -58.96 -42.4 96.81 Favored Glycine 0 C--N 1.315 -0.603 0 C-N-CA 120.295 -0.955 . . . . 0.0 111.525 173.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.514 ' O ' ' HB2' ' A' ' 46' ' ' ARG . 24.4 tttt -48.75 -47.96 41.22 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 123.623 0.769 . . . . 0.0 110.96 173.063 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.655 ' O ' ' HB2' ' A' ' 47' ' ' MET . 0.9 OUTLIER -74.6 -35.58 38.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.966 -178.48 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.487 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 11.8 mmt -63.7 -38.14 89.97 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 175.225 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.651 ' HG3' ' O ' ' A' ' 42' ' ' GLY . 62.0 mtp180 -55.74 -49.45 73.05 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.211 169.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.655 ' HB2' ' O ' ' A' ' 44' ' ' VAL . 0.4 OUTLIER -53.79 -28.78 36.99 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.638 -1.164 . . . . 0.0 111.686 173.281 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.487 ' HB2' ' HA ' ' A' ' 45' ' ' MET . 11.0 mt -97.18 -3.25 41.29 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-N 114.494 -1.23 . . . . 0.0 112.094 -171.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 105.55 -15.9 45.16 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 121.07 -0.586 . . . . 0.0 113.423 175.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.506 ' HB3' ' HD3' ' A' ' 52' ' ' PRO . 1.7 mp0 -91.33 -176.69 4.63 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.238 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.478 ' N ' ' HD3' ' A' ' 52' ' ' PRO . 6.9 p30 -155.4 60.32 2.51 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.665 0.745 . . . . 0.0 110.521 168.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.528 ' HB3' HG22 ' A' ' 146' ' ' VAL . 74.6 Cg_exo -53.19 173.12 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.948 3.099 . . . . 0.0 114.254 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.8 p -109.19 162.26 20.77 Favored Pre-proline 0 C--N 1.316 -0.849 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.891 176.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.62 -33.54 98.27 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 121.829 1.686 . . . . 0.0 110.557 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -48.53 -52.38 22.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.427 172.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 1.004 ' HB3' HG21 ' A' ' 146' ' ' VAL . 47.3 mt-10 -73.19 -45.72 54.76 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 113.869 -1.514 . . . . 0.0 112.879 -178.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.942 HD22 ' HG ' ' A' ' 41' ' ' LEU . 21.8 mt -64.36 -37.38 87.31 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.707 -177.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.617 ' HG3' HG21 ' A' ' 38' ' ' THR . 56.0 mt-30 -57.26 -33.49 67.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.418 0.151 . . . . 0.0 111.259 178.236 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.519 ' HG3' HD11 ' A' ' 143' ' ' LEU . 4.7 mm-40 -65.62 -48.72 71.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.145 0.498 . . . . 0.0 110.386 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.553 ' CE ' ' HB ' ' A' ' 148' ' ' ILE . 31.4 mmm -65.6 -37.1 85.68 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.202 178.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.641 HG13 ' O ' ' A' ' 57' ' ' LEU . 2.4 mt -65.28 -56.95 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 176.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.628 ' HA ' ' HB3' ' A' ' 65' ' ' ASP . 19.4 t70 -55.96 -35.93 67.26 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.484 -176.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.582 ' CD ' ' HZ3' ' A' ' 137' ' ' LYS . 9.9 mt-10 -47.94 -50.22 27.75 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.311 0.576 . . . . 0.0 111.915 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.733 HG21 ' HB2' ' A' ' 80' ' ' MET . 9.3 m -99.95 -20.03 5.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.39 -177.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.628 ' HB3' ' HA ' ' A' ' 62' ' ' ASP . 66.7 t0 -59.82 130.3 46.11 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.312 174.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -89.64 -32.87 16.87 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -175.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -105.32 -7.35 18.93 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -174.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 73.86 25.64 71.22 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.052 -1.071 . . . . 0.0 112.741 174.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 78.0 p -78.73 -1.54 35.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.217 0.532 . . . . 0.0 111.28 -176.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.31 17.67 70.95 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.38 -178.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 0.8 OUTLIER -141.41 133.15 27.23 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.74 0.781 . . . . 0.0 111.265 178.584 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.59 ' CG2' HG23 ' A' ' 64' ' ' VAL . 0.9 OUTLIER -101.17 117.0 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.736 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.473 ' HA ' ' CE1' ' A' ' 24' ' ' PHE . 20.4 t70 -96.75 -165.99 1.35 Allowed 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.568 ' CG ' ' HD3' ' A' ' 21' ' ' LYS . 10.3 t80 -56.01 -60.42 3.51 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -167.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.522 ' OD2' ' HG3' ' A' ' 1' ' ' MET . 13.9 t70 -63.27 -43.35 98.19 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.816 -173.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.511 ' O ' ' HB ' ' A' ' 64' ' ' VAL . 2.6 mp0 -50.85 -53.79 29.37 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.35 0.595 . . . . 0.0 111.422 170.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.403 ' HE2' ' CE2' ' A' ' 27' ' ' PHE . 73.0 t80 -56.59 -46.99 80.54 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.138 178.053 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.413 HD22 ' CE1' ' A' ' 74' ' ' PHE . 2.1 tp -60.73 -39.83 90.1 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.379 -178.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.564 ' O ' ' HG3' ' A' ' 83' ' ' ARG . 54.9 t -56.7 -50.93 72.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 170.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.733 ' HB2' HG21 ' A' ' 64' ' ' VAL . 44.8 ttp -56.89 -35.22 68.7 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.667 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.404 ' HB2' ' O ' ' A' ' 78' ' ' LEU . 27.3 mmt -63.76 -48.73 75.78 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.175 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.687 ' HA ' ' HB2' ' A' ' 85' ' ' MET . 0.6 OUTLIER -66.59 -31.49 53.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.524 177.434 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.594 ' HG2' ' CE2' ' A' ' 5' ' ' TYR . 29.9 mtp180 -62.13 -46.62 88.21 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.356 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 51.7 p -79.1 -6.47 56.53 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.014 0.435 . . . . 0.0 111.034 176.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.687 ' HB2' ' HA ' ' A' ' 82' ' ' VAL . 0.6 OUTLIER -83.31 -46.27 12.81 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.964 -177.364 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.517 ' HB3' ' HG2' ' A' ' 90' ' ' LYS . 0.9 OUTLIER -60.96 -46.98 88.52 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 121.361 0.6 . . . . 0.0 110.055 177.546 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.475 ' HB3' ' HA ' ' A' ' 90' ' ' LYS . 30.0 t70 -159.7 164.39 34.0 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -177.007 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -63.82 -28.54 69.93 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.96 178.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.2 t -113.85 -35.96 4.97 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.14 177.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.517 ' HG2' ' HB3' ' A' ' 86' ' ' LYS . 0.0 OUTLIER 68.52 -67.76 0.19 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.397 0.679 . . . . 0.0 111.969 176.162 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 158.17 43.5 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -173.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.582 ' HZ3' ' CD ' ' A' ' 63' ' ' GLU . 6.0 mtpm? -74.47 -35.51 63.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.766 -0.717 . . . . 0.0 111.638 -170.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -167.63 -50.52 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.827 0.346 . . . . 0.0 110.518 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -137.58 -69.2 0.46 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.408 176.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.638 ' N ' ' HD2' ' A' ' 141' ' ' PRO . 21.8 tpt180 175.4 -53.72 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.904 -173.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.638 ' HD2' ' N ' ' A' ' 140' ' ' ARG . 10.1 Cg_endo -51.54 -38.58 64.98 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 123.036 2.491 . . . . 0.0 113.083 -176.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.551 ' HB ' ' NE ' ' A' ' 147' ' ' ARG . 91.8 m 52.43 64.8 1.71 Allowed 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.756 0.788 . . . . 0.0 110.13 -177.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.538 ' HB2' ' HB ' ' A' ' 146' ' ' VAL . 2.8 mm? 58.43 15.97 3.85 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.656 179.093 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.471 ' NE ' ' HA ' ' A' ' 144' ' ' ARG . 5.1 tpm_? 63.29 -81.02 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.632 0.773 . . . . 0.0 112.191 175.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.411 ' CZ ' ' HA ' ' A' ' 52' ' ' PRO . 6.3 tmm_? -85.79 -17.63 35.22 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.465 0.65 . . . . 0.0 110.746 -174.152 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 1.004 HG21 ' HB3' ' A' ' 56' ' ' GLU . 19.7 t -96.21 75.07 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 121.68 0.752 . . . . 0.0 110.806 -171.026 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.551 ' NE ' ' HB ' ' A' ' 142' ' ' THR . 14.7 mmt85 -109.57 120.02 41.2 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 114.849 -1.069 . . . . 0.0 112.737 -174.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.553 ' HB ' ' CE ' ' A' ' 60' ' ' MET . 5.5 mm -95.69 120.93 45.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 169.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.45 ' HB2' ' HB3' ' A' ' 152' ' ' ALA . 42.6 m -119.43 113.98 21.61 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 119.447 -0.311 . . . . 0.0 110.296 -178.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.804 ' O ' ' HG2' ' A' ' 154' ' ' MET . . . -44.29 -59.59 2.31 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 123.702 0.626 . . . . 0.0 112.185 -172.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.661 ' O ' ' HG3' ' A' ' 155' ' ' GLN . 5.0 m-20 -50.84 -53.69 30.11 Favored 'General case' 0 CA--C 1.518 -0.265 0 O-C-N 123.28 0.362 . . . . 0.0 110.74 179.198 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.45 ' HB3' ' HB2' ' A' ' 149' ' ' SER . . . -59.84 -34.44 73.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.18 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' MET . . . . . 0.611 ' HA ' ' CE ' ' A' ' 153' ' ' MET . 2.2 tpt -68.02 -36.17 79.49 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.777 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.804 ' HG2' ' O ' ' A' ' 150' ' ' ALA . 14.9 mmt -69.67 -27.77 65.3 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.516 178.146 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.661 ' HG3' ' O ' ' A' ' 151' ' ' ASP . 41.4 mt-30 -72.42 -57.94 3.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.225 177.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -62.52 -45.59 92.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.036 -174.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.561 HD11 ' CD2' ' A' ' 27' ' ' PHE . 22.6 mt -85.63 -66.62 0.88 Allowed 'General case' 0 CA--C 1.504 -0.814 0 CA-C-O 121.48 0.657 . . . . 0.0 111.768 -177.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.518 HD21 ' N ' ' A' ' 23' ' ' ALA . 83.7 mt -68.32 -48.43 64.89 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.954 -166.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 36.6 -90.05 0.01 OUTLIER Glycine 0 C--N 1.342 0.913 0 O-C-N 125.121 1.513 . . . . 0.0 113.582 174.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -36.62 -52.45 0.88 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 123.955 0.902 . . . . 0.0 111.785 171.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 44.2 ttt180 -86.19 -17.86 33.72 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.396 -176.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -64.25 -33.13 75.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.869 0.366 . . . . 0.0 111.254 -175.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.554 ' HD2' ' H ' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -116.16 6.82 14.0 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.034 0.445 . . . . 0.0 110.471 177.16 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -125.26 68.32 0.51 Allowed Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.359 -176.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 81.1 t60 . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.541 -0.743 . . . . 0.0 109.753 175.915 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.453 ' HB2' ' HG2' ' A' ' 66' ' ' GLU . 27.1 ttm . . . . . 0 N--CA 1.479 0.991 0 N-CA-C 110.264 -0.272 . . . . 0.0 110.264 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -73.18 109.23 6.56 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 174.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -66.39 -13.06 60.12 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -173.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.3 tt -55.79 -41.07 64.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.572 0.701 . . . . 0.0 109.322 172.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.663 ' HB3' ' CG1' ' A' ' 82' ' ' VAL . 55.2 m-85 -83.37 -27.0 29.96 Favored 'General case' 0 C--O 1.215 -0.75 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.162 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.576 ' O ' ' HG3' ' A' ' 10' ' ' GLU . 8.6 ttpt -65.17 -32.36 74.0 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 174.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.68 ' HA ' ' CG ' ' A' ' 10' ' ' GLU . . . -79.15 -23.76 43.76 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.976 173.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.539 ' O ' ' HG ' ' A' ' 12' ' ' LEU . . . -71.42 -27.34 63.23 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 166.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.475 ' HB ' ' O ' ' A' ' 6' ' ' LYS . 54.3 t -72.5 -29.92 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 121.183 0.516 . . . . 0.0 109.82 167.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.68 ' CG ' ' HA ' ' A' ' 7' ' ' ALA . 45.3 mt-10 -69.81 -27.27 64.75 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 122.195 0.998 . . . . 0.0 108.802 171.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.489 ' HB3' ' O ' ' A' ' 8' ' ' ALA . 6.3 tp-100 -79.94 -34.91 38.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 113.622 -1.626 . . . . 0.0 110.19 178.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' A' ' 8' ' ' ALA . 51.2 mt -58.82 135.36 57.48 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.85 172.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.593 ' OG1' ' HG3' ' A' ' 16' ' ' GLN . 17.5 p -77.08 166.72 22.91 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -58.54 -35.11 71.8 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 175.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -63.7 -48.28 77.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.736 176.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.593 ' HG3' ' OG1' ' A' ' 13' ' ' THR . 35.2 mt-30 -58.07 -54.08 50.96 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 121.396 0.617 . . . . 0.0 111.176 177.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.462 ' HA ' HD21 ' A' ' 78' ' ' LEU . 55.0 mtpt -55.55 -42.51 74.73 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.363 176.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -58.64 -37.52 76.12 Favored 'General case' 0 CA--C 1.51 -0.596 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.315 177.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -65.7 -37.47 86.52 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-O 121.255 0.55 . . . . 0.0 110.036 -176.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.443 ' HD1' ' CD2' ' A' ' 78' ' ' LEU . 21.4 m-85 -78.56 -23.09 46.32 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.496 176.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.485 ' HD3' ' CD1' ' A' ' 74' ' ' PHE . 22.4 tptp -65.17 -52.79 52.83 Favored 'General case' 0 CA--C 1.499 -1.013 0 CA-C-O 122.031 0.919 . . . . 0.0 109.028 174.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.15 -36.74 31.35 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 113.476 -1.693 . . . . 0.0 110.403 173.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.504 ' O ' ' HB2' ' A' ' 27' ' ' PHE . . . -71.94 -46.54 57.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.381 175.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.722 ' O ' HG22 ' A' ' 28' ' ' VAL . 20.8 t80 -47.87 -49.52 29.35 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 124.091 0.869 . . . . 0.0 109.597 175.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -49.44 -52.5 28.53 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 113.892 -1.504 . . . . 0.0 112.527 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.449 HG23 HD12 ' A' ' 29' ' ' LEU . 21.7 mt -77.82 -33.51 18.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.206 -177.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.66 ' HE1' ' SD ' ' A' ' 153' ' ' MET . 0.7 OUTLIER -56.25 -36.7 68.83 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 114.506 -1.225 . . . . 0.0 109.302 177.73 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.722 HG22 ' O ' ' A' ' 24' ' ' PHE . 29.1 m -114.65 23.68 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.634 -178.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.449 HD12 HG23 ' A' ' 26' ' ' ILE . 4.6 mt -64.04 118.19 8.13 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 173.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.97 12.78 67.74 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.442 -0.885 . . . . 0.0 111.936 -175.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -84.64 143.38 29.27 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.583 0.706 . . . . 0.0 111.014 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -78.73 -45.53 20.97 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.134 -178.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -87.25 -17.24 33.03 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.345 -177.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.07 1.89 75.8 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.766 -178.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.448 ' HB2' ' HB ' ' A' ' 71' ' ' THR . 2.5 m -119.74 155.09 33.14 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 173.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.71 ' O ' ' HA ' ' A' ' 71' ' ' THR . 69.9 mt -64.45 107.84 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.049 -171.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 84.4 p -82.73 175.93 9.74 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 169.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.587 ' O ' HD13 ' A' ' 57' ' ' LEU . 12.9 p -69.76 -45.14 68.74 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.303 -178.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -51.76 -40.98 61.25 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.434 0.635 . . . . 0.0 109.807 171.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.17 -42.35 93.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.98 176.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.753 HD21 ' SD ' ' A' ' 60' ' ' MET . 0.5 OUTLIER -71.02 -36.23 72.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.859 0.838 . . . . 0.0 109.711 -179.113 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.48 -21.52 76.14 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 114.705 -1.134 . . . . 0.0 112.014 178.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.615 ' O ' ' HG3' ' A' ' 47' ' ' MET . 8.1 ptmt -55.4 -50.3 70.12 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.462 ' N ' ' CG ' ' A' ' 43' ' ' LYS . 5.6 p -78.01 -28.11 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 CA-C-N 116.793 -0.185 . . . . 0.0 110.944 -174.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.634 ' CB ' ' HG3' ' A' ' 52' ' ' PRO . 9.1 mmt -64.08 -41.83 97.18 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 174.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -59.47 -43.95 93.12 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.977 172.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.615 ' HG3' ' O ' ' A' ' 43' ' ' LYS . 37.0 mtm -66.0 -9.97 35.26 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.541 175.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.516 HD11 ' HG3' ' A' ' 153' ' ' MET . 8.9 mt -108.56 3.15 22.68 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.914 -173.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 95.41 -1.51 64.39 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.994 -0.622 . . . . 0.0 113.015 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -93.02 177.21 6.14 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 120.952 0.406 . . . . 0.0 111.264 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -145.87 66.23 11.59 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-O 121.989 0.9 . . . . 0.0 110.177 165.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.675 ' HB3' HG11 ' A' ' 146' ' ' VAL . 59.3 Cg_endo -66.9 143.82 68.09 Favored 'Trans proline' 0 C--N 1.327 -0.566 0 C-N-CA 123.379 2.72 . . . . 0.0 113.604 -174.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 22.0 p -82.59 144.08 48.49 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.143 174.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.448 ' HA ' ' HB2' ' A' ' 57' ' ' LEU . 13.6 Cg_endo -58.46 -18.94 41.52 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.699 2.266 . . . . 0.0 111.628 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -70.51 -49.23 50.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.932 174.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.606 ' CG ' HG22 ' A' ' 146' ' ' VAL . 0.9 OUTLIER -63.38 -40.28 96.82 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 121.772 0.796 . . . . 0.0 109.833 177.367 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.587 HD13 ' O ' ' A' ' 38' ' ' THR . 52.5 mt -67.05 -36.1 81.32 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.542 178.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.439 ' HB2' ' O ' ' A' ' 54' ' ' PRO . 25.8 tt0 -64.07 -44.34 92.71 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 121.235 -0.186 . . . . 0.0 110.894 -174.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.571 ' O ' ' HG3' ' A' ' 63' ' ' GLU . 12.1 mm-40 -61.97 -44.0 97.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.74 -0.209 . . . . 0.0 110.659 175.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.753 ' SD ' HD21 ' A' ' 41' ' ' LEU . 20.9 ttm -53.33 -49.16 67.65 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 174.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.648 HG23 HG23 ' A' ' 72' ' ' VAL . 1.0 OUTLIER -54.99 -56.9 8.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.869 177.372 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -50.01 -40.57 45.03 Favored 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 124.532 1.133 . . . . 0.0 112.154 -176.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.589 ' HB2' ' O ' ' A' ' 60' ' ' MET . 80.4 mt-10 -46.54 -42.17 15.37 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 113.729 -1.578 . . . . 0.0 111.894 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.722 HG21 ' HB2' ' A' ' 80' ' ' MET . 3.4 m -116.46 -14.64 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.591 -173.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -65.96 116.92 7.61 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 170.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.453 ' HG2' ' HB2' ' A' ' 1' ' ' MET . 44.6 mt-10 -76.9 -18.38 58.34 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -174.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -112.3 -8.43 13.94 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.133 0.492 . . . . 0.0 111.34 -174.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 73.8 19.61 79.74 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.785 -0.722 . . . . 0.0 111.495 -178.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 76.1 p -68.38 -32.44 72.51 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 121.25 0.548 . . . . 0.0 112.329 -172.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 107.77 16.35 13.01 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.429 -178.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.71 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 2.0 p -145.41 132.06 19.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.121 0.486 . . . . 0.0 110.76 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.65 HG12 HD12 ' A' ' 36' ' ' ILE . 2.7 t -100.05 118.79 47.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.155 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.443 ' HA ' ' CE1' ' A' ' 24' ' ' PHE . 15.6 t70 -98.87 -172.03 2.21 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.485 ' CD1' ' HD3' ' A' ' 21' ' ' LYS . 12.7 t80 -58.14 -54.23 49.34 Favored 'General case' 0 C--O 1.219 -0.546 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -162.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.443 ' HA ' ' HB2' ' A' ' 78' ' ' LEU . 34.7 t70 -71.82 -34.12 69.07 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.073 0.463 . . . . 0.0 110.44 -174.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -59.74 -44.64 93.69 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.813 169.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.422 ' HZ ' ' HE1' ' A' ' 153' ' ' MET . 60.1 t80 -65.22 -35.67 81.78 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.412 176.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.496 ' O ' ' HB ' ' A' ' 82' ' ' VAL . 17.0 mt -63.9 -43.93 94.49 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 122.297 0.239 . . . . 0.0 110.68 176.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.542 HG12 HG12 ' A' ' 64' ' ' VAL . 5.0 t -64.39 -45.78 94.92 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.608 0 C-N-CA 120.449 -0.501 . . . . 0.0 109.777 174.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.722 ' HB2' HG21 ' A' ' 64' ' ' VAL . 43.4 ttp -61.05 -39.04 88.32 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.144 0.497 . . . . 0.0 111.343 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 8.6 mmt -68.43 -51.16 46.82 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.946 174.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.663 ' CG1' ' HB3' ' A' ' 5' ' ' TYR . 0.4 OUTLIER -63.86 -29.49 47.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.114 -177.759 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.418 HH11 HG13 ' A' ' 64' ' ' VAL . 26.9 mtp180 -58.48 -35.55 72.38 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.462 -178.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.4 m -79.4 -17.46 54.33 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.849 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.417 ' HE2' ' CD2' ' A' ' 12' ' ' LEU . 2.7 ptt? -93.88 -9.6 36.7 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.543 -0.463 . . . . 0.0 112.104 -175.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -61.94 -40.79 96.75 Favored 'General case' 0 C--N 1.339 0.136 0 CA-C-O 121.616 0.722 . . . . 0.0 109.976 -178.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -136.55 -159.0 0.91 Allowed 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 172.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -55.92 -58.49 7.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 118.363 0.529 . . . . 0.0 110.365 174.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.7 m -134.19 -7.89 2.64 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.823 175.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.459 ' HE2' ' OH ' ' A' ' 5' ' ' TYR . 16.3 mmmt 68.25 137.31 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.753 -174.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -102.11 -86.97 1.97 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.534 -177.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.406 ' HD3' ' HA ' ' A' ' 137' ' ' LYS . 43.0 mmtm -100.79 -174.9 2.74 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.641 0.258 . . . . 0.0 111.374 -178.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 9.9 t80 58.98 36.47 24.47 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -167.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 140' ' ' ARG . 37.5 tttt -171.32 143.76 1.9 Allowed 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 112.891 -1.959 . . . . 0.0 108.35 -170.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.421 ' O ' ' HG2' ' A' ' 139' ' ' LYS . 23.4 mmm180 -77.45 151.11 80.39 Favored Pre-proline 0 C--N 1.325 -0.5 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 175.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -86.96 -5.32 7.83 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 124.017 3.145 . . . . 0.0 113.079 -168.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.412 HG22 HG23 ' A' ' 146' ' ' VAL . 3.9 m 58.21 50.3 10.01 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.682 0.753 . . . . 0.0 109.841 -177.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.7 mm? 64.55 -89.04 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.125 -175.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.425 ' HD3' ' N ' ' A' ' 144' ' ' ARG . 0.0 OUTLIER 174.7 -27.05 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.499 0.72 . . . . 0.0 109.246 178.09 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -72.83 -59.88 2.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.9 -176.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.675 HG11 ' HB3' ' A' ' 52' ' ' PRO . 3.2 m -98.87 155.82 3.85 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.823 0 C-N-CA 120.48 -0.488 . . . . 0.0 112.301 -177.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.507 ' HD2' ' H ' ' A' ' 148' ' ' ILE . 17.7 tpt180 -169.94 133.01 1.15 Allowed 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.03 161.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.727 HG13 ' SD ' ' A' ' 60' ' ' MET . 13.5 mt -65.35 111.65 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 114.838 -1.073 . . . . 0.0 112.197 177.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 48.7 m -82.82 99.78 9.92 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 167.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.627 ' O ' ' HG2' ' A' ' 154' ' ' MET . . . -44.93 -62.64 1.15 Allowed 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.824 0.702 . . . . 0.0 112.812 -168.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.429 ' O ' ' HG3' ' A' ' 155' ' ' GLN . 26.9 t70 -62.2 -43.26 99.24 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.114 -175.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.06 -34.77 79.22 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.609 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . 0.66 ' SD ' ' HE1' ' A' ' 27' ' ' PHE . 34.7 ttp -76.42 -33.13 58.81 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.754 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.627 ' HG2' ' O ' ' A' ' 150' ' ' ALA . 4.8 mmt -53.57 -37.92 63.4 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 173.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.429 ' HG3' ' O ' ' A' ' 151' ' ' ASP . 24.6 mt-30 -61.85 -44.98 95.74 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.63 -179.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -65.02 -33.35 75.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.421 -0.808 . . . . 0.0 112.568 -173.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.42 ' HG ' ' CG2' ' A' ' 44' ' ' VAL . 9.4 mt -93.72 -63.55 1.19 Allowed 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.831 0.824 . . . . 0.0 112.257 -178.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.575 HD22 ' HD2' ' A' ' 161' ' ' ARG . 68.2 mt -63.44 -42.22 98.67 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 113.468 -1.696 . . . . 0.0 112.837 -161.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.527 ' O ' ' HB3' ' A' ' 160' ' ' ALA . . . 54.01 94.37 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.602 -178.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 159' ' ' GLY . . . 87.41 -51.7 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.897 0.879 . . . . 0.0 111.356 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.677 ' HD3' ' O ' ' A' ' 161' ' ' ARG . 0.0 OUTLIER -60.06 -25.71 65.58 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.583 -178.057 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.2 -11.3 59.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.477 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.499 ' HD2' ' N ' ' A' ' 163' ' ' LYS . 0.2 OUTLIER -92.81 119.97 32.7 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.063 0.459 . . . . 0.0 110.022 178.045 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 167.11 -47.15 0.25 Allowed Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.251 -178.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 18.9 p-80 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.855 -0.593 . . . . 0.0 110.557 178.214 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.608 ' SD ' ' HG3' ' A' ' 6' ' ' LYS . 24.0 ttm . . . . . 0 N--CA 1.479 1.022 0 CA-C-O 120.859 0.361 . . . . 0.0 111.294 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.474 ' H ' HG21 ' A' ' 79' ' ' VAL . 1.0 OUTLIER -89.84 143.2 27.0 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 175.746 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.534 ' HA ' ' CB ' ' A' ' 6' ' ' LYS . 4.5 p30 -77.53 -11.53 59.87 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.689 -0.405 . . . . 0.0 112.034 -173.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.461 HG22 ' OD2' ' A' ' 2' ' ' ASP . 2.7 tp -62.13 -44.83 99.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 122.311 1.053 . . . . 0.0 108.864 169.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.792 ' HB2' HG22 ' A' ' 79' ' ' VAL . 25.1 m-85 -81.5 -29.1 33.75 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 114.143 -1.389 . . . . 0.0 109.995 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.746 ' O ' ' HG3' ' A' ' 10' ' ' GLU . 15.6 ttpt -67.3 -31.5 71.84 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.016 176.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.686 ' HA ' ' HG3' ' A' ' 10' ' ' GLU . . . -76.46 -26.44 55.4 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.163 0.506 . . . . 0.0 110.821 176.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.41 -40.99 94.08 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 167.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.687 ' HB ' ' O ' ' A' ' 6' ' ' LYS . 17.8 t -60.02 -29.18 42.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 114.3 -1.318 . . . . 0.0 111.412 171.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.746 ' HG3' ' O ' ' A' ' 6' ' ' LYS . 75.0 mt-10 -69.52 -30.39 68.21 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.635 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -78.1 -36.07 48.53 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 170.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.564 HD12 ' HA ' ' A' ' 9' ' ' VAL . 81.6 mt -56.76 143.89 34.93 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 169.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 61.6 p -104.24 165.46 11.04 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 120.074 -0.65 . . . . 0.0 109.696 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -54.55 -29.09 49.94 Favored 'General case' 0 C--O 1.212 -0.919 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 177.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -69.04 -51.48 38.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.469 175.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -55.78 -57.08 13.53 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.943 0.878 . . . . 0.0 111.37 174.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -53.21 -40.83 64.77 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 114.13 -1.395 . . . . 0.0 111.732 175.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -59.51 -47.45 85.48 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 121.02 0.438 . . . . 0.0 110.657 174.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -58.12 -38.61 76.84 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.754 -179.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.524 ' CD1' ' HG3' ' A' ' 81' ' ' MET . 18.2 m-85 -70.24 -34.44 72.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.51 177.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.617 ' O ' ' HD2' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -70.87 -53.13 16.31 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.589 ' O ' HG13 ' A' ' 26' ' ' ILE . . . -48.3 -45.66 35.15 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.29 -1.323 . . . . 0.0 110.211 175.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.551 ' HB2' HD21 ' A' ' 158' ' ' LEU . . . -70.54 -31.7 68.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.36 178.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.641 ' O ' HG22 ' A' ' 28' ' ' VAL . 55.6 t80 -52.63 -52.86 53.56 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 173.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -48.23 -39.62 21.83 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 113.605 -1.634 . . . . 0.0 111.439 177.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.591 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 1.8 mt -83.04 -35.89 12.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.101 -174.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.683 ' CE2' ' HA ' ' A' ' 41' ' ' LEU . 7.8 t80 -62.04 -29.71 70.47 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 177.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.641 HG22 ' O ' ' A' ' 24' ' ' PHE . 30.8 m -108.73 26.0 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.638 175.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.591 ' HB2' ' O ' ' A' ' 26' ' ' ILE . 0.2 OUTLIER -71.67 116.34 11.92 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -178.471 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.28 9.34 60.55 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.93 -174.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -85.7 148.93 25.64 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.047 0.451 . . . . 0.0 111.28 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -77.1 -45.86 25.5 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.54 -178.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -91.52 -17.91 24.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.879 0.371 . . . . 0.0 111.176 -176.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.96 5.75 85.8 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.745 177.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.562 ' HB2' ' HB ' ' A' ' 71' ' ' THR . 3.9 m -120.11 154.14 35.13 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 176.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.583 ' HB ' ' HB ' ' A' ' 72' ' ' VAL . 54.5 mt -68.97 107.72 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-O 121.119 0.485 . . . . 0.0 111.27 -172.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 96.3 p -90.4 -176.67 4.86 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 171.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.605 ' O ' HD13 ' A' ' 57' ' ' LEU . 47.1 p -69.26 -34.03 74.15 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -61.32 -56.08 24.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.832 176.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.506 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 0.7 OUTLIER -49.22 -44.58 43.51 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.938 174.888 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.683 ' HA ' ' CE2' ' A' ' 27' ' ' PHE . 4.6 tt -74.91 -37.53 62.04 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.371 -0.532 . . . . 0.0 109.709 -175.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -67.77 -35.77 85.98 Favored Glycine 0 C--N 1.333 0.366 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 175.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.506 ' HB3' ' O ' ' A' ' 40' ' ' GLU . 9.3 tttp -46.83 -53.22 12.48 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.498 0.719 . . . . 0.0 110.634 172.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.754 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 77.1 t -72.7 -44.06 60.41 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.7 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.759 -178.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.56 ' HE2' ' HA ' ' A' ' 45' ' ' MET . 31.5 mmt -53.44 -45.29 69.41 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 123.047 0.217 . . . . 0.0 111.306 178.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.549 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 29.2 mtt180 -60.35 -49.61 76.89 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.26 0.552 . . . . 0.0 110.989 176.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.27 -25.89 49.71 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.622 173.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.754 ' HB2' ' O ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -99.98 6.1 45.14 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.104 -169.316 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 107.12 -18.64 36.12 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 120.726 -0.75 . . . . 0.0 114.025 177.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.549 ' O ' ' HA ' ' A' ' 46' ' ' ARG . 1.7 mp0 -86.47 -177.97 6.31 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 117.649 0.724 . . . . 0.0 111.139 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.9 p-10 -156.01 62.12 2.97 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.845 169.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.688 ' HB3' HG11 ' A' ' 146' ' ' VAL . 72.9 Cg_endo -69.03 161.84 44.17 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 123.404 2.736 . . . . 0.0 113.855 -174.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.54 156.39 35.27 Favored Pre-proline 0 N--CA 1.441 -0.896 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.652 169.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -44.86 -37.6 12.19 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.885 2.39 . . . . 0.0 112.645 176.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.494 ' O ' ' HG2' ' A' ' 59' ' ' GLU . 1.3 tt0 -54.89 -51.82 64.8 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.636 178.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.736 ' HG3' HG22 ' A' ' 146' ' ' VAL . 7.5 tp10 -67.63 -41.93 83.13 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.689 0.757 . . . . 0.0 110.191 177.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.723 ' O ' HG12 ' A' ' 61' ' ' ILE . 73.6 mt -62.71 -41.39 99.11 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.079 -0.964 . . . . 0.0 112.057 -174.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -67.25 -23.39 65.7 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.759 0.314 . . . . 0.0 110.317 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.592 ' HG3' HH12 ' A' ' 144' ' ' ARG . 9.7 mm-40 -73.07 -37.2 66.89 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.974 0.416 . . . . 0.0 110.274 176.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.422 ' O ' ' HB3' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -71.9 -37.19 70.15 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 174.253 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.723 HG12 ' O ' ' A' ' 57' ' ' LEU . 51.2 mm -57.69 -54.12 35.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.453 171.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.559 ' HA ' ' HB3' ' A' ' 65' ' ' ASP . 9.3 t70 -60.86 -29.82 69.76 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.074 -176.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.422 ' HB3' ' O ' ' A' ' 60' ' ' MET . 13.9 tp10 -43.44 -49.46 7.17 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-O 122.309 1.052 . . . . 0.0 109.639 175.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.912 HG11 ' HB2' ' A' ' 80' ' ' MET . 0.0 OUTLIER -116.03 -1.9 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.722 0 CA-C-N 113.628 -1.623 . . . . 0.0 111.96 -172.169 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.559 ' HB3' ' HA ' ' A' ' 62' ' ' ASP . 21.6 t0 -88.69 82.59 6.81 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.036 0.446 . . . . 0.0 110.003 175.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -83.16 -26.25 31.08 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.742 -176.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -80.59 -8.53 59.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.224 0.535 . . . . 0.0 110.514 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 74.68 25.61 69.45 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.498 177.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.0 m -78.44 -8.7 58.8 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.948 0.404 . . . . 0.0 111.499 -175.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 72.59 9.96 75.0 Favored Glycine 0 C--N 1.323 -0.166 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.892 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.562 ' HB ' ' HB2' ' A' ' 35' ' ' SER . 0.6 OUTLIER -152.3 133.39 14.26 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.236 0.541 . . . . 0.0 110.136 -177.832 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.676 HG21 HG23 ' A' ' 64' ' ' VAL . 3.6 t -91.63 118.1 36.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.248 -177.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.401 ' HA ' ' CE1' ' A' ' 24' ' ' PHE . 1.9 p30 -94.39 179.04 5.42 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.405 176.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.434 ' CE1' HD22 ' A' ' 78' ' ' LEU . 10.9 t80 -53.42 -48.89 68.34 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -171.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -68.74 -35.94 77.76 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.732 0.301 . . . . 0.0 110.54 -173.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.417 ' OE2' ' HA ' ' A' ' 76' ' ' GLU . 3.8 mm-40 -64.03 -49.99 70.19 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.854 0.835 . . . . 0.0 109.752 172.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.409 ' O ' ' HG2' ' A' ' 81' ' ' MET . 5.2 t80 -57.62 -33.79 68.61 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 113.931 -1.486 . . . . 0.0 111.394 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.434 HD22 ' CE1' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -62.72 -51.37 67.43 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 177.221 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.906 HG12 HG12 ' A' ' 64' ' ' VAL . 1.2 t -53.24 -44.34 52.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.687 169.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.912 ' HB2' HG11 ' A' ' 64' ' ' VAL . 62.1 ttp -56.83 -44.87 82.49 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 122.002 0.906 . . . . 0.0 109.783 -179.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.618 ' O ' ' HG3' ' A' ' 85' ' ' MET . 18.5 mmt -60.85 -40.4 92.71 Favored 'General case' 0 N--CA 1.424 -1.766 0 CA-C-N 113.741 -1.572 . . . . 0.0 112.555 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.692 ' HA ' ' SD ' ' A' ' 85' ' ' MET . 0.8 OUTLIER -77.41 -28.53 16.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.448 178.203 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.705 ' HG3' ' O ' ' A' ' 79' ' ' VAL . 23.8 mtp180 -62.17 -36.36 81.63 Favored 'General case' 0 CA--C 1.522 -0.13 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.7 p -80.35 -6.92 58.77 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.334 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.692 ' SD ' ' HA ' ' A' ' 82' ' ' VAL . 61.4 mtt -76.0 -63.64 1.27 Allowed 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -177.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.614 ' HB3' ' HA ' ' A' ' 90' ' ' LYS . 17.6 tptp -61.2 -67.14 0.43 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.791 0.805 . . . . 0.0 110.857 -174.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -125.11 -164.6 1.3 Allowed 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 -177.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.503 ' HB3' HG21 ' A' ' 142' ' ' THR . 9.0 m-20 -66.05 -36.11 82.34 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 173.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.9 p -119.89 3.09 11.06 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.917 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.614 ' HA ' ' HB3' ' A' ' 86' ' ' LYS . 9.7 tmtt? 66.46 -68.59 0.13 Allowed 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -171.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -163.27 84.86 0.11 Allowed Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 176.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.7 175.67 4.07 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -173.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -90.8 -64.02 1.19 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.624 -174.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -142.03 -53.85 0.43 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.909 0.385 . . . . 0.0 110.943 -173.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -68.61 159.5 81.33 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.561 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -72.97 168.48 24.59 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.349 2.033 . . . . 0.0 110.627 176.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.503 HG21 ' HB3' ' A' ' 88' ' ' ASP . 6.2 m -75.92 67.26 2.27 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.085 0.469 . . . . 0.0 110.943 -177.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 19.6 mt 63.86 -171.63 0.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.017 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.592 HH12 ' HG3' ' A' ' 59' ' ' GLU . 0.7 OUTLIER -118.63 -65.09 1.21 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.082 0.468 . . . . 0.0 110.493 -176.673 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -85.46 -56.64 3.42 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.649 -175.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.736 HG22 ' HG3' ' A' ' 56' ' ' GLU . 14.6 m -101.64 156.07 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -170.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 19.5 tpt180 -163.99 135.67 4.72 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 114.395 -1.275 . . . . 0.0 110.106 164.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 13.7 mt -87.22 127.62 40.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.153 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.509 ' HB2' ' CB ' ' A' ' 152' ' ' ALA . 31.2 m -93.82 141.15 28.83 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 163.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.619 ' O ' ' HG2' ' A' ' 154' ' ' MET . . . -46.9 -62.96 1.16 Allowed 'General case' 0 N--CA 1.467 0.379 0 O-C-N 123.249 0.343 . . . . 0.0 111.908 -173.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.619 ' HA ' ' HB2' ' A' ' 154' ' ' MET . 3.9 p30 -73.99 -24.56 59.61 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.524 -174.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.509 ' CB ' ' HB2' ' A' ' 149' ' ' SER . . . -58.24 -42.35 86.16 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.899 177.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . 0.507 ' HG2' HD23 ' A' ' 157' ' ' LEU . 1.1 tmt? -80.57 -35.17 34.64 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.179 174.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.619 ' HG2' ' O ' ' A' ' 150' ' ' ALA . 28.4 mmt -47.86 -56.61 7.1 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.104 177.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.537 ' HG2' ' O ' ' A' ' 151' ' ' ASP . 11.3 pt20 -56.92 -46.17 82.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.469 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.452 ' N ' ' HG3' ' A' ' 155' ' ' GLN . . . -51.62 -44.1 62.79 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.727 -177.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.507 HD23 ' HG2' ' A' ' 153' ' ' MET . 3.9 mm? -91.27 -52.45 4.81 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.485 0.66 . . . . 0.0 111.767 -174.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.564 ' HB2' ' HB2' ' A' ' 162' ' ' ALA . 4.7 mt -85.71 -47.87 9.37 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.021 -0.991 . . . . 0.0 112.966 -170.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 66.32 -97.09 0.3 Allowed Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 111.229 -0.749 . . . . 0.0 111.229 -170.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.405 ' O ' ' HG2' ' A' ' 163' ' ' LYS . . . -67.82 -33.46 74.83 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.536 0.684 . . . . 0.0 111.479 177.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.458 ' HB3' ' HB3' ' A' ' 158' ' ' LEU . 0.2 OUTLIER -84.72 23.47 1.16 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.384 -172.935 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.564 ' HB2' ' HB2' ' A' ' 158' ' ' LEU . . . -126.99 23.06 6.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.381 178.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.405 ' HG2' ' O ' ' A' ' 160' ' ' ALA . 16.1 ptpt -155.85 -172.91 4.3 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.948 -176.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 88.0 29.86 19.16 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.629 178.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 56.7 m-70 . . . . . 0 C--O 1.245 0.86 0 CA-C-O 118.369 -0.824 . . . . 0.0 109.475 179.623 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.2 ttt . . . . . 0 N--CA 1.48 1.063 0 CA-C-O 120.75 0.31 . . . . 0.0 110.548 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.443 ' HB2' ' CD1' ' A' ' 5' ' ' TYR . 9.9 m-20 -69.53 115.19 8.49 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 176.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.413 ' HA ' ' CB ' ' A' ' 6' ' ' LYS . 7.8 p-10 -76.84 -12.56 59.99 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -173.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.3 tp -57.89 -40.99 78.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 122.195 0.998 . . . . 0.0 108.649 167.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.636 ' CB ' HG22 ' A' ' 79' ' ' VAL . 22.9 m-85 -82.82 -34.22 26.99 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.934 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.736 ' O ' ' HG3' ' A' ' 10' ' ' GLU . 14.1 ttpt -66.39 -30.85 71.32 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.36 176.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.705 ' HA ' ' CG ' ' A' ' 10' ' ' GLU . . . -77.64 -27.25 51.01 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.058 0.456 . . . . 0.0 111.046 176.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.448 ' O ' ' HG ' ' A' ' 12' ' ' LEU . . . -63.15 -41.0 99.2 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 167.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.625 ' HB ' ' O ' ' A' ' 6' ' ' LYS . 16.8 t -61.5 -33.11 55.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.246 171.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.736 ' HG3' ' O ' ' A' ' 6' ' ' LYS . 71.5 mt-10 -65.1 -27.22 68.61 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.035 178.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -85.61 -36.27 20.48 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.831 172.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.53 ' HA ' ' OE1' ' A' ' 16' ' ' GLN . 73.4 mt -56.78 141.51 44.06 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-O 121.78 0.8 . . . . 0.0 109.644 172.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.519 HG23 ' OE1' ' A' ' 16' ' ' GLN . 3.3 p -100.61 164.95 11.65 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.511 -176.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -57.4 -25.9 60.27 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.343 -0.543 . . . . 0.0 109.954 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -73.09 -51.67 17.14 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.475 173.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.53 ' OE1' ' HA ' ' A' ' 12' ' ' LEU . 38.4 mt-30 -54.31 -58.0 9.08 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-O 121.727 0.775 . . . . 0.0 111.054 174.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.448 ' HG2' HD21 ' A' ' 78' ' ' LEU . 57.2 mtpt -50.79 -45.5 59.26 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.581 -1.19 . . . . 0.0 111.969 174.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -60.12 -43.38 95.68 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 120.951 0.405 . . . . 0.0 110.691 175.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -57.77 -40.24 79.34 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.025 -177.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.434 ' CD2' ' HG3' ' A' ' 81' ' ' MET . 40.8 m-85 -70.57 -38.57 74.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.901 176.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.708 ' O ' ' HB3' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -62.7 -51.54 66.78 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 122.121 0.962 . . . . 0.0 109.579 178.846 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.642 ' O ' HG13 ' A' ' 26' ' ' ILE . . . -50.52 -49.54 55.44 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.06 -1.427 . . . . 0.0 110.643 177.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.496 ' HB2' HD21 ' A' ' 158' ' ' LEU . . . -67.32 -33.37 75.12 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.172 177.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.708 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 40.2 t80 -48.98 -55.51 11.68 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 172.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.525 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 23.9 t70 -51.68 -36.77 47.75 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 113.705 -1.589 . . . . 0.0 111.914 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.642 HG13 ' O ' ' A' ' 22' ' ' ALA . 2.8 mt -80.38 -41.19 20.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.93 -175.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.588 ' CE2' ' HA ' ' A' ' 41' ' ' LEU . 2.8 t80 -56.72 -30.86 63.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.324 177.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.553 HG22 ' O ' ' A' ' 24' ' ' PHE . 27.0 m -107.71 16.41 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.96 -176.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.526 ' HG ' ' HA ' ' A' ' 26' ' ' ILE . 33.8 mt -72.78 121.2 19.51 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 173.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.46 5.71 58.92 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.268 -171.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.45 149.44 21.7 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.338 0.589 . . . . 0.0 110.692 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -78.98 -45.61 19.94 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.219 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -94.66 -18.33 21.43 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.088 0.471 . . . . 0.0 111.302 -175.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.4 3.28 84.51 Favored Glycine 0 C--O 1.225 -0.436 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.043 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.514 ' HB2' ' HB ' ' A' ' 71' ' ' THR . 5.1 m -111.57 148.01 34.19 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 174.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.572 HD11 ' HD2' ' A' ' 77' ' ' PHE . 53.0 mt -68.15 107.17 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 C-N-CA 121.313 -0.155 . . . . 0.0 111.059 -175.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 82.0 p -90.88 -175.43 4.35 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 170.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.59 ' O ' HD13 ' A' ' 57' ' ' LEU . 55.5 p -64.15 -36.24 83.41 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 120.992 0.425 . . . . 0.0 110.132 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -59.46 -56.11 26.15 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.094 177.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -48.98 -49.62 39.74 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 114.647 -1.16 . . . . 0.0 112.489 175.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.588 ' HA ' ' CE2' ' A' ' 27' ' ' PHE . 2.3 tt -71.07 -34.39 71.13 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 120.42 -0.512 . . . . 0.0 109.993 -174.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.9 ' O ' ' HG3' ' A' ' 46' ' ' ARG . . . -64.23 -46.93 89.53 Favored Glycine 0 C--O 1.218 -0.872 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 173.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 35.0 tttt -46.31 -47.79 18.33 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.328 0.651 . . . . 0.0 111.138 -178.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.481 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 92.1 t -74.44 -38.65 47.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.151 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.578 ' HG3' ' HG3' ' A' ' 52' ' ' PRO . 34.2 mmt -55.03 -49.72 70.85 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 174.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.9 ' HG3' ' O ' ' A' ' 42' ' ' GLY . 41.1 mtt180 -50.16 -59.41 3.95 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.682 0.753 . . . . 0.0 110.286 174.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 4.9 ttp -52.27 -23.87 6.43 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.074 -1.421 . . . . 0.0 112.534 174.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.518 HD21 ' O ' ' A' ' 152' ' ' ALA . 5.2 mt -97.68 0.29 46.85 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -175.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 105.92 -2.59 38.49 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.8 -0.714 . . . . 0.0 113.089 177.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.725 ' HB3' ' HD3' ' A' ' 52' ' ' PRO . 1.2 mp0 -99.77 -179.6 4.23 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 120.747 0.308 . . . . 0.0 111.037 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -159.36 58.23 1.17 Allowed Pre-proline 0 CA--C 1.536 0.426 0 CA-C-O 121.544 0.687 . . . . 0.0 111.223 166.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.725 ' HD3' ' HB3' ' A' ' 50' ' ' GLN . 43.7 Cg_endo -63.41 157.72 49.0 Favored 'Trans proline' 0 N--CA 1.476 0.499 0 C-N-CA 123.964 3.109 . . . . 0.0 113.473 -177.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.99 156.48 57.81 Favored Pre-proline 0 CA--C 1.504 -0.816 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.376 175.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -46.29 -35.5 15.69 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 122.641 2.227 . . . . 0.0 113.048 174.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -63.23 -51.11 67.57 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.581 177.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.58 ' O ' HG21 ' A' ' 146' ' ' VAL . 7.5 tt0 -65.01 -32.48 74.23 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.662 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.684 ' O ' HG12 ' A' ' 61' ' ' ILE . 65.7 mt -76.12 -37.72 57.74 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.811 178.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.53 -36.21 75.69 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-O 120.563 0.22 . . . . 0.0 110.792 -178.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.463 ' HG3' ' CD1' ' A' ' 143' ' ' LEU . 7.6 pt-20 -77.88 -27.31 49.65 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.578 -177.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.472 ' SD ' ' HG ' ' A' ' 143' ' ' LEU . 10.5 tpt -71.68 -39.98 69.87 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 169.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.684 HG12 ' O ' ' A' ' 57' ' ' LEU . 47.6 mm -58.55 -54.13 37.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.275 172.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -62.63 -30.22 71.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.331 -172.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.643 ' OE2' HG23 ' A' ' 142' ' ' THR . 2.6 tt0 -56.03 -37.6 69.43 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 121.875 0.845 . . . . 0.0 109.329 177.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 1.009 HG11 ' HB2' ' A' ' 80' ' ' MET . 0.1 OUTLIER -100.3 -33.36 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.722 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.702 -173.067 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -58.28 111.71 1.3 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.297 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -70.48 -31.85 69.14 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.146 -177.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -107.35 -6.33 17.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.807 -173.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 75.16 26.06 67.24 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.654 175.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.7 m -75.29 -26.77 58.99 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.219 0.533 . . . . 0.0 111.621 -175.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 104.97 20.04 10.23 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -176.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.544 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 0.8 OUTLIER -149.89 131.48 14.87 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.345 0.593 . . . . 0.0 111.147 -178.63 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.476 HG22 ' HB ' ' A' ' 64' ' ' VAL . 18.0 t -101.36 113.05 36.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.777 178.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.559 ' HA ' ' CE2' ' A' ' 24' ' ' PHE . 3.2 t70 -99.62 174.18 6.36 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.418 ' O ' ' HB3' ' A' ' 77' ' ' PHE . 17.7 t80 -42.94 -55.64 3.65 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -167.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -62.13 -41.14 97.95 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 118.15 0.432 . . . . 0.0 110.766 -176.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.422 ' CB ' HG13 ' A' ' 72' ' ' VAL . 1.6 mp0 -56.99 -56.32 23.26 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.593 0.711 . . . . 0.0 109.287 169.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.572 ' HD2' HD11 ' A' ' 36' ' ' ILE . 20.7 t80 -47.73 -35.62 10.08 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.21 -1.359 . . . . 0.0 111.445 -176.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.46 ' HG ' HG22 ' A' ' 9' ' ' VAL . 3.0 tp -75.36 -42.82 53.28 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.239 -177.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.798 ' O ' ' HG3' ' A' ' 83' ' ' ARG . 1.0 OUTLIER -55.5 -44.96 78.19 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.523 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 167.052 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 1.009 ' HB2' HG11 ' A' ' 64' ' ' VAL . 55.2 ttp -59.2 -44.02 92.24 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.134 0.492 . . . . 0.0 110.785 177.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.623 ' O ' ' HB2' ' A' ' 85' ' ' MET . 24.5 mmt -57.87 -55.1 39.25 Favored 'General case' 0 N--CA 1.426 -1.669 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.078 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.594 ' HA ' ' HB2' ' A' ' 85' ' ' MET . 18.8 m -63.0 -29.16 46.55 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.635 0 C-N-CA 120.729 -0.388 . . . . 0.0 111.026 176.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.798 ' HG3' ' O ' ' A' ' 79' ' ' VAL . 57.9 mtt-85 -58.77 -42.39 88.81 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.951 0.405 . . . . 0.0 110.55 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.506 ' HG ' ' HA ' ' A' ' 149' ' ' SER . 29.1 t -79.4 -44.21 21.89 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.533 0.682 . . . . 0.0 109.759 174.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.623 ' HB2' ' O ' ' A' ' 81' ' ' MET . 0.2 OUTLIER -50.36 -40.52 49.66 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 124.563 1.145 . . . . 0.0 113.998 177.869 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.534 ' HA ' ' HE2' ' A' ' 86' ' ' LYS . 3.5 mmpt? -54.31 -61.47 2.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.918 0.389 . . . . 0.0 111.716 -176.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -174.12 151.25 1.66 Allowed 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -175.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.405 ' O ' ' HD3' ' A' ' 137' ' ' LYS . 11.7 t70 -69.55 -15.78 63.3 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.92 0.39 . . . . 0.0 110.417 -178.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 56.3 m -100.71 -9.78 21.49 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.323 174.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 22.1 tptp -57.63 -41.56 81.6 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 176.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.672 ' C ' HG21 ' A' ' 142' ' ' THR . . . -151.55 115.1 0.68 Allowed Glycine 0 N--CA 1.435 -1.41 0 CA-C-N 114.616 -1.175 . . . . 0.0 110.889 174.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.464 ' O ' ' HB ' ' A' ' 142' ' ' THR . 4.6 tptm -152.94 -80.2 0.1 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.765 0.317 . . . . 0.0 110.281 177.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -104.01 -43.22 5.34 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.517 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 99.6 mttt -68.05 148.75 50.56 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 172.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.517 ' HB2' ' O ' ' A' ' 139' ' ' LYS . 0.2 OUTLIER 68.77 162.21 0.14 Allowed Pre-proline 0 C--O 1.234 0.259 0 O-C-N 124.02 0.825 . . . . 0.0 110.229 -168.903 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -64.75 57.15 0.26 Allowed 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 123.996 3.13 . . . . 0.0 111.463 171.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.672 HG21 ' C ' ' A' ' 136' ' ' GLY . 1.4 m -98.1 -159.4 0.74 Allowed 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.78 -175.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.669 ' H ' HG22 ' A' ' 142' ' ' THR . 3.2 mm? -125.0 122.25 36.77 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -160.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 22.0 tpt180 -90.72 127.73 36.42 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 167.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.495 ' CZ ' ' HG3' ' A' ' 50' ' ' GLN . 0.0 OUTLIER 76.14 -51.35 0.61 Allowed 'General case' 0 N--CA 1.471 0.6 0 O-C-N 123.775 0.672 . . . . 0.0 111.714 178.312 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.58 HG21 ' O ' ' A' ' 56' ' ' GLU . 0.9 OUTLIER -87.98 27.24 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.662 0 CA-C-O 121.049 0.452 . . . . 0.0 111.716 -178.022 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.412 HH22 ' HB3' ' A' ' 83' ' ' ARG . 32.7 tpt180 -88.09 95.54 10.19 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 120.214 -0.594 . . . . 0.0 109.412 177.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 32.2 mt -54.32 116.43 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.322 -0.853 . . . . 0.0 111.129 176.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.51 ' HB2' ' CB ' ' A' ' 152' ' ' ALA . 21.2 m -80.89 134.61 35.77 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 167.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.672 ' O ' ' HG2' ' A' ' 154' ' ' MET . . . -44.63 -63.48 0.89 Allowed 'General case' 0 N--CA 1.465 0.284 0 O-C-N 123.805 0.69 . . . . 0.0 112.297 -173.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.536 ' HA ' ' HB2' ' A' ' 154' ' ' MET . 5.5 m-20 -75.34 -22.71 57.4 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.318 -175.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.518 ' O ' HD21 ' A' ' 48' ' ' LEU . . . -59.09 -46.14 89.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.791 0.329 . . . . 0.0 111.169 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . 0.447 ' HA ' HD11 ' A' ' 48' ' ' LEU . 7.7 ptm -79.74 -26.42 40.77 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 119.916 -0.714 . . . . 0.0 110.175 176.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.672 ' HG2' ' O ' ' A' ' 150' ' ' ALA . 27.8 mmt -51.66 -56.97 10.6 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.224 177.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.551 ' HG3' ' N ' ' A' ' 156' ' ' ALA . 10.6 pt20 -58.91 -48.45 81.43 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.791 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.551 ' N ' ' HG3' ' A' ' 155' ' ' GLN . . . -53.31 -42.37 66.6 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.025 -0.989 . . . . 0.0 112.44 -176.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.517 ' HB3' ' HB ' ' A' ' 26' ' ' ILE . 3.3 mm? -91.51 -44.03 9.33 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.951 0.405 . . . . 0.0 111.805 -177.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.598 HD22 ' HB3' ' A' ' 161' ' ' ARG . 16.3 mt -85.56 -48.08 9.27 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.127 -171.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 67.05 3.28 22.41 Favored Glycine 0 CA--C 1.508 -0.353 0 CA-C-N 115.686 -0.688 . . . . 0.0 113.98 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.517 ' C ' ' H ' ' A' ' 162' ' ' ALA . . . 177.81 -48.06 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.687 0.756 . . . . 0.0 110.613 -169.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.598 ' HB3' HD22 ' A' ' 158' ' ' LEU . 0.0 OUTLIER -75.34 32.16 0.1 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.707 179.081 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.517 ' H ' ' C ' ' A' ' 160' ' ' ALA . . . -114.08 -8.78 13.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.12 171.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.438 ' N ' ' HD3' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -129.05 -48.84 1.21 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.961 -1.018 . . . . 0.0 108.707 179.063 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 143.54 -106.18 0.41 Allowed Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.503 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 45.7 m80 . . . . . 0 C--O 1.246 0.904 0 CA-C-O 118.554 -0.736 . . . . 0.0 109.733 176.977 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.1 ttt . . . . . 0 N--CA 1.477 0.877 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.463 ' HB2' ' CD2' ' A' ' 5' ' ' TYR . 11.0 m-20 -65.08 118.72 9.58 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -75.48 -10.59 59.58 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -171.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.2 tt -59.27 -38.47 74.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 122.0 0.905 . . . . 0.0 108.775 169.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.645 ' CB ' HG22 ' A' ' 79' ' ' VAL . 18.1 m-85 -83.06 -30.38 28.07 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.57 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.413 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 33.8 tttt -70.01 -33.5 72.1 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.094 177.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.2 -34.73 78.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.995 0.426 . . . . 0.0 110.321 176.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.52 ' O ' ' HG ' ' A' ' 12' ' ' LEU . . . -62.05 -46.95 86.87 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.163 171.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.513 ' HA ' ' HB2' ' A' ' 12' ' ' LEU . 1.5 t -54.42 -37.88 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.683 172.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -69.5 -27.79 65.5 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.014 -0.994 . . . . 0.0 112.097 -178.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -85.59 -29.71 23.9 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.529 170.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 8' ' ' ALA . 22.6 mt -59.86 135.75 57.79 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.129 172.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.465 ' H ' ' HB2' ' A' ' 16' ' ' GLN . 31.6 p -98.89 165.51 11.73 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.566 -176.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -55.63 -28.7 56.74 Favored 'General case' 0 C--O 1.212 -0.875 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 179.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -70.67 -48.72 53.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.649 176.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.465 ' HB2' ' H ' ' A' ' 13' ' ' THR . 69.9 mm-40 -57.83 -57.9 10.74 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.816 0.817 . . . . 0.0 111.355 174.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.449 ' HG3' ' HB3' ' A' ' 12' ' ' LEU . 58.4 mtpt -54.71 -44.07 73.14 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 113.971 -1.468 . . . . 0.0 111.577 178.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -59.39 -45.44 91.48 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.755 174.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -56.96 -41.3 78.06 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.539 -177.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.431 ' CD1' ' HG3' ' A' ' 81' ' ' MET . 32.2 m-85 -68.55 -36.92 79.46 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.112 176.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.656 ' O ' ' HB3' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -65.37 -51.14 62.49 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 122.037 0.922 . . . . 0.0 108.865 179.602 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.767 ' O ' HG13 ' A' ' 26' ' ' ILE . . . -48.73 -49.04 40.03 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.127 -1.397 . . . . 0.0 110.351 175.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.45 ' HA ' HD12 ' A' ' 26' ' ' ILE . . . -67.85 -33.67 75.2 Favored 'General case' 0 CA--C 1.518 -0.265 0 O-C-N 123.054 0.221 . . . . 0.0 110.959 178.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.656 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 64.8 t80 -51.29 -56.17 14.41 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 171.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.463 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 35.7 t70 -49.53 -43.48 45.77 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 113.835 -1.529 . . . . 0.0 111.921 178.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.767 HG13 ' O ' ' A' ' 22' ' ' ALA . 4.5 mt -72.06 -43.97 66.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.68 0.753 . . . . 0.0 109.922 -177.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.663 ' CE2' ' HA ' ' A' ' 41' ' ' LEU . 3.7 t80 -58.6 -29.66 66.63 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.286 -1.325 . . . . 0.0 109.628 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.552 HG22 ' O ' ' A' ' 24' ' ' PHE . 30.2 m -109.7 18.66 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.119 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.487 ' HG ' ' HA ' ' A' ' 26' ' ' ILE . 18.3 mt -67.53 117.24 9.22 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 119.808 -0.757 . . . . 0.0 109.46 177.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.21 11.97 53.05 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.814 -174.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -85.78 151.76 23.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.23 0.538 . . . . 0.0 111.052 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -77.95 -45.66 23.33 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.486 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -95.24 -17.55 21.61 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.109 -176.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.54 -2.04 86.05 Favored Glycine 0 C--O 1.221 -0.665 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.065 -176.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.403 ' CB ' ' HB ' ' A' ' 71' ' ' THR . 69.8 m -105.81 157.04 17.74 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 176.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.49 ' HB ' ' HB ' ' A' ' 72' ' ' VAL . 66.1 mt -72.74 107.69 3.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.954 -175.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 62.7 p -90.62 -175.97 4.58 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 170.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.544 ' O ' HD13 ' A' ' 57' ' ' LEU . 62.8 p -66.69 -38.82 87.54 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 120.655 -0.418 . . . . 0.0 109.938 178.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 58.6 tttp -58.31 -51.35 70.17 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.42 176.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.705 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 0.6 OUTLIER -51.96 -43.87 63.72 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.782 175.511 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.663 ' HA ' ' CE2' ' A' ' 27' ' ' PHE . 4.5 tt -75.26 -33.5 61.29 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.9 -175.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.788 ' O ' ' HG3' ' A' ' 46' ' ' ARG . . . -66.27 -33.61 85.58 Favored Glycine 0 C--O 1.222 -0.602 0 C-N-CA 120.324 -0.941 . . . . 0.0 111.182 173.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.705 ' HB3' ' O ' ' A' ' 40' ' ' GLU . 0.6 OUTLIER -45.92 -47.84 16.3 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.598 0.713 . . . . 0.0 109.949 175.412 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.612 HG21 ' CD1' ' A' ' 27' ' ' PHE . 98.3 t -80.14 -42.08 21.5 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.922 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.51 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 4.9 mmt -59.64 -51.48 69.63 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 117.826 0.285 . . . . 0.0 111.043 -177.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.788 ' HG3' ' O ' ' A' ' 42' ' ' GLY . 76.3 mtt180 -50.97 -56.64 11.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.406 0.622 . . . . 0.0 110.346 172.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.405 ' CE ' ' HA ' ' A' ' 44' ' ' VAL . 6.1 ttp -51.35 -29.7 16.17 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.778 -1.101 . . . . 0.0 112.82 173.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.575 ' HB2' ' O ' ' A' ' 44' ' ' VAL . 4.3 mt -92.57 -2.27 56.29 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 123.152 0.581 . . . . 0.0 112.085 -172.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 103.01 -9.51 54.95 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.339 177.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.599 ' HB3' ' HD3' ' A' ' 52' ' ' PRO . 10.8 mp0 -84.64 175.54 9.16 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 175.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -158.31 63.54 2.63 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-O 122.035 0.922 . . . . 0.0 109.708 172.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.738 ' HB3' HG11 ' A' ' 146' ' ' VAL . 48.9 Cg_endo -68.89 161.93 43.61 Favored 'Trans proline' 0 CA--C 1.512 -0.623 0 C-N-CA 123.673 2.915 . . . . 0.0 113.087 -178.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.9 p -87.87 161.49 44.15 Favored Pre-proline 0 CA--C 1.499 -0.989 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.905 166.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -47.78 -26.38 6.92 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 122.846 2.364 . . . . 0.0 112.576 169.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -65.65 -53.8 36.33 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.813 177.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -65.25 -41.4 94.36 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.586 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.707 ' O ' HG12 ' A' ' 61' ' ' ILE . 98.5 mt -59.34 -45.6 90.92 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.091 175.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -65.38 -29.84 70.59 Favored 'General case' 0 C--O 1.216 -0.671 0 C-N-CA 121.077 -0.249 . . . . 0.0 110.485 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -68.52 -39.97 81.0 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.829 0.347 . . . . 0.0 111.037 176.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.48 ' HG2' ' O ' ' A' ' 146' ' ' VAL . 0.0 OUTLIER -71.15 -37.39 72.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.945 175.727 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.707 HG12 ' O ' ' A' ' 57' ' ' LEU . 47.4 mm -59.12 -49.92 81.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.636 0.732 . . . . 0.0 109.149 171.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.437 ' HA ' ' HB3' ' A' ' 65' ' ' ASP . 15.6 t70 -65.15 -25.34 67.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.873 -174.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.448 ' HB2' ' O ' ' A' ' 60' ' ' MET . 2.6 mm-40 -49.43 -33.16 13.36 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-O 121.712 0.768 . . . . 0.0 110.102 173.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.997 HG11 ' HB2' ' A' ' 80' ' ' MET . 0.0 OUTLIER -130.5 -14.46 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.568 0 CA-C-N 114.318 -1.31 . . . . 0.0 113.431 -167.768 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.437 ' HB3' ' HA ' ' A' ' 62' ' ' ASP . 25.3 t70 -63.21 92.03 0.05 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.079 0.466 . . . . 0.0 111.301 176.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -91.18 -35.74 14.36 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.405 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -78.88 -8.74 59.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.169 0.509 . . . . 0.0 110.783 -176.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.408 ' HA2' ' OD1' ' A' ' 65' ' ' ASP . . . 74.27 18.17 79.78 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.947 -0.57 . . . . 0.0 113.07 174.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 57.5 m -90.87 6.86 42.77 Favored 'General case' 0 C--N 1.321 -0.64 0 O-C-N 122.585 -0.362 . . . . 0.0 111.661 -176.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 71.31 19.81 77.76 Favored Glycine 0 CA--C 1.507 -0.464 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.216 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 0.8 OUTLIER -146.6 139.67 25.51 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 114.802 -0.699 . . . . 0.0 110.496 -175.89 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.582 HG21 HG23 ' A' ' 64' ' ' VAL . 6.7 t -96.52 121.66 47.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.458 176.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -96.69 179.27 5.04 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 177.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.434 ' CZ ' HD22 ' A' ' 78' ' ' LEU . 12.0 t80 -53.1 -54.33 37.19 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -170.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -67.44 -34.05 76.41 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.636 -172.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.404 ' OE2' ' HA ' ' A' ' 72' ' ' VAL . 82.0 mt-10 -62.34 -54.14 44.89 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-O 121.6 0.714 . . . . 0.0 109.749 171.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.47 ' O ' ' HG2' ' A' ' 81' ' ' MET . 4.1 t80 -55.55 -30.59 61.05 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.577 178.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.499 ' O ' HG13 ' A' ' 82' ' ' VAL . 0.9 OUTLIER -69.78 -47.78 61.63 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 178.116 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.799 HG12 HG12 ' A' ' 64' ' ' VAL . 0.5 OUTLIER -54.52 -43.48 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 168.768 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.997 ' HB2' HG11 ' A' ' 64' ' ' VAL . 64.0 ttp -56.24 -47.65 78.06 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.459 0.647 . . . . 0.0 110.122 177.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.636 ' O ' ' HG3' ' A' ' 85' ' ' MET . 23.7 mmt -60.42 -37.49 81.05 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 114.785 -1.098 . . . . 0.0 112.158 -177.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.591 ' HA ' ' SD ' ' A' ' 85' ' ' MET . 1.3 m -79.95 -28.87 12.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 119.934 -0.706 . . . . 0.0 110.319 176.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.794 ' HG3' ' O ' ' A' ' 79' ' ' VAL . 54.6 mtp85 -62.33 -34.56 76.87 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 177.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.486 ' HB3' ' O ' ' A' ' 148' ' ' ILE . 3.9 p -80.15 -16.98 53.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.054 -0.976 . . . . 0.0 112.394 177.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.636 ' HG3' ' O ' ' A' ' 81' ' ' MET . 57.0 mtt -69.37 -46.19 67.55 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 121.319 0.581 . . . . 0.0 111.366 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.444 ' HB2' ' HG2' ' A' ' 90' ' ' LYS . 64.9 mmtt -60.0 -37.99 81.31 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.051 -0.977 . . . . 0.0 112.11 -175.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.43 ' OD2' ' HD3' ' A' ' 137' ' ' LYS . 21.1 t70 -178.97 165.15 1.53 Allowed 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -178.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -47.91 -43.95 29.34 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 123.372 0.42 . . . . 0.0 109.897 175.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.402 ' OG ' ' HB3' ' A' ' 137' ' ' LYS . 0.1 OUTLIER -123.17 23.94 9.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.853 -179.062 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.444 ' HG2' ' HB2' ' A' ' 86' ' ' LYS . 0.4 OUTLIER 52.12 -95.03 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.226 0.61 . . . . 0.0 110.367 -179.396 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.432 ' H ' ' HB3' ' A' ' 90' ' ' LYS . . . -94.8 61.03 1.69 Allowed Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 178.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.43 ' HD3' ' OD2' ' A' ' 87' ' ' ASP . 49.9 pttt -56.99 139.37 52.33 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.607 -0.297 . . . . 0.0 110.884 -178.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 61.3 t80 76.91 -24.18 0.23 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.658 -177.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -95.72 -30.12 13.91 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.28 0.562 . . . . 0.0 110.682 178.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.435 ' NE ' ' HA ' ' A' ' 140' ' ' ARG . 2.4 mmp_? -121.31 155.15 59.04 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-O 121.342 0.592 . . . . 0.0 110.342 177.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -80.62 53.36 4.73 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 123.585 2.857 . . . . 0.0 111.169 174.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.08 60.05 2.33 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.389 -175.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.579 ' HB3' ' O ' ' A' ' 145' ' ' ARG . 6.4 mp 70.14 138.99 0.04 OUTLIER 'General case' 0 C--N 1.334 -0.094 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.753 169.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 20.7 ptp180 -88.76 -4.89 58.4 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.443 173.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.579 ' O ' ' HB3' ' A' ' 143' ' ' LEU . 0.1 OUTLIER -160.09 170.69 20.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.485 -179.707 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.738 HG11 ' HB3' ' A' ' 52' ' ' PRO . 28.1 m 44.82 37.94 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 N-CA-C 114.684 1.365 . . . . 0.0 114.684 173.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.539 ' NH2' ' HB3' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -84.36 94.14 8.41 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 169.872 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.486 ' O ' ' HB3' ' A' ' 84' ' ' SER . 35.3 mt -51.37 132.51 12.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.414 -176.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 74.2 m -92.89 144.57 25.14 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 165.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.583 ' O ' ' HG2' ' A' ' 154' ' ' MET . . . -50.12 -62.73 1.41 Allowed 'General case' 0 C--N 1.33 -0.28 0 O-C-N 123.306 0.379 . . . . 0.0 111.653 -172.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.6 ' HA ' ' HB2' ' A' ' 154' ' ' MET . 4.2 p-10 -72.76 -24.87 61.01 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.706 -174.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -55.09 -48.37 73.64 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.757 176.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . 0.489 ' O ' HD23 ' A' ' 157' ' ' LEU . 3.7 ppp? -80.85 -28.1 36.22 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.591 177.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.6 ' HB2' ' HA ' ' A' ' 151' ' ' ASP . 26.9 mmt -50.76 -55.95 14.34 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.002 0.429 . . . . 0.0 110.777 177.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.519 ' HG2' ' O ' ' A' ' 151' ' ' ASP . 7.0 pt20 -58.38 -50.88 72.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.113 -176.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -55.19 -40.97 71.33 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.098 -0.956 . . . . 0.0 112.298 -175.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.489 HD23 ' O ' ' A' ' 153' ' ' MET . 3.8 mm? -86.02 -53.08 5.3 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.403 0.62 . . . . 0.0 111.434 -177.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.751 HD22 ' HG2' ' A' ' 161' ' ' ARG . 57.4 mt -79.17 -47.59 15.75 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.003 -0.999 . . . . 0.0 112.573 -169.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.43 ' O ' ' HE3' ' A' ' 163' ' ' LYS . . . 68.5 -107.16 1.97 Allowed Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.3 -172.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.433 ' O ' ' HG2' ' A' ' 163' ' ' LYS . . . -61.06 -43.38 98.97 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.558 0.694 . . . . 0.0 111.559 177.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.751 ' HG2' HD22 ' A' ' 158' ' ' LEU . 1.8 tpm_? -62.88 -20.81 65.49 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.023 -0.99 . . . . 0.0 111.674 -177.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.549 ' HB2' ' HB2' ' A' ' 158' ' ' LEU . . . -71.21 -45.25 63.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.236 0.541 . . . . 0.0 110.685 178.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.433 ' HG2' ' O ' ' A' ' 160' ' ' ALA . 9.8 ptpt -85.73 -31.3 22.51 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.137 -175.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 79.79 -47.94 3.4 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.791 177.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 54.3 m80 . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.703 -0.665 . . . . 0.0 110.454 -178.418 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.427 ' CE ' HG23 ' A' ' 79' ' ' VAL . 21.6 ttt . . . . . 0 N--CA 1.478 0.941 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -69.84 116.05 9.78 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 178.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.456 ' HA ' ' CB ' ' A' ' 6' ' ' LYS . 5.0 p-10 -76.38 -12.61 60.09 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.98 -172.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 7.1 tt -59.36 -40.56 81.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 121.686 0.755 . . . . 0.0 109.439 169.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.775 ' HB2' HG22 ' A' ' 79' ' ' VAL . 23.1 m-85 -82.39 -32.44 29.17 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.246 177.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.748 ' O ' ' HG3' ' A' ' 10' ' ' GLU . 18.4 ttpt -66.95 -34.52 77.94 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.593 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.729 ' HA ' ' CG ' ' A' ' 10' ' ' GLU . . . -75.45 -25.84 57.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.862 0.363 . . . . 0.0 111.226 176.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.452 ' O ' ' HG ' ' A' ' 12' ' ' LEU . . . -65.03 -39.94 94.11 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 167.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.663 ' HB ' ' O ' ' A' ' 6' ' ' LYS . 13.5 t -61.53 -36.39 72.97 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.363 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.826 170.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.748 ' HG3' ' O ' ' A' ' 6' ' ' LYS . 50.8 mt-10 -61.58 -35.18 77.09 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.515 178.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -72.66 -38.04 67.75 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.187 170.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' A' ' 8' ' ' ALA . 76.0 mt -59.09 137.66 57.86 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-O 121.893 0.854 . . . . 0.0 109.279 173.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 52.0 p -96.42 160.56 14.34 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.217 -177.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -54.55 -24.03 19.16 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 177.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -69.54 -56.51 7.15 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.624 171.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -53.63 -57.05 12.18 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.869 0.842 . . . . 0.0 111.53 176.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.483 ' HG2' HD21 ' A' ' 78' ' ' LEU . 50.3 mtpt -52.04 -43.92 63.99 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 114.21 -1.359 . . . . 0.0 111.92 174.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -58.61 -42.53 88.36 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-O 121.32 0.581 . . . . 0.0 110.341 176.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -57.94 -38.95 76.88 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 114.572 -1.194 . . . . 0.0 109.66 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.488 ' CD1' ' HG3' ' A' ' 81' ' ' MET . 26.4 m-85 -72.29 -32.32 66.51 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.119 178.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.687 ' O ' ' HB3' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -71.44 -50.29 33.21 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 122.056 0.932 . . . . 0.0 109.459 -179.403 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.758 ' O ' HG13 ' A' ' 26' ' ' ILE . . . -53.42 -47.51 69.53 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.177 -1.374 . . . . 0.0 110.23 175.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.508 ' HA ' HD12 ' A' ' 26' ' ' ILE . . . -71.29 -25.54 62.48 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.181 178.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.687 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 44.5 t80 -54.0 -54.72 35.15 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 169.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.451 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 23.3 t70 -53.42 -37.82 62.9 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 113.53 -1.668 . . . . 0.0 111.51 178.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.758 HG13 ' O ' ' A' ' 22' ' ' ALA . 8.1 mt -76.97 -41.58 31.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.774 -176.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.513 ' HD1' ' HE3' ' A' ' 153' ' ' MET . 0.5 OUTLIER -61.82 -21.93 65.04 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.515 179.016 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.577 HG22 ' O ' ' A' ' 24' ' ' PHE . 27.6 m -114.72 19.66 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.01 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.546 ' HG ' ' HA ' ' A' ' 26' ' ' ILE . 22.9 mt -70.17 117.99 12.43 Favored 'General case' 0 C--O 1.236 0.389 0 O-C-N 121.543 -0.723 . . . . 0.0 109.771 175.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.17 12.57 57.35 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.503 -173.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -90.41 158.16 17.23 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.256 0.55 . . . . 0.0 111.495 -179.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -80.1 -46.81 15.82 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.264 -178.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -91.76 -17.34 25.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.166 0.508 . . . . 0.0 111.188 -176.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.8 9.34 87.16 Favored Glycine 0 N--CA 1.449 -0.5 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -171.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.3 m -119.63 145.98 45.96 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 177.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.482 ' HB ' ' HB ' ' A' ' 72' ' ' VAL . 66.3 mt -68.93 106.84 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.674 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.314 -174.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.449 ' H ' ' HB2' ' A' ' 40' ' ' GLU . 88.9 p -87.31 -168.45 2.24 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 170.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.519 ' O ' HD13 ' A' ' 57' ' ' LEU . 72.0 p -69.62 -42.85 73.81 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 122.127 -0.358 . . . . 0.0 110.548 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -59.1 -49.19 78.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.573 177.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.688 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 0.9 OUTLIER -54.86 -50.64 68.18 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.131 -0.94 . . . . 0.0 112.975 172.84 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.868 HD12 HD22 ' A' ' 57' ' ' LEU . 0.8 OUTLIER -51.53 -58.14 7.12 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 175.886 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.816 ' O ' ' HG3' ' A' ' 46' ' ' ARG . . . -60.45 -31.73 75.27 Favored Glycine 0 C--O 1.219 -0.832 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.1 -178.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.688 ' HB3' ' O ' ' A' ' 40' ' ' GLU . 23.6 tttp -45.89 -50.42 14.48 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 123.282 0.633 . . . . 0.0 110.865 -176.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.512 ' HB ' ' CZ ' ' A' ' 27' ' ' PHE . 92.5 t -78.36 -41.52 25.98 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.977 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.773 178.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 37.9 mmm -54.59 -45.53 73.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 118.316 0.507 . . . . 0.0 109.914 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.816 ' HG3' ' O ' ' A' ' 42' ' ' GLY . 37.5 mtp180 -50.87 -57.56 8.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.426 0.632 . . . . 0.0 111.079 171.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.456 ' HE3' HG22 ' A' ' 44' ' ' VAL . 1.8 ttp -53.33 -34.39 57.3 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.35 174.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.511 ' HB3' ' OE1' ' A' ' 50' ' ' GLN . 6.5 mt -79.42 -5.02 53.75 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 124.061 0.944 . . . . 0.0 112.555 -174.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 107.19 -18.6 35.97 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.116 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.63 ' O ' ' HA ' ' A' ' 46' ' ' ARG . 26.6 mp0 -83.91 177.56 8.25 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 122.346 0.258 . . . . 0.0 110.371 177.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -160.38 59.92 1.3 Allowed Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.5 0.667 . . . . 0.0 111.732 169.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.894 ' HG2' HD21 ' A' ' 57' ' ' LEU . 40.0 Cg_endo -67.82 156.12 67.18 Favored 'Trans proline' 0 CA--C 1.519 -0.242 0 C-N-CA 123.578 2.852 . . . . 0.0 113.666 -176.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.618 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 1.0 OUTLIER -84.9 161.04 54.22 Favored Pre-proline 0 C--N 1.318 -0.803 0 CA-C-N 114.631 -1.168 . . . . 0.0 112.059 -177.948 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -41.24 -39.08 3.72 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 123.365 2.71 . . . . 0.0 112.906 170.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 59' ' ' GLU . 26.8 tt0 -58.42 -52.61 64.89 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.29 176.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -64.65 -35.97 82.75 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-O 121.992 0.901 . . . . 0.0 111.519 -178.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.894 HD21 ' HG2' ' A' ' 52' ' ' PRO . 85.0 mt -76.02 -43.61 43.29 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 114.381 -1.281 . . . . 0.0 111.117 -175.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -65.65 -25.41 67.34 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 177.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.653 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 29.3 mt-10 -66.27 -54.02 29.88 Favored 'General case' 0 C--O 1.214 -0.779 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.548 172.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.46 ' CG ' HD21 ' A' ' 41' ' ' LEU . 8.9 tpt -60.14 -32.51 71.09 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.728 0.299 . . . . 0.0 110.581 176.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.679 HG12 ' O ' ' A' ' 57' ' ' LEU . 17.1 mm -62.64 -57.62 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 171.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -60.78 -30.11 69.84 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.965 -176.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.653 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 7.1 mm-40 -44.89 -38.74 4.84 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.125 -1.398 . . . . 0.0 111.275 177.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.837 HG12 HG12 ' A' ' 79' ' ' VAL . 5.1 m -132.31 -15.84 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.428 -172.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -61.09 110.11 1.28 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 172.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -70.48 -21.8 62.74 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -173.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -115.58 -7.62 12.18 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.476 -0.489 . . . . 0.0 111.941 -173.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 77.25 25.27 64.1 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.537 -0.84 . . . . 0.0 111.53 -176.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 36.8 m -62.13 -40.7 96.8 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 122.953 0.501 . . . . 0.0 112.282 -175.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 109.35 11.28 22.17 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 -174.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 0.5 OUTLIER -149.18 131.72 15.78 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 121.28 0.562 . . . . 0.0 110.742 179.737 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.582 ' CG2' HG23 ' A' ' 64' ' ' VAL . 2.9 t -99.1 126.76 52.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.619 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.445 ' HA ' ' CZ ' ' A' ' 24' ' ' PHE . 0.7 OUTLIER -101.48 178.87 4.52 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 176.235 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -47.79 -51.35 22.82 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -170.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -66.92 -41.75 86.52 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.183 0.516 . . . . 0.0 110.816 -172.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -60.92 -47.41 86.53 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.268 174.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.578 ' O ' ' HG2' ' A' ' 81' ' ' MET . 15.4 t80 -57.45 -35.5 70.21 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.806 177.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.592 ' HG ' HG22 ' A' ' 9' ' ' VAL . 2.6 tp -72.62 -43.63 63.04 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.143 -178.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.837 HG12 HG12 ' A' ' 64' ' ' VAL . 1.0 OUTLIER -59.06 -41.42 83.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 169.741 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.746 ' CA ' HG11 ' A' ' 64' ' ' VAL . 60.8 ttp -57.15 -46.03 83.08 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.521 178.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.637 ' O ' ' HG3' ' A' ' 85' ' ' MET . 24.9 mmt -55.18 -52.34 63.63 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 114.295 -1.32 . . . . 0.0 111.571 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.65 ' HA ' ' SD ' ' A' ' 85' ' ' MET . 2.5 m -69.48 -33.26 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.924 -176.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.819 ' HG3' ' O ' ' A' ' 79' ' ' VAL . 27.3 mtp-105 -58.22 -40.98 83.07 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.99 0.9 . . . . 0.0 108.695 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.725 ' HB3' ' O ' ' A' ' 148' ' ' ILE . 4.8 m -80.19 -8.48 59.46 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 113.79 -1.55 . . . . 0.0 111.658 -177.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.65 ' SD ' ' HA ' ' A' ' 82' ' ' VAL . 62.0 mtt -78.63 -45.34 21.77 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.69 ' HB3' ' HA ' ' A' ' 90' ' ' LYS . 35.3 tptt -58.11 -56.45 21.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.848 -169.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -172.69 170.42 4.73 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -170.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -48.65 -49.49 37.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.929 0.395 . . . . 0.0 110.348 175.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.5 t -100.8 8.06 43.43 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.97 -177.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.69 ' HA ' ' HB3' ' A' ' 86' ' ' LYS . 8.1 tmtt? 62.35 -77.92 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.016 0.526 . . . . 0.0 109.6 -174.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -162.93 21.96 0.18 Allowed Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 177.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -97.37 -166.29 1.37 Allowed 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.301 0.572 . . . . 0.0 110.757 -177.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.422 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 9.1 t80 -138.69 -176.83 4.61 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.023 -0.989 . . . . 0.0 108.426 177.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 138' ' ' PHE . 94.8 mttt 76.08 -65.25 0.32 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.222 0.609 . . . . 0.0 111.693 176.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 9.1 mtm180 -130.9 160.77 65.13 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-O 121.565 0.698 . . . . 0.0 110.009 176.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -87.22 55.88 3.07 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 124.24 3.294 . . . . 0.0 111.714 -178.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 1.4 m 53.22 74.57 0.29 Allowed 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.578 -176.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.462 ' HG ' HH21 ' A' ' 147' ' ' ARG . 25.4 mt 80.82 171.46 0.14 Allowed 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.283 -171.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -82.88 -66.42 0.89 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.127 0.489 . . . . 0.0 110.951 -177.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.472 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 0.1 OUTLIER -100.19 -39.38 8.09 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.568 -178.845 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -83.42 76.98 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.948 -164.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.462 HH21 ' HG ' ' A' ' 143' ' ' LEU . 5.6 tpp180 -124.34 105.12 9.2 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.354 171.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.725 ' O ' ' HB3' ' A' ' 84' ' ' SER . 11.1 mt -71.99 131.53 34.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.624 -178.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.539 ' HB2' ' HB2' ' A' ' 152' ' ' ALA . 20.4 m -82.56 134.21 35.19 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 167.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.661 ' O ' ' HG2' ' A' ' 154' ' ' MET . . . -46.53 -63.37 1.03 Allowed 'General case' 0 N--CA 1.468 0.426 0 O-C-N 123.345 0.403 . . . . 0.0 112.011 -172.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.589 ' HA ' ' HB2' ' A' ' 154' ' ' MET . 4.3 p-10 -71.88 -24.16 61.62 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.647 -175.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.627 ' HA ' HE21 ' A' ' 155' ' ' GLN . . . -55.35 -45.26 76.45 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.277 177.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . 0.533 ' HE1' ' HZ ' ' A' ' 77' ' ' PHE . 7.9 ptm -79.83 -31.98 40.61 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.155 175.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.661 ' HG2' ' O ' ' A' ' 150' ' ' ALA . 32.3 mmt -50.15 -50.35 49.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.028 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.627 HE21 ' HA ' ' A' ' 152' ' ' ALA . 13.1 pt20 -59.98 -56.23 24.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.877 0.37 . . . . 0.0 111.932 -178.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.513 ' H ' ' HG3' ' A' ' 155' ' ' GLN . . . -54.57 -40.88 69.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.14 -175.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.536 HD12 HG22 ' A' ' 26' ' ' ILE . 3.4 mm? -80.49 -60.84 2.17 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.39 0.614 . . . . 0.0 111.008 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.568 HD12 ' HB2' ' A' ' 162' ' ' ALA . 64.4 mt -65.81 -35.72 81.48 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.908 -1.042 . . . . 0.0 112.252 -169.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 76.14 -64.77 2.73 Favored Glycine 0 CA--C 1.499 -0.952 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.513 -176.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -148.15 45.66 1.07 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.333 0.587 . . . . 0.0 111.135 -175.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.713 ' HD3' ' O ' ' A' ' 161' ' ' ARG . 0.0 OUTLIER -133.13 -7.19 3.03 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.656 178.718 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.568 ' HB2' HD12 ' A' ' 158' ' ' LEU . . . -81.25 47.72 1.06 Allowed 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -172.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.53 164.69 2.57 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.731 0.3 . . . . 0.0 110.3 -178.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -101.63 37.99 3.38 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 175.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 49.4 p-80 . . . . . 0 C--O 1.246 0.894 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.233 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.7 ttt . . . . . 0 N--CA 1.477 0.885 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -65.14 110.58 2.58 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 175.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.463 ' HA ' ' CB ' ' A' ' 6' ' ' LYS . 4.2 p-10 -70.7 -6.95 41.07 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -172.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.478 HD11 ' NZ ' ' A' ' 90' ' ' LYS . 3.0 tt -61.36 -43.21 96.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 169.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.646 ' CE2' ' HG2' ' A' ' 83' ' ' ARG . 23.3 m-85 -80.63 -32.01 36.38 Favored 'General case' 0 N--CA 1.428 -1.57 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.694 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.643 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 19.3 ttpt -63.78 -35.95 82.3 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.648 172.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.74 -35.29 79.77 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.228 0.537 . . . . 0.0 110.22 176.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.527 ' O ' ' HG ' ' A' ' 12' ' ' LEU . . . -61.14 -39.74 91.22 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.562 171.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 5' ' ' TYR . 98.0 t -66.59 -35.61 75.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.291 175.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.643 ' HG2' ' O ' ' A' ' 6' ' ' LYS . 7.9 mm-40 -64.54 -27.38 68.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.421 178.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -82.77 -38.77 22.74 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.64 170.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.602 HD21 ' HE1' ' A' ' 85' ' ' MET . 32.9 mt -52.3 134.38 33.84 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-O 121.448 0.642 . . . . 0.0 109.853 177.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.529 HG23 ' OE1' ' A' ' 16' ' ' GLN . 6.7 p -82.3 164.71 20.94 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -55.12 -44.5 75.06 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 177.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -53.37 -49.62 66.79 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.046 174.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.553 ' HB3' HD22 ' A' ' 12' ' ' LEU . 37.6 mt-30 -58.24 -54.3 48.49 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.029 0.442 . . . . 0.0 111.755 178.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -55.55 -45.17 77.28 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.444 175.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -59.86 -41.33 91.23 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.713 176.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.412 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 6.2 tt0 -59.95 -44.17 94.57 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.23 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.41 ' HB3' ' HG3' ' A' ' 81' ' ' MET . 23.5 m-85 -73.08 -25.54 60.93 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.46 176.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.526 ' O ' ' HB3' ' A' ' 24' ' ' PHE . 0.6 OUTLIER -69.82 -46.51 65.51 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 176.161 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.583 ' O ' HG13 ' A' ' 26' ' ' ILE . . . -51.82 -43.47 63.13 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 113.632 -1.622 . . . . 0.0 110.103 171.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.672 ' O ' ' HB2' ' A' ' 27' ' ' PHE . . . -64.58 -43.42 93.91 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.536 177.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.526 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 35.5 t80 -51.12 -52.25 45.63 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.707 0.765 . . . . 0.0 109.466 171.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -51.99 -55.57 19.65 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 113.98 -1.464 . . . . 0.0 112.168 -177.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.641 ' HA ' ' HG ' ' A' ' 29' ' ' LEU . 21.3 mt -67.77 -38.0 79.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.17 -178.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.672 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 0.3 OUTLIER -54.43 -32.01 56.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.988 177.568 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 24' ' ' PHE . 22.2 m -112.4 24.47 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.028 -177.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.641 ' HG ' ' HA ' ' A' ' 26' ' ' ILE . 91.0 mt -76.48 117.01 17.7 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 170.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.16 13.29 54.81 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.29 -0.957 . . . . 0.0 111.454 -169.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -86.6 144.54 27.13 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.626 0.727 . . . . 0.0 111.428 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -80.46 -39.84 27.35 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.319 -1.309 . . . . 0.0 111.129 -178.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -105.3 -16.46 14.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.676 -177.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.7 -3.2 83.17 Favored Glycine 0 C--O 1.222 -0.599 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.576 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.8 m -111.91 150.56 30.3 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 174.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.6 ' O ' ' HA ' ' A' ' 71' ' ' THR . 57.1 mt -68.42 107.44 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.015 -175.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 96.9 p -89.05 -174.34 4.41 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 169.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 32.0 p -76.49 -25.37 54.18 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.2 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 30.6 tttm -59.1 -57.13 14.43 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 169.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.426 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 2.1 mp0 -52.59 -52.73 53.88 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.244 -0.889 . . . . 0.0 113.06 173.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.934 ' HG ' HD22 ' A' ' 57' ' ' LEU . 16.8 tp -61.0 -55.31 34.41 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.889 -177.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.09 -33.86 85.74 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.36 178.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.426 ' HB3' ' O ' ' A' ' 40' ' ' GLU . 6.3 tttp -52.14 -40.88 62.0 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.256 0.551 . . . . 0.0 110.124 169.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.596 HG21 ' CD2' ' A' ' 27' ' ' PHE . 33.9 t -76.0 -43.59 38.62 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.546 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.272 178.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.845 ' HE1' HG13 ' A' ' 148' ' ' ILE . 13.1 mmt -56.07 -34.53 66.03 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.473 178.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 65.6 mtp180 -62.28 -47.92 82.2 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.833 0.825 . . . . 0.0 110.098 172.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.512 ' HB3' ' HB1' ' A' ' 156' ' ' ALA . 2.5 mtm -61.58 -16.7 50.45 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 114.164 -1.38 . . . . 0.0 111.204 174.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.595 ' HB2' ' HA ' ' A' ' 45' ' ' MET . 17.9 mt -99.08 -8.2 25.62 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.901 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 106.0 -13.02 45.31 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 121.026 -0.606 . . . . 0.0 113.348 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.527 ' HB3' ' HD3' ' A' ' 52' ' ' PRO . 1.7 mp0 -99.62 -174.37 2.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.018 0.437 . . . . 0.0 110.506 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 29.1 p-10 -159.01 60.94 1.75 Allowed Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.057 167.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 1.13 ' HG2' HD21 ' A' ' 57' ' ' LEU . 43.7 Cg_endo -66.78 165.53 25.42 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.064 2.509 . . . . 0.0 112.066 -178.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.671 ' OG1' ' HG3' ' A' ' 56' ' ' GLU . 38.1 p -90.6 157.6 43.97 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.525 -172.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -50.21 -29.82 23.96 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.084 1.856 . . . . 0.0 111.223 173.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -59.3 -55.05 39.77 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.206 173.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.763 ' HB3' HG11 ' A' ' 146' ' ' VAL . 40.5 mt-10 -59.34 -49.0 79.5 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.749 176.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 1.13 HD21 ' HG2' ' A' ' 52' ' ' PRO . 80.7 mt -67.89 -29.06 68.07 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 114.606 -1.179 . . . . 0.0 112.776 -171.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.428 ' O ' ' HB2' ' A' ' 62' ' ' ASP . 36.9 tt0 -75.24 -27.17 59.39 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.061 -0.655 . . . . 0.0 110.064 -172.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.82 -36.55 28.21 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.036 -178.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.592 ' HE2' ' HB ' ' A' ' 148' ' ' ILE . 2.1 ttt -66.91 -37.02 83.57 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.846 175.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.6 HG23 HG23 ' A' ' 72' ' ' VAL . 5.5 mt -65.28 -50.36 73.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.351 169.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.677 ' HA ' ' HB3' ' A' ' 65' ' ' ASP . 12.9 t70 -56.6 -32.96 65.76 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.783 -177.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.566 ' OE2' ' HG2' ' A' ' 137' ' ' LYS . 4.1 mt-10 -44.85 -48.63 11.08 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.453 178.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.695 HG21 ' HB2' ' A' ' 80' ' ' MET . 28.6 m -110.6 -15.31 9.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.987 -176.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.677 ' HB3' ' HA ' ' A' ' 62' ' ' ASP . 61.7 t0 -64.76 107.61 1.49 Allowed 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 173.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -64.82 -38.36 90.73 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.793 -175.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -94.34 -7.94 40.34 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -175.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.42 24.0 77.0 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.357 -0.925 . . . . 0.0 111.74 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 65.0 p -73.49 -7.6 52.47 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -171.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.51 16.77 67.82 Favored Glycine 0 C--N 1.311 -0.826 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -175.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.6 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 0.7 OUTLIER -146.22 131.17 18.18 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.996 0.903 . . . . 0.0 111.594 179.567 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.6 HG23 HG23 ' A' ' 61' ' ' ILE . 1.0 OUTLIER -104.39 119.03 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 CA-C-N 114.301 -1.318 . . . . 0.0 109.588 -179.05 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.467 ' CG ' ' H ' ' A' ' 74' ' ' PHE . 18.9 t70 -98.57 -169.08 1.74 Allowed 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 177.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.467 ' H ' ' CG ' ' A' ' 73' ' ' ASP . 8.8 t80 -55.52 -57.46 11.81 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -167.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -65.41 -43.37 90.78 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.768 -172.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.482 ' HG2' ' HA ' ' A' ' 65' ' ' ASP . 2.5 mp0 -50.74 -55.17 17.93 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.481 0.657 . . . . 0.0 111.34 169.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.415 ' HZ ' ' SD ' ' A' ' 153' ' ' MET . 89.7 t80 -58.96 -43.28 91.26 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.104 -178.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.5 tp -60.62 -41.01 93.96 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.403 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.575 ' O ' ' HG3' ' A' ' 83' ' ' ARG . 46.9 t -54.21 -50.55 54.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 170.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.695 ' HB2' HG21 ' A' ' 64' ' ' VAL . 45.2 ttp -58.15 -38.06 75.85 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.56 -178.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.415 ' O ' ' HG3' ' A' ' 85' ' ' MET . 23.9 mmt -61.4 -44.11 97.71 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 115.173 -0.922 . . . . 0.0 112.184 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.673 ' HA ' ' HB2' ' A' ' 85' ' ' MET . 1.7 m -69.34 -28.98 40.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 121.048 0.451 . . . . 0.0 110.487 178.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.646 ' HG2' ' CE2' ' A' ' 5' ' ' TYR . 21.3 mtp180 -67.31 -40.64 86.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.978 -178.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.4 m -80.8 -12.44 59.44 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.898 174.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.673 ' HB2' ' HA ' ' A' ' 82' ' ' VAL . 1.0 OUTLIER -75.62 -63.38 1.31 Allowed 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 123.768 0.827 . . . . 0.0 112.273 -179.763 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.2 tptm -59.99 -37.55 80.0 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.286 0.565 . . . . 0.0 110.64 -173.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -153.65 167.88 28.08 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -175.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -64.91 -21.92 66.9 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.104 178.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.542 ' HA ' ' HD2' ' A' ' 137' ' ' LYS . 51.9 m -131.42 -36.02 1.29 Allowed 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.478 ' NZ ' HD11 ' A' ' 4' ' ' ILE . 0.4 OUTLIER 69.93 -77.42 0.05 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.046 0.539 . . . . 0.0 110.321 -176.316 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -151.54 46.23 0.61 Allowed Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 178.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.566 ' HG2' ' OE2' ' A' ' 63' ' ' GLU . 56.8 mttm -90.31 -105.96 0.09 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.542 -0.329 . . . . 0.0 110.856 -178.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.537 ' O ' ' HG2' ' A' ' 141' ' ' PRO . 16.2 t80 56.12 -161.49 0.19 Allowed 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -177.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.413 ' HB3' ' HD2' ' A' ' 141' ' ' PRO . 55.7 mtmt 58.22 -160.83 0.25 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 174.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.651 ' N ' ' HD2' ' A' ' 141' ' ' PRO . 92.2 mtt180 -55.87 -50.14 88.88 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 114.742 -1.117 . . . . 0.0 112.804 173.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.651 ' HD2' ' N ' ' A' ' 140' ' ' ARG . 1.7 Cg_endo -39.08 -63.2 0.28 Allowed 'Trans proline' 0 C--N 1.362 1.285 0 C-N-CA 124.068 3.179 . . . . 0.0 114.384 -177.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.522 ' OG1' ' HD3' ' A' ' 137' ' ' LYS . 97.5 m -100.92 117.39 34.88 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.475 0.655 . . . . 0.0 110.183 177.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.721 ' HB2' ' CG1' ' A' ' 146' ' ' VAL . 5.9 mp -92.05 176.06 6.64 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.381 -172.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.475 ' O ' ' HB2' ' A' ' 145' ' ' ARG . 89.0 mtm180 -88.77 57.76 4.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.836 -168.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.498 ' NE ' ' HA ' ' A' ' 52' ' ' PRO . 4.3 tmm_? 171.78 -58.57 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.791 0.805 . . . . 0.0 109.556 175.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.763 HG11 ' HB3' ' A' ' 56' ' ' GLU . 1.3 p -57.79 108.83 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 114.158 -1.383 . . . . 0.0 110.515 172.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.427 ' HA ' ' HD3' ' A' ' 147' ' ' ARG . 4.0 tpp180 -144.89 131.59 20.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.312 0.577 . . . . 0.0 112.39 -175.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.845 HG13 ' HE1' ' A' ' 45' ' ' MET . 4.2 mt -113.07 111.41 35.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.284 174.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 73.4 m -99.24 136.78 38.69 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 171.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.613 ' O ' ' HG2' ' A' ' 154' ' ' MET . . . -54.94 -58.31 8.14 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 118.295 0.498 . . . . 0.0 110.649 -173.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.523 ' O ' ' HG2' ' A' ' 155' ' ' GLN . 3.8 m-20 -52.46 -49.26 65.0 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 123.993 0.808 . . . . 0.0 110.587 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.13 -48.7 80.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.32 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . 0.87 ' HE2' HD23 ' A' ' 157' ' ' LEU . 0.0 OUTLIER -58.08 -47.19 83.95 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.946 -179.804 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.613 ' HG2' ' O ' ' A' ' 150' ' ' ALA . 22.6 mmt -56.78 -31.73 64.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.054 0.454 . . . . 0.0 111.235 178.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.523 ' HG2' ' O ' ' A' ' 151' ' ' ASP . 14.7 mm100 -77.2 -45.14 27.56 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.258 -0.428 . . . . 0.0 112.086 -177.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.512 ' HB1' ' HB3' ' A' ' 47' ' ' MET . . . -65.53 -47.55 75.54 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.947 -175.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.87 HD23 ' HE2' ' A' ' 153' ' ' MET . 3.1 mm? -86.28 -64.4 1.16 Allowed 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.193 0.521 . . . . 0.0 111.488 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.605 ' HB2' ' O ' ' A' ' 154' ' ' MET . 97.3 mt -62.24 -48.25 80.79 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.998 -167.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 34.54 -90.74 0.01 OUTLIER Glycine 0 C--N 1.343 0.956 0 O-C-N 124.857 1.348 . . . . 0.0 114.023 175.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -46.02 -46.47 16.57 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.914 0.886 . . . . 0.0 112.146 176.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.442 HH11 ' HD3' ' A' ' 161' ' ' ARG . 0.0 OUTLIER -94.96 -6.75 41.72 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.575 -174.751 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.565 ' HB2' ' HB2' ' A' ' 158' ' ' LEU . . . -76.04 -78.89 0.11 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.294 -176.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 49.06 45.6 22.87 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.437 0.637 . . . . 0.0 109.846 -174.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -74.38 172.92 51.79 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.225 -0.898 . . . . 0.0 113.19 -172.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 86.3 t60 . . . . . 0 C--O 1.247 0.934 0 CA-C-O 118.515 -0.755 . . . . 0.0 110.33 -178.27 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.442 ' O ' ' HB2' ' A' ' 2' ' ' ASP . 19.1 ttt . . . . . 0 N--CA 1.481 1.077 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.567 ' HB3' HG22 ' A' ' 4' ' ' ILE . 7.1 m-20 72.52 106.91 0.07 Allowed 'General case' 0 C--O 1.237 0.435 0 O-C-N 123.72 0.637 . . . . 0.0 110.005 -170.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.453 ' HA ' ' HB3' ' A' ' 6' ' ' LYS . 5.0 p-10 -69.74 -5.41 24.98 Favored 'General case' 0 C--O 1.224 -0.284 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -175.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.567 HG22 ' HB3' ' A' ' 2' ' ' ASP . 3.5 tt -57.77 -44.66 86.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 170.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.669 ' CE2' ' HG2' ' A' ' 83' ' ' ARG . 27.1 m-85 -82.0 -33.12 30.25 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.513 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.609 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 26.1 ttpt -64.45 -39.29 93.53 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.584 176.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.27 -29.65 70.94 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.27 0.557 . . . . 0.0 110.053 176.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.554 ' O ' ' HG ' ' A' ' 12' ' ' LEU . . . -66.97 -39.6 87.24 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.413 172.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.531 HG22 ' HG ' ' A' ' 78' ' ' LEU . 52.7 t -67.03 -32.29 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 121.232 0.539 . . . . 0.0 110.312 174.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.609 ' HG2' ' O ' ' A' ' 6' ' ' LYS . 8.7 mm-40 -67.94 -27.74 66.88 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.517 177.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -85.1 -37.52 20.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.116 171.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.658 HD21 ' HE1' ' A' ' 85' ' ' MET . 49.5 mt -53.7 135.01 41.73 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 172.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.795 HG23 HE21 ' A' ' 16' ' ' GLN . 16.4 p -86.24 157.0 20.05 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 -178.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -52.95 -37.46 61.08 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 118.97 0.805 . . . . 0.0 108.928 177.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -53.7 -57.26 11.46 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.979 170.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.795 HE21 HG23 ' A' ' 13' ' ' THR . 35.4 mt-30 -52.8 -52.58 56.24 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 121.381 0.61 . . . . 0.0 111.708 176.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 34.2 mtpt -56.38 -39.46 72.98 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 123.898 0.879 . . . . 0.0 112.283 176.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -69.04 -32.88 72.69 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 121.343 0.592 . . . . 0.0 109.817 177.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.484 ' HB3' ' O ' ' A' ' 16' ' ' GLN . 21.0 tt0 -62.23 -35.81 80.05 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 176.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.419 ' CD2' ' HG3' ' A' ' 81' ' ' MET . 28.9 m-85 -78.9 -29.42 44.3 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.469 174.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.494 ' O ' ' HB3' ' A' ' 24' ' ' PHE . 40.5 tptt -59.78 -51.73 68.52 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-O 122.363 1.078 . . . . 0.0 109.319 172.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.49 ' O ' HG13 ' A' ' 26' ' ' ILE . . . -51.46 -37.62 49.71 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 112.898 -1.955 . . . . 0.0 110.96 173.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.496 ' O ' HD13 ' A' ' 157' ' ' LEU . . . -73.39 -42.04 62.6 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.283 177.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.705 ' O ' HG22 ' A' ' 28' ' ' VAL . 23.4 t80 -48.89 -51.34 30.43 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.685 0.755 . . . . 0.0 108.997 171.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.452 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 19.2 t70 -49.23 -54.99 14.02 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.62 -1.627 . . . . 0.0 112.204 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.612 ' HB ' HD22 ' A' ' 157' ' ' LEU . 24.3 mt -74.48 -31.17 27.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.67 -175.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.66 ' CD2' HD11 ' A' ' 157' ' ' LEU . 0.2 OUTLIER -56.11 -31.92 63.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.292 176.596 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.705 HG22 ' O ' ' A' ' 24' ' ' PHE . 30.7 m -121.54 23.35 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.564 -172.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.579 ' HG ' ' HA ' ' A' ' 26' ' ' ILE . 82.7 mt -69.83 118.05 12.18 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 175.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.87 12.38 59.23 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.961 -174.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -86.02 155.31 20.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.073 0.463 . . . . 0.0 111.006 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -79.54 -45.44 19.23 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.151 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -100.04 -15.46 18.23 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.865 -175.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.7 4.53 85.15 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.203 -0.999 . . . . 0.0 112.329 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.446 ' HB2' ' HB ' ' A' ' 71' ' ' THR . 0.8 OUTLIER -122.18 149.98 42.87 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 175.627 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.678 ' O ' ' HA ' ' A' ' 71' ' ' THR . 58.8 mt -63.29 107.34 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.569 -0.742 . . . . 0.0 112.01 -169.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.443 ' H ' ' HB2' ' A' ' 40' ' ' GLU . 90.9 p -85.38 178.65 7.38 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 172.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.566 ' O ' HD13 ' A' ' 57' ' ' LEU . 16.9 p -71.74 -34.81 69.85 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.407 178.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -57.24 -56.12 25.98 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 171.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.629 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 0.9 OUTLIER -49.18 -48.44 45.12 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.592 -1.185 . . . . 0.0 113.456 172.181 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.801 ' HG ' HD22 ' A' ' 57' ' ' LEU . 24.5 tp -64.5 -51.3 63.67 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 121.029 -0.269 . . . . 0.0 110.531 -178.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.33 -40.11 74.96 Favored Glycine 0 C--O 1.224 -0.509 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.224 174.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.629 ' HB3' ' O ' ' A' ' 40' ' ' GLU . 14.7 tttp -48.31 -50.54 29.7 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.524 0.73 . . . . 0.0 110.812 172.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.601 HG21 ' CD1' ' A' ' 27' ' ' PHE . 2.6 t -71.83 -45.59 64.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.947 178.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.568 ' SD ' HG12 ' A' ' 146' ' ' VAL . 1.1 mmt -54.23 -37.71 64.93 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 176.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.707 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 97.1 mtt180 -61.32 -48.69 80.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.324 171.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.558 ' SD ' ' HA ' ' A' ' 44' ' ' VAL . 81.2 mtp -51.6 -29.19 16.49 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.907 0.86 . . . . 0.0 110.533 171.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.405 ' HB2' ' HA ' ' A' ' 45' ' ' MET . 16.6 mt -94.87 7.96 44.28 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 114.023 -1.444 . . . . 0.0 112.404 -172.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.34 -9.47 77.31 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.741 -0.663 . . . . 0.0 113.207 174.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.707 ' O ' ' HA ' ' A' ' 46' ' ' ARG . 74.8 mt-30 -102.12 -179.66 4.06 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -160.77 69.72 2.71 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-O 121.395 0.617 . . . . 0.0 109.577 167.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.881 ' HG2' HD21 ' A' ' 57' ' ' LEU . 9.8 Cg_endo -65.23 170.93 9.87 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.7 2.267 . . . . 0.0 111.564 176.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.624 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 4.4 p -96.21 157.1 36.19 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.023 -177.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.487 ' HA ' ' HB2' ' A' ' 57' ' ' LEU . 8.8 Cg_endo -50.68 -34.03 42.14 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.575 2.184 . . . . 0.0 111.348 175.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.507 ' O ' ' HG2' ' A' ' 59' ' ' GLU . 19.5 tt0 -54.67 -45.71 73.94 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.993 173.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.544 ' HB3' HG22 ' A' ' 146' ' ' VAL . 57.4 mt-10 -79.11 -28.43 42.97 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.408 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.881 HD21 ' HG2' ' A' ' 52' ' ' PRO . 65.4 mt -79.93 -35.58 37.55 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.147 -177.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -68.04 -32.89 73.56 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.609 -178.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.613 ' HB2' HD21 ' A' ' 143' ' ' LEU . 2.8 mm-40 -67.12 -49.88 63.36 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.351 0.596 . . . . 0.0 110.112 176.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.694 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 31.6 ttm -58.37 -37.9 76.16 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.931 -1.031 . . . . 0.0 112.201 175.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.538 HG13 HD22 ' A' ' 41' ' ' LEU . 47.3 mt -66.7 -47.88 81.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 174.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.63 ' HA ' ' HB3' ' A' ' 65' ' ' ASP . 23.4 t70 -58.08 -29.38 65.38 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.386 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.694 ' HB2' ' O ' ' A' ' 60' ' ' MET . 14.2 mt-10 -44.44 -51.5 8.64 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.674 177.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.874 HG21 ' HB2' ' A' ' 80' ' ' MET . 4.2 m -111.45 -18.34 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 CA-C-N 114.559 -1.201 . . . . 0.0 111.384 -175.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.63 ' HB3' ' HA ' ' A' ' 62' ' ' ASP . 44.0 t0 -60.01 122.59 14.71 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 172.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -85.69 -37.47 19.38 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.598 -177.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -91.03 -8.52 48.83 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.125 0.488 . . . . 0.0 110.974 -175.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 73.43 25.03 73.79 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.508 -0.853 . . . . 0.0 111.24 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 86.2 p -71.26 -8.86 56.44 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -170.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.68 11.61 83.8 Favored Glycine 0 C--N 1.316 -0.575 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -176.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.678 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 1.1 p -144.43 132.52 21.62 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.93 -0.635 . . . . 0.0 110.222 178.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.844 HG21 HG23 ' A' ' 64' ' ' VAL . 1.2 t -102.74 127.66 56.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.385 -178.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.523 ' HA ' ' CE2' ' A' ' 24' ' ' PHE . 20.1 t70 -105.05 -172.32 2.08 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.431 ' H ' ' CG ' ' A' ' 73' ' ' ASP . 19.3 t80 -58.1 -43.09 86.94 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -165.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -70.45 -48.47 55.76 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.246 -175.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.727 ' HB3' HG22 ' A' ' 72' ' ' VAL . 2.0 mp0 -50.0 -52.4 34.22 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.52 0.676 . . . . 0.0 111.677 169.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.516 ' HE2' ' CE2' ' A' ' 27' ' ' PHE . 89.6 t80 -60.01 -39.28 85.24 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.224 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.531 ' HG ' HG22 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -61.21 -41.53 97.0 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.737 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.478 HG12 HG12 ' A' ' 64' ' ' VAL . 53.3 t -60.24 -46.28 94.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.55 174.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.874 ' HB2' HG21 ' A' ' 64' ' ' VAL . 5.7 tmm? -63.82 -28.96 70.22 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.543 0.687 . . . . 0.0 109.926 -178.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.456 ' O ' ' HB2' ' A' ' 85' ' ' MET . 4.1 mmt -71.93 -37.69 69.97 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.675 -177.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.637 ' HA ' ' HB2' ' A' ' 85' ' ' MET . 2.0 m -76.72 -31.99 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-O 120.997 0.427 . . . . 0.0 110.528 177.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.669 ' HG2' ' CE2' ' A' ' 5' ' ' TYR . 24.9 mtp180 -62.42 -43.59 98.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.713 -176.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.409 ' HB2' ' HB2' ' A' ' 150' ' ' ALA . 13.2 m -81.05 -19.46 43.75 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.119 0.485 . . . . 0.0 111.334 174.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.658 ' HE1' HD21 ' A' ' 12' ' ' LEU . 0.1 OUTLIER -67.65 -49.43 62.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.867 -176.602 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.483 ' HB3' ' HG2' ' A' ' 90' ' ' LYS . 27.4 tptp -68.2 -44.76 75.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.857 0.361 . . . . 0.0 110.538 -176.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -175.77 158.03 2.07 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -62.72 -29.36 70.61 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.1 0.476 . . . . 0.0 110.542 177.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.5 m -96.06 5.95 49.95 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.711 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.581 ' HB3' ' O ' ' A' ' 83' ' ' ARG . 55.7 tptt -68.62 -68.65 0.38 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.925 0.393 . . . . 0.0 110.527 178.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.497 ' HA3' ' HB3' ' A' ' 83' ' ' ARG . . . -115.77 10.6 18.59 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.302 -0.951 . . . . 0.0 111.944 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.488 ' HE3' ' HB ' ' A' ' 148' ' ' ILE . 58.1 mttm -133.15 -163.12 1.31 Allowed 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 177.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.457 ' HB3' ' O ' ' A' ' 137' ' ' LYS . 81.5 t80 75.89 -30.56 0.19 Allowed 'General case' 0 N--CA 1.473 0.675 0 O-C-N 123.46 0.475 . . . . 0.0 110.95 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.468 ' CB ' ' HD2' ' A' ' 141' ' ' PRO . 94.9 mttt -74.88 -167.44 0.59 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.855 177.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.659 ' N ' ' HD2' ' A' ' 141' ' ' PRO . 99.3 mtt180 -48.76 -48.72 69.54 Favored Pre-proline 0 CA--C 1.54 0.581 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.986 172.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.659 ' HD2' ' N ' ' A' ' 140' ' ' ARG . 3.5 Cg_exo -37.95 -58.76 0.61 Allowed 'Trans proline' 0 C--N 1.366 1.463 0 C-N-CA 124.051 3.167 . . . . 0.0 113.775 -178.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 1.7 m -93.93 123.73 37.48 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.079 0.466 . . . . 0.0 110.186 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.71 HD22 ' H ' ' A' ' 143' ' ' LEU . 0.3 OUTLIER -74.03 -172.9 1.46 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.23 -178.816 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 4.0 tpp180 -69.34 -51.98 31.68 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -170.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.95 -65.06 0.72 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.18 0.514 . . . . 0.0 110.305 -178.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.568 HG12 ' SD ' ' A' ' 45' ' ' MET . 0.0 OUTLIER -47.6 137.26 3.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 114.382 -1.281 . . . . 0.0 112.261 -174.586 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.421 ' NH2' ' HA ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -170.12 101.23 0.28 Allowed 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 120.529 -0.469 . . . . 0.0 111.898 177.27 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.522 HG12 ' SD ' ' A' ' 60' ' ' MET . 27.2 mm -86.13 102.16 11.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 174.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.466 ' HB2' ' HB3' ' A' ' 152' ' ' ALA . 41.8 m -89.2 115.17 26.51 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 175.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.638 ' O ' ' HG2' ' A' ' 154' ' ' MET . . . -49.38 -57.86 6.15 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -169.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.665 ' O ' ' HG3' ' A' ' 155' ' ' GLN . 6.8 p-10 -55.37 -41.07 72.09 Favored 'General case' 0 C--N 1.323 -0.571 0 O-C-N 123.451 0.469 . . . . 0.0 110.622 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.491 ' HA ' ' HG3' ' A' ' 155' ' ' GLN . . . -71.54 -34.47 70.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.053 0.454 . . . . 0.0 111.269 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . 0.617 ' CE ' ' HG ' ' A' ' 157' ' ' LEU . 3.2 tpt -61.61 -40.87 96.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 122.008 0.909 . . . . 0.0 109.599 177.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.638 ' HG2' ' O ' ' A' ' 150' ' ' ALA . 13.2 mmt -66.07 -28.78 69.1 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.319 -1.309 . . . . 0.0 109.951 178.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.665 ' HG3' ' O ' ' A' ' 151' ' ' ASP . 39.5 mt-30 -73.77 -57.92 3.65 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.428 177.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.96 -52.11 61.73 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.9 -176.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.66 HD11 ' CD2' ' A' ' 27' ' ' PHE . 85.2 mt -78.99 -65.76 0.95 Allowed 'General case' 0 CA--C 1.501 -0.919 0 CA-C-O 121.026 0.441 . . . . 0.0 111.979 -176.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.459 HD21 ' N ' ' A' ' 23' ' ' ALA . 86.3 mt -66.74 -50.33 63.11 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.157 -0.929 . . . . 0.0 112.527 -159.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.501 ' O ' ' HE3' ' A' ' 163' ' ' LYS . . . 44.91 -95.28 0.01 OUTLIER Glycine 0 C--N 1.338 0.653 0 O-C-N 124.11 0.881 . . . . 0.0 112.035 -177.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -36.98 -54.78 0.94 Allowed 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 122.401 1.096 . . . . 0.0 111.472 168.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.458 ' HD3' HD11 ' A' ' 26' ' ' ILE . 45.0 mtp180 -89.97 5.27 47.19 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 113.358 -1.746 . . . . 0.0 111.051 -169.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -83.77 -15.14 49.6 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.98 0.419 . . . . 0.0 110.717 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.501 ' HE3' ' O ' ' A' ' 159' ' ' GLY . 0.0 OUTLIER -144.42 177.88 8.33 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.48 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -134.17 58.37 0.69 Allowed Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.127 -1.035 . . . . 0.0 112.525 178.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 23.7 p80 . . . . . 0 C--O 1.245 0.857 0 CA-C-O 118.729 -0.653 . . . . 0.0 109.347 176.925 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.759 ' SD ' ' HB2' ' A' ' 6' ' ' LYS . 1.1 tmt? . . . . . 0 N--CA 1.48 1.043 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -63.25 119.17 9.1 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 120.866 0.365 . . . . 0.0 110.785 -178.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.55 ' HA ' ' HB3' ' A' ' 6' ' ' LYS . 5.2 p-10 -71.73 -7.4 47.87 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -173.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.4 tt -60.4 -43.51 94.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 169.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.646 ' HA ' HG21 ' A' ' 82' ' ' VAL . 25.3 m-85 -81.54 -30.7 33.04 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.455 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.759 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 24.5 ttpt -65.06 -37.07 86.34 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.337 172.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.51 -28.31 69.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.336 0.588 . . . . 0.0 110.402 176.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 5' ' ' TYR . . . -67.76 -46.03 73.22 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.475 170.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.495 ' HA ' ' HB2' ' A' ' 12' ' ' LEU . 50.0 t -60.32 -32.38 50.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.571 174.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.582 ' HG2' ' O ' ' A' ' 6' ' ' LYS . 55.1 mm-40 -64.39 -29.43 70.49 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.722 177.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -82.06 -38.62 24.64 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.223 170.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.695 ' HA ' ' OE1' ' A' ' 16' ' ' GLN . 57.0 mt -55.74 135.86 51.3 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 121.942 0.877 . . . . 0.0 110.132 175.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.468 ' OG1' ' HG3' ' A' ' 16' ' ' GLN . 6.1 p -86.42 155.2 20.67 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -47.17 -42.95 20.68 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 118.629 0.65 . . . . 0.0 109.395 177.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -54.6 -56.74 15.8 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.447 173.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.695 ' OE1' ' HA ' ' A' ' 12' ' ' LEU . 88.4 mt-30 -52.37 -54.11 36.14 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 121.184 0.516 . . . . 0.0 111.626 176.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.469 ' HG3' ' HB3' ' A' ' 12' ' ' LEU . 32.8 mtpt -53.15 -48.92 67.56 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.748 175.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.427 ' O ' ' HB3' ' A' ' 21' ' ' LYS . 56.6 t30 -60.47 -34.75 74.48 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.839 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -66.75 -34.92 78.9 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.191 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -72.96 -31.64 64.7 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.622 174.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.568 ' HD3' ' CG ' ' A' ' 74' ' ' PHE . 29.3 tptp -61.13 -38.14 85.33 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.433 0.635 . . . . 0.0 110.187 172.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.449 ' O ' HG13 ' A' ' 26' ' ' ILE . . . -62.0 -38.37 88.34 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.493 173.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.565 ' O ' ' HB2' ' A' ' 27' ' ' PHE . . . -71.38 -38.38 71.53 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 177.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.648 ' O ' HG22 ' A' ' 28' ' ' VAL . 28.2 t80 -51.24 -53.75 32.37 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.878 0.846 . . . . 0.0 109.069 170.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -51.99 -53.59 39.87 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 113.646 -1.615 . . . . 0.0 112.239 -178.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.546 ' HA ' ' HG ' ' A' ' 29' ' ' LEU . 40.0 mt -70.79 -33.36 52.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.329 -177.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.565 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 0.4 OUTLIER -53.85 -42.87 69.0 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.356 175.461 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.648 HG22 ' O ' ' A' ' 24' ' ' PHE . 35.5 m -111.07 23.03 4.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.809 -174.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.546 ' HG ' ' HA ' ' A' ' 26' ' ' ILE . 19.7 mt -61.99 117.08 5.49 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.34 -0.944 . . . . 0.0 109.319 177.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.29 12.99 72.04 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.508 -176.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.41 154.13 38.92 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 117.129 0.464 . . . . 0.0 111.221 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -69.33 -46.43 67.1 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.868 -176.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -101.58 -16.62 16.69 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.899 -176.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.06 -0.58 86.16 Favored Glycine 0 C--O 1.224 -0.51 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.34 -175.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 52.5 m -108.49 151.25 26.32 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 174.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.575 HD12 HG12 ' A' ' 72' ' ' VAL . 61.3 mt -65.95 106.92 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.972 0 O-C-N 123.342 0.401 . . . . 0.0 110.311 -175.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 61.9 p -90.39 170.67 10.04 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 170.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.617 HG21 ' HG3' ' A' ' 58' ' ' GLN . 32.1 p -65.79 -21.82 66.52 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.359 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -60.28 -55.49 33.09 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.801 172.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.505 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 18.5 mm-40 -65.76 -38.16 88.3 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 177.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.942 ' HG ' HD22 ' A' ' 57' ' ' LEU . 4.1 tp -65.8 -49.82 66.9 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.729 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.651 ' O ' ' HG3' ' A' ' 46' ' ' ARG . . . -58.96 -42.4 96.81 Favored Glycine 0 C--N 1.315 -0.603 0 C-N-CA 120.295 -0.955 . . . . 0.0 111.525 173.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.514 ' O ' ' HB2' ' A' ' 46' ' ' ARG . 24.4 tttt -48.75 -47.96 41.22 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 123.623 0.769 . . . . 0.0 110.96 173.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.655 ' O ' ' HB2' ' A' ' 47' ' ' MET . 0.9 OUTLIER -74.6 -35.58 38.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.966 -178.48 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.487 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 11.8 mmt -63.7 -38.14 89.97 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 175.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.651 ' HG3' ' O ' ' A' ' 42' ' ' GLY . 62.0 mtp180 -55.74 -49.45 73.05 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.211 169.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.655 ' HB2' ' O ' ' A' ' 44' ' ' VAL . 0.4 OUTLIER -53.79 -28.78 36.99 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.638 -1.164 . . . . 0.0 111.686 173.281 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.487 ' HB2' ' HA ' ' A' ' 45' ' ' MET . 11.0 mt -97.18 -3.25 41.29 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-N 114.494 -1.23 . . . . 0.0 112.094 -171.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 105.55 -15.9 45.16 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 121.07 -0.586 . . . . 0.0 113.423 175.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.506 ' HB3' ' HD3' ' A' ' 52' ' ' PRO . 1.7 mp0 -91.33 -176.69 4.63 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.478 ' N ' ' HD3' ' A' ' 52' ' ' PRO . 6.9 p30 -155.4 60.32 2.51 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.665 0.745 . . . . 0.0 110.521 168.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.528 ' HB3' HG22 ' A' ' 146' ' ' VAL . 74.6 Cg_exo -53.19 173.12 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.948 3.099 . . . . 0.0 114.254 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.8 p -109.19 162.26 20.77 Favored Pre-proline 0 C--N 1.316 -0.849 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.891 176.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.62 -33.54 98.27 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 121.829 1.686 . . . . 0.0 110.557 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -48.53 -52.38 22.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.427 172.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 1.004 ' HB3' HG21 ' A' ' 146' ' ' VAL . 47.3 mt-10 -73.19 -45.72 54.76 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 113.869 -1.514 . . . . 0.0 112.879 -178.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.942 HD22 ' HG ' ' A' ' 41' ' ' LEU . 21.8 mt -64.36 -37.38 87.31 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.707 -177.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.617 ' HG3' HG21 ' A' ' 38' ' ' THR . 56.0 mt-30 -57.26 -33.49 67.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.418 0.151 . . . . 0.0 111.259 178.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.519 ' HG3' HD11 ' A' ' 143' ' ' LEU . 4.7 mm-40 -65.62 -48.72 71.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.145 0.498 . . . . 0.0 110.386 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.553 ' CE ' ' HB ' ' A' ' 148' ' ' ILE . 31.4 mmm -65.6 -37.1 85.68 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.202 178.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.641 HG13 ' O ' ' A' ' 57' ' ' LEU . 2.4 mt -65.28 -56.95 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 176.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.628 ' HA ' ' HB3' ' A' ' 65' ' ' ASP . 19.4 t70 -55.96 -35.93 67.26 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.484 -176.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.582 ' CD ' ' HZ3' ' A' ' 137' ' ' LYS . 9.9 mt-10 -47.94 -50.22 27.75 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.311 0.576 . . . . 0.0 111.915 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.733 HG21 ' HB2' ' A' ' 80' ' ' MET . 9.3 m -99.95 -20.03 5.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.39 -177.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.628 ' HB3' ' HA ' ' A' ' 62' ' ' ASP . 66.7 t0 -59.82 130.3 46.11 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.312 174.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -89.64 -32.87 16.87 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -175.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -105.32 -7.35 18.93 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -174.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 73.86 25.64 71.22 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.052 -1.071 . . . . 0.0 112.741 174.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 78.0 p -78.73 -1.54 35.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.217 0.532 . . . . 0.0 111.28 -176.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.31 17.67 70.95 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.38 -178.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 0.8 OUTLIER -141.41 133.15 27.23 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.74 0.781 . . . . 0.0 111.265 178.584 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.59 ' CG2' HG23 ' A' ' 64' ' ' VAL . 0.9 OUTLIER -101.17 117.0 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.736 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.473 ' HA ' ' CE1' ' A' ' 24' ' ' PHE . 20.4 t70 -96.75 -165.99 1.35 Allowed 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.568 ' CG ' ' HD3' ' A' ' 21' ' ' LYS . 10.3 t80 -56.01 -60.42 3.51 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -167.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.522 ' OD2' ' HG3' ' A' ' 1' ' ' MET . 13.9 t70 -63.27 -43.35 98.19 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.816 -173.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.511 ' O ' ' HB ' ' A' ' 64' ' ' VAL . 2.6 mp0 -50.85 -53.79 29.37 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.35 0.595 . . . . 0.0 111.422 170.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.403 ' HE2' ' CE2' ' A' ' 27' ' ' PHE . 73.0 t80 -56.59 -46.99 80.54 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.138 178.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.413 HD22 ' CE1' ' A' ' 74' ' ' PHE . 2.1 tp -60.73 -39.83 90.1 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.379 -178.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.564 ' O ' ' HG3' ' A' ' 83' ' ' ARG . 54.9 t -56.7 -50.93 72.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 170.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.733 ' HB2' HG21 ' A' ' 64' ' ' VAL . 44.8 ttp -56.89 -35.22 68.7 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.667 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.404 ' HB2' ' O ' ' A' ' 78' ' ' LEU . 27.3 mmt -63.76 -48.73 75.78 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.175 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.687 ' HA ' ' HB2' ' A' ' 85' ' ' MET . 0.6 OUTLIER -66.59 -31.49 53.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.524 177.434 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.594 ' HG2' ' CE2' ' A' ' 5' ' ' TYR . 29.9 mtp180 -62.13 -46.62 88.21 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.356 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 51.7 p -79.1 -6.47 56.53 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.014 0.435 . . . . 0.0 111.034 176.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.687 ' HB2' ' HA ' ' A' ' 82' ' ' VAL . 0.6 OUTLIER -83.31 -46.27 12.81 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.964 -177.364 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.517 ' HB3' ' HG2' ' A' ' 90' ' ' LYS . 0.9 OUTLIER -60.96 -46.98 88.52 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 121.361 0.6 . . . . 0.0 110.055 177.546 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.475 ' HB3' ' HA ' ' A' ' 90' ' ' LYS . 30.0 t70 -159.7 164.39 34.0 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -177.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -63.82 -28.54 69.93 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.96 178.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.2 t -113.85 -35.96 4.97 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.14 177.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.517 ' HG2' ' HB3' ' A' ' 86' ' ' LYS . 0.0 OUTLIER 68.52 -67.76 0.19 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.397 0.679 . . . . 0.0 111.969 176.162 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 158.17 43.5 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -173.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.582 ' HZ3' ' CD ' ' A' ' 63' ' ' GLU . 6.0 mtpm? -74.47 -35.51 63.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.766 -0.717 . . . . 0.0 111.638 -170.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -167.63 -50.52 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.827 0.346 . . . . 0.0 110.518 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -137.58 -69.2 0.46 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.408 176.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.638 ' N ' ' HD2' ' A' ' 141' ' ' PRO . 21.8 tpt180 175.4 -53.72 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.904 -173.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.638 ' HD2' ' N ' ' A' ' 140' ' ' ARG . 10.1 Cg_endo -51.54 -38.58 64.98 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 123.036 2.491 . . . . 0.0 113.083 -176.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.551 ' HB ' ' NE ' ' A' ' 147' ' ' ARG . 91.8 m 52.43 64.8 1.71 Allowed 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.756 0.788 . . . . 0.0 110.13 -177.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.538 ' HB2' ' HB ' ' A' ' 146' ' ' VAL . 2.8 mm? 58.43 15.97 3.85 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.656 179.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.471 ' NE ' ' HA ' ' A' ' 144' ' ' ARG . 5.1 tpm_? 63.29 -81.02 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.632 0.773 . . . . 0.0 112.191 175.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.411 ' CZ ' ' HA ' ' A' ' 52' ' ' PRO . 6.3 tmm_? -85.79 -17.63 35.22 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.465 0.65 . . . . 0.0 110.746 -174.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 1.004 HG21 ' HB3' ' A' ' 56' ' ' GLU . 19.7 t -96.21 75.07 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 121.68 0.752 . . . . 0.0 110.806 -171.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.551 ' NE ' ' HB ' ' A' ' 142' ' ' THR . 14.7 mmt85 -109.57 120.02 41.2 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 114.849 -1.069 . . . . 0.0 112.737 -174.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.553 ' HB ' ' CE ' ' A' ' 60' ' ' MET . 5.5 mm -95.69 120.93 45.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 169.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.45 ' HB2' ' HB3' ' A' ' 152' ' ' ALA . 42.6 m -119.43 113.98 21.61 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 119.447 -0.311 . . . . 0.0 110.296 -178.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.804 ' O ' ' HG2' ' A' ' 154' ' ' MET . . . -44.29 -59.59 2.31 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 123.702 0.626 . . . . 0.0 112.185 -172.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.661 ' O ' ' HG3' ' A' ' 155' ' ' GLN . 5.0 m-20 -50.84 -53.69 30.11 Favored 'General case' 0 CA--C 1.518 -0.265 0 O-C-N 123.28 0.362 . . . . 0.0 110.74 179.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.45 ' HB3' ' HB2' ' A' ' 149' ' ' SER . . . -59.84 -34.44 73.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.18 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . 0.611 ' HA ' ' CE ' ' A' ' 153' ' ' MET . 2.2 tpt -68.02 -36.17 79.49 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.777 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.804 ' HG2' ' O ' ' A' ' 150' ' ' ALA . 14.9 mmt -69.67 -27.77 65.3 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.516 178.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.661 ' HG3' ' O ' ' A' ' 151' ' ' ASP . 8.8 mt-30 -72.42 -57.94 3.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.225 177.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -62.52 -45.59 92.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.036 -174.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.561 HD11 ' CD2' ' A' ' 27' ' ' PHE . 22.6 mt -85.63 -66.62 0.88 Allowed 'General case' 0 CA--C 1.504 -0.814 0 CA-C-O 121.48 0.657 . . . . 0.0 111.768 -177.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.518 HD21 ' N ' ' A' ' 23' ' ' ALA . 83.7 mt -68.32 -48.43 64.89 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.954 -166.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 36.6 -90.05 0.01 OUTLIER Glycine 0 C--N 1.342 0.913 0 O-C-N 125.121 1.513 . . . . 0.0 113.582 174.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -36.62 -52.45 0.88 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 123.955 0.902 . . . . 0.0 111.785 171.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 44.2 ttt180 -86.19 -17.86 33.72 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.396 -176.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -64.25 -33.13 75.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.869 0.366 . . . . 0.0 111.254 -175.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.554 ' HD2' ' H ' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -116.16 6.82 14.0 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.034 0.445 . . . . 0.0 110.471 177.16 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -125.26 68.32 0.51 Allowed Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.359 -176.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 81.1 t60 . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.541 -0.743 . . . . 0.0 109.753 175.915 . . . . . . . . 0 0 . 1 stop_ save_